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Abstract 
Probe based confocal laser endomicroscopy (pCLE) is an in vivo device which 
acquires high resolution superficial optical biopsies. Despite encouraging data on 
neoplasia identification in colorectal polyps and Barrett’s oesophagus, there are 
many hurdles to pCLE advancement beyond the research arena. This thesis 
defines these challenges, and via 5 experimental chapters expounds four key 
requirements: 1) the effect of probe contact force upon the tissue needs assessing 
and harnessing; 2) the probe’s diagnostic accuracy needs to be improved; 3) the 
probe’s site of optical biopsy acquisition needs improved tracking; and 4) the 
ergonomics of pCLE optical biopsy need development.  
 
These challenges are elucidated and elaborated upon using two short clinical 
studies. A library is created describing the differences between normal, 
inflammatory and neoplastic endobronchial pCLE images from 16 pCLE 
bronchoscopies, but an inability to distinguish between endobronchial carcinoma 
and carcinoma-in-situ is shown. The tolerability of pCLE imaging of the 
colorectum over five sessions during chemoradiotherapy for advanced rectal 
cancer is explored, and possible morphological changes are described. 
 
The accuracy of bronchoscopic pCLE for diagnosing peripheral lung diseases is 
investigated. In 116 bronchopulmonary segments in 43 subjects pCLE safely 
provided video sequences for comparison with computed tomography, 
transbronchial biopsy, and bronchoalveolar lavage. With pCLE, non-
emphysematous peripheral diseases tend to create diminishment of the distinct 
elastin alveolar microstructure, and distinction between microvessels and septal 
walls becomes more difficult. Alveolar septal wall density is reduced in severe 
emphysema, and the pleura is demonstrated beyond bullae in two patients. 
Though assessors have some consistency, they are shown to be unable to 
accurately judge the category of emphysema severity in this small study. 
Intravenous fluorescein is shown to cause “white-out” and thus provide no 
advantage for pCLE imaging of the pulmonary lobule. 
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At least in the laboratory, this thesis demonstrates that mucosal distension/colonic 
inflation and probe contact force significantly affect the consistency of pCLE 
images in terms of gland diameter and intergland separation. It also introduces the 
concept of pCLE elastography: if a device attaches to the probe to enable it to 
produce a sinusoidal force upon the tissue, the amount with which the glands 
individually expand/shrink and separate is altered if the mucosa is artificially 
stiffened to mimic disease. 
 
It suggests there is potential for improving pCLE ergonomics, and tracking (at 
least within peripheral lung). A transvaginal flexible endoscopic robot is predicted 
to reach 88% of a human peritoneal cavity for pCLE periteoneoscopy; a porcine 
feasibility study provides interpretable abdominal cavity images. Probe tracking in 
the peripheral lung is especially difficult and important in heterogeneously 
distributed disease. A study using ex vivo porcine lung assesses the predictability 
of probe tip destination; it shows that only half of the probe deployments beyond 
the most distally visible bronchus have a single possible path. 
 
Finally, a role for pCLE evaluation of chronic radiation proctopathy is proposed. 
26 patients with symptomatic disease are pCLE sigmoidoscoped with correlative 
pinch biopsy. Macroscopically severe disease is associated with pCLE sequences 
showing glandular disruption and vasculopathy (dilated or absent vessels; 
“dilabscence”). A score from 16 histological features correlates with pCLE vessel 
dilabscence and glandular disruption suggesting pCLE may have a role in the 
longitudinal monitoring of this unpleasant disease. 
 
Overall, the thesis approaches pCLE challenges from several angles in both 
laboratory and clinical settings, and the data are often descriptive and preliminary. 
However, it significantly expands upon the understanding of pCLE in peripheral 
and endobronchial lung disease, describes two novel clinical roles for pCLE 
(radiation proctopathy and evaluation of neoadjuvant therapy response), and 
contains the first description of two technical pCLE developments (elastographic 
interrogation and robotic actuation). The time is fast approaching when one of 
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these clinical niches capitalises on pCLEs enormous potential for mainstream 
deployment. 
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Chapter 1  Introduction and Overview  
1.1  Introduction - the Development of pCLE 
The scanning confocal microscope is a well established laboratory imaging tool that 
provides optical sections with superior resolution to conventional microscopes courtesy 
of its confocal pinhole that rejects out of focus light. However, being relatively unwieldy, 
its in vivo application is limited to externally accessible tissues such as skin, eye and the 
oral cavity[1]. Improvements in optic fibre technology have enabled the probe based 
confocal endomicroscope (pCLE) to be developed in the last decade; thousands of fibres 
individually act as a light source and detection pinhole. By inserting the probe through the 
working channel of an endoscope, pCLE provides impressive, near histological grade 
images of mucosal surfaces. It is therefore one of several technologies competing to 
provide clinically useful “optical biopsies” - nondestructive in vivo in situ assessment of 
mucosal microarchitecture and function using light to provide realtime tissue diagnosis. 
The scientific and clinical communities are keen for CLE to fulfil its potential (Figure 
1.1) and have described typical pCLE imaging in health and disease of several organs 
including most areas of the gastrointestinal and respiratory tracts.   
 
 
Figure 1.1 The rapidly escalating interest in miniaturised confocal microscopy is demonstrated 
with a graph showing the number of new annual publications listed on PubMed. This is contrasted 
with titles containing "endoscopy", showing a more typical growth in other technological research. 
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Nevertheless, as with most optical biopsy technologies, there are several hurdles that are 
still obstructing its expansion from a fascinating but expensive toy used by academics in 
the research setting to a device with widespread uptake that has genuine impact on patient 
management. Indeed, a survey of gastroenterologists from the 31 North American 
institutions listed by Mauna Kea Technologies as using pCLE in September 2010 showed 
that 40% considered the technology an experimental/research tool and 63% felt it was not 
ready for primetime[2]. The technical challenges and optimal clinical applications of 
pCLE form the subject of this thesis.  It aims to identify (and attempt to address) the main 
challenges to pCLEs development, and in so doing, identify new niches for its 
advancement. 
 
1.2  A Synopsis of Each Chapter 
Chapter 2: This includes a comprehensive review of pCLE, describing its historical 
development, and the state of the art for pre-clinical and clinical applications. The chapter 
discusses the challenges which pCLE present to the scientific and clinical community, 
amongst which are: 
1. Force (probe contact force is currently difficult to control and this may affect the 
resulting image) 
2. Accuracy (the device is useless without adequate confidence in its diagnostic 
abilities) 
3. Tracking (the operator must be able to define exactly from where  the optical 
biopsies have been obtained) 
4. Ergonomics (the probe must be easily manipulated to the relevant target) 
 
Chapter 3:  Here, two largely descriptive clinical studies are used to explore the ubiquity 
of these four challenges in vivo. For the first study, healthy and diseased endobronchium 
were pCLE imaged and pinch biopsied during 16 bronchoscopies. For the second study, a 
patient undergoing neoadjuvant chemoradiotherapy for an advanced rectal tumour 
underwent flexible sigmoidoscopy on five separate occasions with pCLE imaging of 
tumour, and healthy mucosa within and outwith the radiation zone. It is shown that in 
these two clinical situations the effect of probe contact pressure needs further evaluation 
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(force), that many tissue differences are not always sensitively and specifically identified 
by the probe (accuracy), that it is difficult to accurately obtain from the same identical 
mucosal target either a) correlative pCLE and pinch biopsies, or b) pCLE biopsies at 
sequential endoscopies (tracking), and that unpredictability with image output may relate 
to ergonomics. 
 
Chapter 4: The pCLE images of healthy peripheral lung are particularly striking. This 
chapter aimed to see if diagnostic accuracy could be enhanced by focussing on the 
imaging of parenchymal lung diseases (with or without the addition of intravenous 
fluorescein – a contrast agent that is employed in gastrointestinal pCLE). pCLE 
sequences were safely acquired from 116 bronchopulmonary segments of healthy lung, or 
lung affected by emphysema or other inflammatory/neoplastic conditions diagnosed using 
radiology, histology and microbiology. With pCLE, alveolar septal wall density was less 
with severe emphysema, and the lung pleura was observed beyond bullae which had been 
entered with the probe. However, despite some intrassessor consistency, it was not 
possible for briefly trained assessors to reliably discern different grades of emphysema. 
Other parenchymal lung diseases caused a marked non-specific loss in the overall 
autofluorescence, and a reduction in the discriminability between alveolar septal walls 
and microvessels. Fluorescein did not improve accuracy. In terms of tracking, it was 
apparent that there is an occasional inability to ascertain if “no image” is due to the 
arrival of the probe in a bullous, or due to inadequate probe deployment.  
 
Chapter 5: Evidence in the literature (mostly circumstantial) and in previous chapters 
implies that probe contact force may have an effect upon the pCLE image captured in 
different tissues, potentially with consequences for standardisation of the technique for 
image acquisition, to ensure image differences can be reliably assumed to be exclusively 
caused by altered tissue microarchitecture. In this chapter, in an in vivo pig study it was 
shown that the mean diameter doubles and the mean number of glands per field decreases 
threefold between collapsed and hyperinflated colon. In a carefully controlled ex vivo 
experiment, increasing probe contact force produced images with glands that were larger 
in diameter but fewer in number.  
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Aware that information regarding tissue characteristics is gleaned from manual palpation 
or compression during ultrasonography, it was next ascertained whether pCLE could 
produce similar elastographic information regarding mechanical phenotype to potentially 
enhance diagnostic accuracy. Indeed, with a sinuisoidally varied contact force, the 
percentage change in gland area was 2½ times greater for fresh ex vivo tissue than 
formalin soaked tissue (a simple disease model). The percentage change in intergland 
separation was fivefold greater in fresh tissue. 
 
Chapter 6: The pCLE probe must be easily and accurately navigated to the tissue target, 
often for very gentle translation across the tissue surface to create “mosaics”. Ergonomic 
obstacles to this are in the literature and preceeding chapters, leading to the hypothesis 
that robotic actuation could be advantageous. This chapter starts with a theoretical 
analysis of human pCLE peritoneoscopy and then describes a transvaginal porcine 
feasibility study in which a seven degree of freedom robot is manipulated within the 
peritoneal cavity to obtain interpretable mosaics of liver, spleen and abdominal wall.  
For reliable image interpretation, the site from which the optical biopsy has been taken 
must be clear. This probe tracking is especially difficult within the peripheral lung, and 
particularly problematic in a heterogeneously diseased segment. The second part of this 
chapter is designed to assess the predictability of the probe tip destination in an ex vivo 
lung porcine model (it does not confront gastrointestinal pCLE tracking). It concludes 
that only half of deployments beyond the most distally visualised part of the bronchial 
tree have a single possible path.  
 
Chapter 7: Having shown in chapter 3 feasibility for pCLE imaging in acute radiation 
proctopathy, with excellent displays of vascularity, the intention in this chapter was to 
establish if pCLE accuracy can be maximised by focussing on the assessment of chronic 
radiation proctopathy, a poorly understood condition with (at least in part) a vascular 
aetiology. 26 patients with symptomatic disease underwent multiple pCLE and pinch 
biopsies during flexible sigmoidoscopy. Macroscopically more severely diseased areas 
were associated with pCLE sequences showing dilated or absent vessels (“dilabscence”), 
and morphological distortion of glandular structure. Following detailed microscopic 
analysis of the biopsies, a score from 16 histological features correlated with pCLE vessel 
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dilabscence and glandular disruption, suggesting pCLE could have a role in the 
assessment of this debilitating condition. 
 
Figure 1.2 The experimental chapters develop from four key themes identified in chapter 2. 
 
1.3 The Main Original Contributions that Advance pCLE 
Understanding in this Thesis and their Clinical Impact 
pCLE is a new technology with the majority of publications centred around colorectal 
polyps and Barrett’s oesophagus. This thesis was highly original, focussing on novel or 
relatively unexplored avenues; therefore data are often preliminary and of a hypothesis 
generating nature. Nevertheless, it significantly contributes to the understanding of pCLE 
in both endobronchial disease and different peripheral lung diseases, leading the way for 
safer realtime more accurate diagnosis in respiratory medicine. It outlines two completely 
novel clinical roles for pCLE (the evaluation of efficacy of neoadjuvant 
chemoradiotherapy towards rectal cancer, and the assessment of chronic radiation 
proctopathy), and contains the world’s first description of two technical pCLE 
developments (robotic actuation and the assessment of tissue phenotype using the 
principles of elastography) which have the clinical potential for enhancing pCLE 
ergonomics and accuracy respectively.  
The ten main contributions of this thesis are: 
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1. The creation of a library of normal, inflammatory and neoplastic endobronchial 
pCLE images. 
2. The first description of pCLE imaging in endobronchial amyloidosis and 
tracheobronchopathia osteochondroplastica. 
3. The ascertainment that pCLE is a feasible and tolerated technique for 
longitudinal colorectal imaging during neoadjuvant chemotherapy for advanced 
rectal cancer, but that any temporal superficial histological changes are not easily 
discernible with pCLE. 
4. The thesis shows that despite showing realtime imaging of the destruction of 
septal walls with the probe, pCLE imaging in peripheral lung diseases is 
tolerated and safe. Severe emphysema and bullae cause obvious alterations to 
pCLE images of the peripheral lung but trained image interpreters cannot 
accurately distinguish between grades of disease. Other peripheral diseases cause 
a non-specific attenuation of septal wall clarity. Fluorescein has no role in 
peripheral lung disease imaging.  
5. The finding that tissue taughtness affects the images generated; in a porcine in 
vivo study, by increasing colonic inflation, the mean gland diameter increased, 
but the number of glands per field of view decreased.  
6. Quantification of the effects of extremes of probe contact force upon ex vivo 
colonic mucosa, with regards to the gland diameter and number of glands per 
field of view.  
7. The first description of pCLE elastography as a feasible future direction; a 
cyclical contact force upon colonic mucosa alters gland area and interglandular 
separation to a far greater extent in fresh tissue than tissue that has been 
toughened. 
8. The finding that transvaginal pCLE peritoneoscopy with a robotic endoscope is 
feasible and safe in a pig and produces interpretable images of abdominal organs. 
9. The conclusion that there is inherent unpredictability of the terminal destination 
in peripheral lung of a 1.4mm diameter pCLE probe. In an ex vivo porcine 
model, half of the deployments into the distal bronchial tree beyond the furthest 
bronchoscopically visualised branch have multiple possible routes to an acinus. 
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10. A detailed analysis of a future role of pCLE in the assessment of chronic 
radiation proctopathy. Glandular disruption, and microvessel dilatation or 
absence on pCLE correlate with severity of disease as defined by either the 
endoscopic view or a novel histological score. 
 
 
1.4 Main Publications Associated with this Thesis 
Only peer reviewed journal publications, first name international/national presentations 
and a book chapter have been included in this list. 
 
Chapter 2 
• Newton R, Yang G-Z. In Vivo Imaging for Cell Therapy. In: Cell Therapy for 
Lung Disease. Ed. Pollack J. Ch 15, Imperial College Press, 2010. 
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Chapter 2  The brief history of probe-
based confocal endomicroscopy 
2.1 Introduction 
2.1.1  Conventional tissue biopsy 
The concept of acquiring samples of internal tissue for subsequent analysis has been 
around since the tenth century when the Arabic physician Abulkasim distinguished 
between different types of goitre using a hollow needle to puncture the thyroid[3]. A 
millennium later, the definitive diagnosis of many human diseases still requires analysis 
of tissue obtained from biopsy. This interrogation of tissue and cellular anatomy within 
thin slices (sections) of biopsy material using a light microscope, or an electron 
microscope, is the science of histopathology; where aspirated lone cells are studied it is 
known as cytology. Usually, tissue biopsy material is preserved (fixed) using formalin or 
glutaraldehyde to cross-link proteins. It is then dehydrated with ethanol, before being 
embedded in wax or acrylic resin, enabling it to be typically visualised as 5µm thick 
vertical slices cut with a microtome. Conducting microscopy using visible light, these 
biological tissue slices have little inherent contrast; therefore stains are used, the industry 
standard being haemotoxylin and eosin: haemotoxylin is blue, and being alkaline it has a 
resulting affinity for staining nuclei; the acidic eosin stains cytoplasm pink.  
However, depending on the method employed and the organ being sampled, there are 
risks to the patient including bleeding, perforation, and infection. Furthermore, there are 
inherent delays and cost implications with the preparation and reporting of tissue samples. 
Due to a lack of quantitative parameters in many fields of histological analysis, 
interobserver and intraobserver variability is an inherent problem. Even intraoperative 
“frozen sections”, sent for histopathological analysis to exclude metastatic deposits, 
confirm adequate clearance of a tumour, or provide lymph node staging information to 
guide the operation, take around 30 minutes to process and do not always provide 
adequate accuracy[4]. Molecular analysis of biological specimens during surgery is 
yielding some promising results: for example, one-step nucleic acid amplification 
(OSNA) to intraoperatively assess axillary sentinel lymph nodes for the mRNA of 
cytokeratin 199, and therefore evidence of breast cancer metastasis,  shows an excellent 
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concordance with subsequent histopathology but again takes over 30 minutes to 
perform[5]. Extracted histology specimens are also susceptible to sampling error, false 
negatives[6], as well as minor morphological alterations from dehydration and chemical 
fixation and they can never retain information about dynamic in vivo processes such as 
blood perfusion or cardiorespiratory movement. For some target organs, less invasive 
alternatives to tissue biopsy are being pursued. For example, liver biopsy is particularly 
risky[7], and a proposed alternative could be the creation of a scoring scheme based 
around variables such as serum biomarkers, cross-sectional imaging, liver stiffness 
measurement, and portal pressure measurement[8]. Such an approach would theoretically 
enable longitudinal assessment but is not sufficiently accurate to be used alone at present.  
 
2.1.2  Optical biopsy methods 
The exploitation of the properties of light has always been an integral part of medicine 
and surgery ever since Celsus described rubor (redness) as being one of the cardinal signs 
of inflammation 2000 years ago; anaemia, jaundice, and cyanosis are further obvious 
examples. Bozzini’s “Lichtleiter” in 1806 allowed these observations to be extended into 
body cavities, and provided the basic principle of endoscopy[9]. Modern white light 
endoscopy provides in-situ imaging, but in its purest form only displays reflected visible 
light, which limits diagnostic power, often acting as a means to survey and direct tissue 
biopsy. 
Developments in fibre optics, light sources, detectors, and molecular biology have 
enabled a plethora of techniques that provides non-destructive in situ evaluation and 
assay of epithelial surfaces, and in some cases underlying structures. This study of the 
interaction between light and tissue to acquire information about morphology and 
function without subjecting the patient to the risks of extracting tissue is the subject of 
“optical biopsy” research[10]. Many of these biophotonic technologies are integrated 
within endoscopes, or designed as a probe for use with conventional endoscopes. They 
can be imperfectly dichotomised into wide-field and narrow-field devices.  
Wide-field surveillance methods to highlight potential pathology include a) 
chromoendoscopy, where absorptive or contrast agents are applied topically to mucosal 
surfaces, b) techniques which narrow the bandwidth of light components to preferentially 
highlight blood vessels such as narrow band imaging[11, 12] or “Fujinon Intelligent 
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Colour Enhancement” system (FICE)[13], c) autofluorescence endoscopy which displays 
the fluorescence from endogenous fluorophores[14-16], and d) high definition/resolution 
or high magnification endoscopy[17]. 
Narrow-field devices, often probe-based, that can only interrogate smaller areas, provide 
either a spectroscopic assessment[18], or an image with a magnification and spatial 
resolution close to that of histology. These high resolution imaging devices include 
optical coherence tomography (OCT), endocytoscopy and confocal endomicroscopy 
which are now discussed in more depth. 
 
2.3 Optical Biopsy with Optical Coherence Tomography 
OCT is being explored for several clinical niches including gastroenterology[19], 
ophthalmology[20], dermatology[21]  and vascular medicine[22, 23]. Analogous to 
ultrasonography, a catheter tip transmits broadband near infrared (NIR) light through an 
optical fibre to detect the reflectance and backscattering properties of the tissue, each of 
which is influenced by changes in tissue density or refractive index boundaries such as 
cell membranes or structures[24]. By measuring the echo time delay between 
transmission and detection using a technique called low coherence interferometry, an 
optical depth scan may be recorded. A B-scan may then be performed by translating the 
optical probe, allowing for instance a circumferential transluminal cross-sectional 
tomographic image to be constructed[25]. Current technology only provides 2-3mm of 
penetration, which is adequate to image the mucosa and basement membrane within most 
organs. As the diffraction limit and coherence length of the light source is a fraction of 
the acoustic waves’ used in ultrasound, the lateral and axial resolution of OCT can be as 
good as 5µm, which is 10-20 times better than high frequency ultrasound[26], though 
commercially 15µm resolution is more realistic, which still enables OCT to image to the 
level of individual nuclei[27]; for comparison, the human eye can only discriminate to a 
resolution of about 76 microns at 25cm.  
OCT displays particular promise in the lung; ex vivo the layered structure of the 
bronchial tree is visible, demarcating the mucosa, lamina propria, and the underlying 
perichondrium and cartilage. The boundary of the epithelium and cartilage is particularly 
distinct, and it also has sufficient resolution to outline mucous glands and layers of 
smooth muscle within the submucosa[28]. The structure of the alveoli adjacent to 
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peripheral airways has also been shown[29]. In vivo, Michel et al. showed that these 
tissue boundaries are destroyed by endobronchial tumours[30], and during fluorescence 
bronchoscopic examination by Lam et al., radial OCT enabled accurate measurement of 
the respiratory epithelium thickness[27]. Breaches of the highly scattering basement 
membrane allowed differentiation between invasive neoplasia (although not histological 
subtype), carcinoma-in-situ, dysplasia and metaplasia (Figure 2.1). However, the 
resolution is currently inadequate to differentiate between grades of dysplasia.  
 
2.4 Optical Biopsy with Endocytoscopy 
The endocytoscope is a system by which real-time in vivo imaging of tissues at a cellular 
level can be achieved under white light conditions. It relies upon the principle of contact 
microscopy, where an image is seen for as long as the probe remains in contact with the 
tissues, and was first used for microhysteroscopy[31]. It has since been used 
predominantly as a research tool in the investigation of cancer in the gastrointestinal 
tract[32-34], and also in the urinary tract[35].  Detailed images of the nuclei allow clear 
distinctions between normal and malignant cells, with sharp borders between atypical and 
normal epithelium, differences in cellularity, and differences in the sizes and shapes of 
the nuclei[36]. The technique seems particularly effective in the colon and 
oesophagus[37].   
Application of a 0.5-1% methylene blue (MB) solution to the area of interest allows sharp 
visualisation of cellular structures down to the level of the nucleolus. Mucous and blood 
can impair the contrast agent application and prevent suitable images being obtained. This 
can be partly overcome by the use of mucolytic agents[38].  
More recently, endocytoscopy of the airways has shown promise[39] (XEC-300-U/F, 
Olympus, Tokyo, Japan), and is available either as an integrated system with normal and 
endocytoscope functions (Figure 2.1), or as a dedicated ultrafine probe with a diameter of 
3.2mm that can be used via the biopsy channel of a larger bronchoscope[40]. Both 
systems have a spatial resolution of 4.2µm and a magnification of x570, with fields of 
view of 400µm x 400µm and 300µm x 300µm respectively.   
Contrasting with OCT, endocytoscopy can only image the most superficial 50µm of the 
tissue. Early work suggests in vivo endocytoscopic images of endobronchial tumours, 
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sprayed with MB, resemble conventional histology, with an increase in cellular density, 
polymorphic cells and an increased nuclear to cytoplasm ratio when compared to images 
of normal mucosa[40, 41].  
 
Figure 2.1 Endobronchial OCT. A, B & C show mild moderate and severe dysplasia respectively 
with corresponding H&E histological images underneath (x20 magnification). Worsening 
dysplasia is demonstrated by increasing thickness of the epithelium (e) above the highly scattering 
basement membrane (bm). The epithelial nuclei become more visible as black dots with moderate 
and severe dysplasia (adapted from Lam et al. 2008[27]). Endocytoscope images using methylene 
blue as the contrast agent are shown of (D) healthy bronchial mucosa and (E) a right upper lobe 
endobronchial tumour with a marked heterogeneous epithelial appearance. The endocytoscope 
distal end is inset. The tumour’s white light endoscope image (F) is shown with the 
autofluorescence image (G), with malignant area indicated by arrow.  
 
There have been many successful attempts at using a “red flag” wide-field technique to 
highlight areas for closer inspection by narrow field optical biopsy methods. For example, 
Kiesslich et al. showed that in colonoscopic surveillance for ulcerative colitis, by using 
confocal endomicroscopy at sites flagged by chromoendoscopy, the numbers of biopsies 
required could be reduced, but the yield of neoplasia increased [42].  
 
 
2.5 The Desktop Confocal Microscope 
Marvin Minsky developed the confocal laser scanning microscope (CLSM) in 1955 
whilst he was a junior fellow at Harvard University[43]. As a desktop instrument it 
became popular in the 1980s to perform high resolution, blur free fluorescence 
microscopy and immunohistochemistry on excised tissues. These sharp images 
representing a thin cross-section of tissue are created by using pinhole apertures in front 
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of both the light source and the detector to exclude most of the light from the specimen 
that is not from the microscope’s focal plane (Figure 2.2)[44]. The pinholes reduce the 
number of detectable photons, thus necessitating the provision of an intense light - 
initially a zirconium arc lamp and now a laser. Some CLSM machines record reflected 
photons, but most record the fluorescence from endogenous or exogenous fluorophores. 
The wavelength of the photons emitted from the laser in the CLSM is often adjustable but 
will always remain shorter than the lower energy photons emitted by the fluorescing 
specimen as the fluorophore electrons return to their ground state from their singlet 
excited state. As an example, fluorescein, a widely used exogenous fluorophore, featuring 
heavily in the subsequent chapters, emits green light when illuminated/excited by shorter 
wavelength blue light. Whilst the dichroic (dichromatic) mirror transmits the outgoing 
laser beam, the longer wavelength fluorescence that returns is reflected to a detector such 
as a photomultiplier tube. At any instant only one point is being examined, so standard 
visualisation of a complete optical plane requires scanning in two axes, with subsequent 
image computation. To scan the specimen, Minsky initially used solenoids to translate the 
stage in x and y axes, obtaining a new frame every 10 seconds. Nowadays, rapidly 
oscillating mirrors are used to provide point-by-point illumination and detection of 
fluorescence over the specimen. By assembling multiple optical slices obtained at narrow 
intervals up the vertical (z) axis, modern CLSM software can then create a 3-dimensional 
representation of the specimen. 
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Figure 2.2 A schematic representation of how the CLSM focuses light of a single wavelength 
upon the tissue under investigation and detects the fluorescence emitted. Only light from the 
required optical plane is detected; “out of focus” light is blocked from detection by the pinhole. 
 
2.6 The Miniaturisation of the Confocal Microscope 
Over the last decade, miniaturisation of the CLSM has enabled it to be used as an in vivo 
device to take the microscope to the patient, and provide real-time virtual histology. In 
1999, Rajadhyaksha et al. developed a CLSM with a mechanical arm and a rotatable head 
to image skin, lip and tongue[1]. Then in Yokohama in 2003, one hundred colonic 
mucosal specimens and one healthy volunteer’s rectum were examined ex vivo and in 
vivo respectively with a CLSM probe that was thin enough to be passed down the 
working channel of an endoscope; both architecture and some pathological differences 
were identifiable[45]. The enormous possibilities of the technology were quickly 
appreciated, and whilst miniaturised CLSM, otherwise known as confocal laser 
endomicroscopy (CLE), is still not in mainstream use, in vivo CLE investigation has been 
considered for most areas of the gastrointestinal tract[46], lung[47, 48], ovary[49], 
cervix[50], bladder[51], peritoneal cavity[52], human skin[53], and oral cavity[54]. 
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. 
Two, fundamentally different, commercially competing clinically certified Communauté 
Européenne (CE)-marked and Food and Drug Administration (FDA)-approved systems 
have been developed, and are compared in Table 2.1.  
1. eCLE: The first system, created as a Pentax (Tokyo, Japan)/Optiscan (Notting 
Hill, Victoria, Australia) collaboration, integrates a miniature objective lens and 
pair of scanning mirrors into the distal end of an endoscope to provide “distal 
scanning”[55]. This is sometimes termed endoscopic confocal laser 
endomicroscopy (eCLE). The EC3870CILK is a gastroscope eCLE; the 
EC3870CIFK is a colonoscope eCLE; and the ISC-1000 is the endoscopic stack. 
2. pCLE: The second system houses the scanning mirrors within the endoscopic 
stack, and thousands of optical fibres form a probe to deliver the excitation 
photons into the patient and return the fluorescence photons to the main unit for 
processing (Cellvizio; Mauna Kea Technologies®, Paris)[56]. Each microfiber is 
scanned one at a time by the laser light and acts as its own pinhole. This proximal 
scanning system is termed fibered confocal fluorescent microscopy (FCFM)[47], 
or more commonly probe-based confocal endomicroscopy (pCLE). There are 
several pCLE probes available (Table 2.1), but all except the MiniOProbe used 
for small animal imaging are deployed down the operating channel of an 
endoscope. In most pCLE units, the probe relays 488nm wavelength blue 
excitation laser light to the tissue, and any radiation between 500nm and 650nm 
from fluorescing tissue is collected. At 12 frames per second pCLE is faster than 
eCLE, so in theory suffers from less movement artefact.  
With pCLE the focal plane depth is fixed for each probe, whereas with eCLE, at 
the press of a button, the image’s focal plane depth along the z-axis is advanced 
in 7µm increments anywhere from 0-250µm. With current systems, pCLE has 
inferior resolution, even with the highest resolution probe, and whilst its initial 
capital outlay is less, its running costs are much greater, with human probes being 
limited to twenty uses and costing several thousand pounds. However, their small 
size provides better accessibility in vivo and they are sufficiently versatile to be 
used with most endoscopes including cholangioscopes and ureterosocopes. 
Therefore, as is frequently flaunted by the manufacturer, the pCLE probe can be 
used on-demand during a procedure if and when required; though in practice all 
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current clinical pCLE probes require a fifteen minute “warm-up” before 
calibration and use. 
Although the field of view is even slightly smaller than the surface area of the 
probes, if the probes can be slid slowly over the biopsy site, video mosaicing 
software can “stitch” adjacent dynamic frames together to create a larger 
panoramic static image of the tissue being analysed[57, 58]. Mosaicing is a 
computational function to juxtapose overlapping video frames, acquired as the 
probe translates across the tissue, into one single composite image, thereby 
creating an increased field of view panorama of the microarchitecture. In a 
relatively unrestricted environment such as the bladder, Wu et al. found that the 
field of view can be increased up to fivefold (0.24mm to 1.27mm)[59] (Figure 
2.8). 
Mosaicing has other theoretical benefits. pCLE is a laser scanning device, 
consequently each whole frame represents a period, and not a single time point. 
This causes motion artefact when the probe moves. Also, probe abutment causes 
small non-rigid deformations of the tissue. However, video mosaicing for pCLE 
follows a hierarchical framework algorithm which identifies the motion of the 
probe relative to the tissue allowing distortions and motion artefacts to be 
removed. pCLE mosaicing was initially a function provided post-procedure, but 
can now be done realtime. It is important to appreciate that any dynamic 
information, such as moving red blood cells, is lost in the mosaics. 
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2.7 Advantages of Conventional Tissue Biopsy over Optical Biopsy 
Whilst optical biopsy is exciting, novel and has many potential advantages, there remain 
fundamental benefits of conventionally extracting tissue for subsequent ex vivo analysis, 
in addition to avoiding the large capital outlay of many optical biopsy technologies. 
Whilst the in vivo information will often be assessed realtime with the obvious time 
pressures inherent in this approach, ex vivo tissue can be carefully prepared at leisure and 
the pathologist allowed sufficient time for full analysis. This assessment can incorporate 
many more types of histological evaluation than can be performed realtime. For example, 
 eCLE 
(distal scanning) 
pCLE 
(proximal scanning) 
Location of 
Scanning 
Mirrors 
Distal to light guide fibres at 
end of endoscope; therefore 
fat  
Proximal to light guide fibres; therefore narrow 
Commercial 
Manufacturer 
Pentax/Optiscan Cellvizio, Mauna Kea Technologies 
Laser 
Wavelength 
(nm)  
488  488 or 660  
Endoscopes/ 
Probes  
Colonoscope 
EC-3870CIK  
Gastroscope  
EC-3870CIK 
S Probe 
(alveoflex®)  
Z Probe 
(gastroflex and 
coloflex)  
Z Probe (UHD 
gastroflex & 
UHD coloflex)  
CholangioFlex  
Target Tissue Large Intestine Oesophagus & 
Stomach 
Proximal and 
Distal Lung 
Upper and 
lower GI tract 
Upper and 
lower GI tract 
Biliary Tree 
Diameter 
(mm)  
12.8 12.8 1.4  2.5  2.5  1  
Compatible 
Operating 
Channel (mm)  
2.8 2.8 >2.2  >2.8  >2.8  >1.2  
Length (m)  N/A N/A 3  3  3  4  
Depth of 
Imaging (µm)  
0-250 in 7µm 
increments 
0-250 in 7µm 
increments 
0-50   (no 
distal optics) 
70-130  55-65  40-70  
Diameter of 
Field of View 
(µm)  
475x475 475x475 600 600 240 325 
Lateral 
Resolution 
(µm)  
0.7  0.7  3.5  3.5  1  3.5  
Axial 
Resolution 
(µm)  
<1  <1  15  15  15  15  
Imaging Rate 
(images/sec)  
0.8 or 1.2  0.8 or 1.2  12  12  12  12  
Table 2.1 A summary of the specifications of the main commercially available confocal 
endomicroscopes for clinical use. Pre-clinical devices are also commercially available. 
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in addition to H&E stains, the pathologist can stain other sections of the same biopsy with 
“special stains” such as congo red, toluidine blue, or masson’s trichrome, or indeed can 
use histochemistry (Perls Prussian blue demonstrates iron deposits in haemochromatosis) 
or use labelled antibodies to test for specifically expressed proteins 
(immunohistochemistry). Whilst the integration of more than one optical biopsy method 
into the procedural workflow or even a single device is achievable [18, 60], the diversity 
of tests feasible for a chunk of ex vivo tissue is unlikely to be achievable in vivo. 
This introduces another issue of who should interpret the information. Whilst remote 
visualisation via “telepathology” may play a role[61], the pathologist cannot be present 
during each examination and therefore the clinician or endoscopist is required to develop 
interpretative skills. Whilst endoscopists are less familiar with assessing tissue structure, 
pCLE images are fundamentally different to those normally assessed by pathologists, 
especially with them being en face rather than orthogonal cross-sections. It is well known 
that even expert histopathologists disagree over interpretation of traditional biopsies[62], 
and Meining et al. found that a pathologist was no more accurate at interpreting pCLE 
images than a gastroenterologist[63]. Just as hepatobiliary surgeons have learned to 
interpret intraoperative cholangiograms and ultrasound during laparoscopy, endoscopists 
can probably adequately learn the rudiments of pCLE image interpretation, and as is 
demonstrated in the next chapters, the learning curve appears to be fairly short[64-66]. 
 
 
2.8 Contrast Agents, Safety and Optimisation of pCLE Imaging 
Protocol 
If pCLE is ever to become a commonplace device, it must have an excellent safety 
profile. As a narrow, stiff but smoothly bevelled probe there are no reports of it causing 
any significant bleeding or visceral injury, although it is appreciated that minor traumatic 
bleeding is possible; indeed, blood absorbs the laser light and impairs the images 
obtained[67].  
Ethics committees in pCLE clinical studies therefore focus more on the contrast agent 
employed. The majority of clinical pCLE is performed using intravenous sodium 
fluorescein as the contrast agent of choice, probably owing to its long history of clinical 
applications. Fluorescein is FDA approved for diagnostic fluorescein angiography or 
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angioscopy of the retinal vasculature. Whilst severe adverse reactions to intravenous 
fluorescein contrast agent are very rare, many patients report transient (1-2 hours) 
yellowish discolouration of the skin and mucous membranes, and bright yellow coloured 
urine for 1-2 days. In a study of 11898 patients given intravenous fluorescein for 
ophthalmological procedures, nausea and vomiting occurred 0.7% and 0.4% 
respectively[68]. There were no complications more significant than an urticarial rash 
(0.2%). A smaller safety study of intravenous fluorescein in pCLE showed no serious 
complications in 410 consecutive patients[69], and a study of 2272 patients in 16 centres 
undergoing CLE procedures yielded no serious events, with mild events such as nausea 
and vomiting, injection site erythema, transient hypotension without shock, diffuse rash 
or mild epigastric pain occurring in 1.4%[70]. At pH 7.6, fluorescein maximally absorbs 
photons of 490nm[71]. This explains why the most frequently used pCLE laser unit 
produces 488nm wavelength blue excitation laser light; this is relayed via the optical 
fibres in the probe to fluoresce the tissue, to return and record any emitted radiation 
between 500nm and 650nm from fluorescing tissue. It can be applied topically, but the 
main advantage of its clinical safety is its more frequently described intravenous 
administration which delineates vasculature by staying in large part well bound to serum 
albumin. To obtain the best contrast and signal to noise ratio with intravenous fluorescein, 
there is some evidence that at least 5mls of 10% should be used[72, 73], and that owing to 
ongoing extravasation of unbound fluorescein into the extracellular matrix and beyond, 
image quality gradually deteriorates from 8 minutes after injection[74]. Whilst topical or 
extravasated fluorescein readily diffuses through extracellular matrix, it is unable to stain 
nuclei. With nuclear size and pleomorphism featuring heavily in many categorisations of 
cellular dysplasia in different organs, the inability to describe nuclear morphology is 
potentially limiting. Whilst several agents such as acriflavin hydrochloride, acridine 
orange, and cresyl violet outline nuclei, their use within clinical pCLE has been restricted 
to topical application, and even then, ongoing concerns regarding mutagenicity restrict 
their use in some countries.  
 
2.9 Optically Biopsying the Gastrointestinal Tract with pCLE 
2.9.1 Imaging the large intestine with pCLE 
In 2008, there were 39 991 new cases of colorectal cancer in the UK[75-78]. Despite 
major advances in surgical treatment[79] and chemoradiotherapy[80, 81], the overall 5 
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year survival is still only about 50%, making it the second leading cause of malignancy-
related deaths after lung cancer[82]. The outcome is highly dependent upon the stage at 
which the disease is identified and treated, with 5 year survivals of greater than 90% 
reported for those tumours confined to the mucosa and submucosa (T1)[83]. Whilst it is 
increasingly realised that some colorectal cancers develop de novo, most are the product 
of pre-malignant adenomas (polypoid or flat) acquiring additional mutations; a process 
which probably takes 10-15 years[84] and has been well studied since it was described by 
Morson in 1968[85]. Thus, it is logical to screen for adenomas and early cancers before 
they become symptomatic, especially as most adenomas, and, albeit with controversy, 
some very early cancers[86] can be removed endoscopically. As a result, the NHS Bowel 
Cancer Screening Programme was introduced in 2006, inviting those who have a positive 
faecal occult blood test for colonoscopy[87]. Nevertheless the sensitivity for detection of 
neoplasia by faecal occult blood testing is less than 50%[88], prompting some authors to 
proffer that a better strategy would be to offer routine colonoscopy[89], or perhaps virtual 
colonoscopy with computed tomography[90] to everyone above a certain age. A simpler 
alternative which avoids the need for full bowel preparation is flexible 
sigmoidoscopy[91]. Indeed, in a recent UK study, a one-off sigmoidoscopy, with 
polypectomy where necessary, offered to asymptomatic men and women between the 
ages of 55 and 64, reduced colorectal cancer incidence by 23% [91].  
However, this strategy has two key problems. Firstly, nearly half of all polyps are 
regenerative/inflammatory (hyperplastic)[92], and therefore display negligible neoplastic 
potential, especially if small, solitary and distal, and excision biopsy therefore constitutes 
overtreatment[93]. Secondly, regardless of the extent of the bowel imaged, white light 
endoscopy is imperfect, and around a fifth of adenomas are not identified[94], especially 
if flat, depressed, or less than 1cm in size. Various endoscopic technologies can act as 
“red-flag” techniques, and are more commonly used for higher risk patients such as those 
with ulcerative colitis or Lynch syndrome[95]. These techniques include autofluorescence 
endoscopy, narrow band imaging (to interrogate the Kudo pit pattern), Fujinon intelligent 
colour enhancement (FICE), or chromoendoscopy using indigo carmine or methylene 
blue combined with magnification colonoscopy. The mucosal pit patterns can then be 
zoomed in on to provide clues[96]. But whilst these technologies can survey the entire 
lumen, and define regions of interest for closer inspection, they have inadequate positive 
predictive value to obviate the need for biopsy or polypectomy with their attendant risks, 
costs and delays to the management pathway[97]. More accurate real time diagnosis of 
abnormal colorectal mucosa could therefore a) improve the yield of any biopsies of 
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suspicious areas, leading towards the paradigm of “smart biopsies”; b) reduce both 
pathology laboratory costs and iatrogenic harm by eliminating the need for 
biopsy/overtreatment of benign polyps (the absolute risk of perforation and bleeding with 
polypectomy is small but the procedure substantially increases the relative risk during 
endoscopy[98]), and even eliminate the need for post-removal histopathological 
assessment of low grade tubular adenomas; c) if sufficiently accurate, allow endoscopic 
resection forthwith of many larger neoplastic lesions that normally require the 
histological report prior to definitive management; and d) confirm the adequacy of 
excision.    
To understand how these ambitions have been explored with confocal endomicroscopy it 
is necessary to have an overview of the microanatomy of the colonic mucosa (Figure 2.3). 
The mucosal layer lines the colon and is adherent to the submucosa, muscularis propria 
and serosa; the submucosa and muscle provide the mural bulk and strength. The mucosa 
comprises the monolayer of epithelium, and the lamina propria; these sandwich a thin 
basement membrane. The lamina propria consists of loose collagenous connective tissue 
containing inflammatory cells and blood vessels. The epithelium invaginates into the 
lamina propria to form straight tubular glands, which form crypts (of lieberkühn) that 
open onto the mucosal surface. The epithelium consists of absorptive columnar 
enterocytes, and mucin excreting goblet cells, all tightly bound to one another. Each 
gland is wrapped with a network of blood vessels embedded into the lamina propria that 
transport absorbed fluid and solutes.  
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Figure 2.3 The histopathological features of colonic mucosa demonstrable with conventional 
haemotoxylin and eosin sections both vertically (A) and en-face (B) are illustrated in a schematic 
(C) and shown in a colour enhanced pCLE mosaic (D). 
 
Several histopathological features of the mucosa that were first described with reflectance 
confocal microscopy on ex vivo samples[45], remain clearly demonstrable with confocal 
endomicroscopy. With colonic pCLE the image is obtained from a fixed plane depth of 
150µm. This contrasts with eCLE, where the plane of imaging can be varied from 0-
250µm below the surface. With both technologies, topical contrast agents that penetrate 
the cellular wall have the theoretical advantage of highlighting nuclear structure. These 
compounds include acriflavine hydrochloride, cresyl violet, and acridine orange. Whilst 
they provide strong superficial contrast, intravenous fluorescein sodium is more widely 
used owing to its ability to delineate the fine blood vessel network embedded within the 
lamina propria, with individual dark erythrocytes squeezing through the vessels. At the 
150µm depth of pCLE images, the blood vessels are seen to weave between the glands, 
each of which has a central crypt surrounded by fluorescent enterocytes and darker goblet 
cells. Kiesslich et al. presented the Mainz criteria in 2004 to illustrate how the confocal 
image changes with mucosal pathology[55]. The subsequent Miami classification is very 
similar and validated for high-definition pCLE[99]. In summary, the crypt openings 
become fused together or star shaped in hyperplastic/regenerative mucosa, with a reduced 
proportion of goblet cells. This is contrasted with neoplastic mucosa where crypts are so 
distorted as to become unrecognisable, and long irregular villous epithelial ridges 
surround dilated, distorted and leaky neo-vessels (Figure 2.4).  
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Figure 2.4  High-resolution pCLE mosaics showing normal (A) [100], hyperplastic (B)[100], and 
adenomatous mucosa (C)[100], with the typical morphological disorganisation of adenocarcinoma 
(D)[101].  
 
The initial results with the Mainz criteria were extremely promising with a sensitivity and 
specificity for detection of neoplasia of 97.4% and 99.4% respectively. There are now 
many studies assessing CLE accuracy for colorectal polyps; they display a large variation 
in terms of accuracy (Table 2.2).  
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Shahid 2012 
[100] 
86 78 76 88 pCLE IVF Screening 
and 
surveillance 
Miami High definition 
colonoscopy 
Only polyps 
<10mm 
Kuiper 
2011[102] 
66 83 n/a n/a pCLE IVF  Novel (3 
vessel and 
7 crypt 
categories) 
  
Hlavaty 
2011[103] 
100 98.4 66.7 100 eCLE TI IBD Mainz WLE +/- CE Only 12 
neoplastic 
lesions  
Günther 
2011[104]  
n/a n/a n/a n/a eCLE IVF IBD Mainz WLE Improved 
biopsy yield 
during IBD 
screening 
Buchner 2011 
[66] 
81-
96 
34-
67 
n/a n/a pCLE IVF Screening 
and 
surveillance 
Mainz n/a Accuracy 
improved with 
learning 
Xie 2011 
[105] 
93.9 95.9 96.9 92.2 eCLE IVF Polyps Bespoke WLE  
van den 
Broek 2011 
[106] 
65 82 n/a n/a pCLE IVF IBD ? NBI and HD 
endoscopy 
NBI with HD 
endoscopy 
more accurate 
De Palma 
2010[101] 
100 84.6 90.5 100 pCLE IVF Known 
superficial 
lesions 
Mainz WLE Small study 
Sanduleanu 
2009[107] 
97.3 92.8 n/a n/a pCLE IVF 
& 
TA 
Screening 
and 
symptomatic 
Bespoke Chromoendoscopy Designed to 
differentiate 
grades of 
dysplasia 
(97% 
accuracy) 
Gomez 
2010[108] 
76 72 n/a n/a pCLE IVF Screening 
and 
surveillance 
Mainz WLE  
Buchner 
2009[109] 
91 76 89 81 pCLE IVF Diverse 
mixture 
Mainz WLE (+FICE or NBI) Less 
experienced 
group 
Hurlstone 
2008[110] 
97.4 99.3 94.6 99.7 eCLE IVF Screening 
and 
surveillance 
Mainz Chromoendoscopy  
Kiesslich 
2007[42] 
94.7 98.3 n/a n/a eCLE IVF Screening UC Mainz Chromoendoscopy  
Kiesslich 
2004[55] 
97.4 99.4 n/a n/a eCLE IVF Screening Mainz Chromoendoscopy 
and WLE 
 
Table 2.2: Studies assessing accuracy of pCLE for the diagnosis of colorectal polyps. IVF = 
intravenous fluorescein;  TA = topical acriflavin; TI = topical indigocarmine 
 
Whilst very encouraging, the results in Table 2.2 are mostly from interpretation of the 
images after the procedure, in tertiary centres, by experts in the field. However, in a 
pCLE study differentiating 80 neoplastic from 74 non-neoplastic polyps at colonoscopy, 
off-line interpretation only improved the overall accuracy from 79% to 83%[111]. 
Similarly, in a study that looked at pCLE diagnosis of gastric intestinal metaplasia, the 
accuracy of realtime interpretation was 88% versus 95% for subsequent blinded off-line 
review[112]. In a recent colorectal polyp metanalysis it has been suggested that real-time 
interpretation, aided by the unblinding effect of having the white light appearance 
available to view together with the optical biopsy, produces a favourable sensitivity and 
specificity[113]. Of note, this analysis sided with eCLE over pCLE in terms of overall 
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sensitivity (96% versus 89%) and specificity (99% versus 82%).  There is also evidence 
that interpretation is easily learnt: eleven pCLE naive endoscopists were given a two hour 
tutorial on the Mainz criteria and then in a formative assessment of their understanding,  
improved their mean accuracy of dichotomising 76 colorectal lesions into neoplastic 
versus benign from 63% (lesions 1-20) to 86% (lesions 61-76)[66]. In a similar study for 
eCLE, but with only three endoscopists, Kuiper et al. described no significant learning 
curve across three slightly larger sequential groups of 30 lesions, with an overall accuracy 
of 91%[64]. If interpretation can be performed straight away and is relatively 
straightforward, perhaps automated classification software  may in the future serve as an 
adjunct for the endoscopist; recently, the computer vision “bag of visual words” 
technique was used to match 135 pCLE video sequences to a training set, showing, 
compared to histology, an identical 89.6% accuracy to two expert endoscopists[114]. 
If the main attraction of colorectal CLE is the prospect of eliminating the current 
mandatory biopsy/polypectomy of every polyp[115], by identifying inflammatory polyps 
or even low grade adenomas[116], great confidence must be invested in the technology; 
indeed, gastroenterologists would require a consistent negative predictive value of 95-
99% to leave a polyp in situ[117]. Therefore several strategies have been trialled to boost 
its accuracy toward this “diagnose and discard” strategy:  
• Expanding the role of the “red-flag” multimodality imaging, Shahid et al. found 
that a neoplasia diagnosis in small polyps was much more accurate (95%) when 
there was agreement between the higher specificity of NBI allied with the higher 
sensitivity of pCLE[100].   
• Wang et al. used quantitative measurements during pCLE with topical fluorescein 
to discriminate between benign and adenomatous polyps with an accuracy of 
96% (Figure 2.5A). During the first 5 seconds after application, fluorescein 
passes through adenomatous mucosa much slower than it travels through healthy 
crypts; and after 5 seconds the contrast ratio between lamina propria and crypt 
was shown to be less for diseased mucosa[118]. 
• Whilst the characteristics of a cell’s nucleus (size, heterogeneity, and chromatin 
arrangement) confer vital information to the histopathologist, fluorescein-based 
CLE is devoid of such information. Several topical contrast agents such as 
acriflavine[55] and cresyl violet[119] (Figure 2.5B) stain the nuclei, but raise 
theoretical risks about mutogenicity, (although epidemiological studies have 
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found no evidence for this[120]), and because they provide less definition 
elsewhere in the image, and fail to delineate blood vessels they have not 
improved diagnostic accuracy. A longer wavelength (685nm) prototype 
reflectance confocal microscope can visualise the irregular nuclei of ex vivo 
neoplastic tissue without contrast agent; but obviously requires 
miniaturisation[121].  
• Great potential exists for molecular imaging with confocal endomicroscopy to 
provide functional information about cellular expression. It was first 
demonstrated in athymic mice, where, having bound to subsurface melanoma 
deposits, fluorescein-labelled antibodies were detected by a confocal probe[122]. 
Most colorectal cancers overexpress epidermal growth factor receptor 
(EGFR)[123], levels of which appear to correlate with poor outcome. EGFR 
monoclonal antibody therapies such as Cetuximab have a proven role in 
metastatic colorectal cancer treatment. Fluorescent labelled EGFR antibodies 
have therefore been trialled as molecular contrast agents to selectively stain 
colorectal cancer cells both in mice models and on ex vivo human tissue[124] 
(Figure 2.5D). More recently, Liu et al. used similar anti-EGFR molecular probes 
with CLE in patients with known neoplastic lesions, to demonstrate fluorescence 
in 18 out of 19 colorectal cancers, and 12 out of 18 adenomas, with substantial 
concordance with immunohistochemistry, and only slight background 
fluorescence of healthy mucosa[125]. Hsiung et al. also translated this theme into 
patients using pCLE to detect a topically applied fluorescein-conjugated 
heptapeptide that was found pre-clinically to have high affinity toward colonic 
adenomas. The best sensitivity and specificity obtainable was 81% and 82% 
respectively[126] (Figure 2.5C). To control for factors such as the contact 
pressure of the probe affecting the results of this study, it was necessary to image 
the exact junction between polyp and normal mucosa (fiddly and very 
challenging).  
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Figure 2.5 Attempts to improve diagnostic accuracy include measurement of the speed of 
absorption of topical fluorescein (A)[118], and the use of nuclear staining topical contrast agents 
like cresyl violet (B)[119]. Fluorescent molecular markers include heptapeptides (C)[126], and 
anti-EGFR antibodies (D) applied topically to the tumour (E) [124]. Fluorescent labelled anti-
endothelial antibodies under colour enhanced eCLE imaging ex vivo illustrate a thinner more 
regularly hexagonal microvascular structure in normal colonic biopsies (F) versus colorectal 
tumour biopsies (G)[127]. 
  
Other diagnostic possibilities abound with transanal CLE. It may have a role in the 
assessment of EMR scars by detecting residual or recurrent areas of dysplasia following 
EMR of colonic adenomas[128]. CLE has been used in inflammatory bowel disease in an 
attempt not only to improve the yield of the approximately 32 random and targeted 
colonoscopic biopsies required for surveillance (time-consuming and of doubtful 
efficiency), but to assess inflammatory activity in ulcerative colitis based around changes 
to crypt and microvascular architecture[129]. With care, the terminal ileum can be 
cannulated with a pCLE probe and occasional epithelial gaps are evident through which 
fluorescein leaks into the lumen; increased shedding of epithelial cells appears to increase 
the density of these gaps in inflammatory bowel disease patients[130], and increased 
epithelial shedding with resulting intravenous fluorescein efflux appears to be a predictive 
marker for disease relapse[131, 132]. With time, CLE differentiation between ulcerative 
colitis and Crohn’s disease is likely[133]. Another diagnostic application is acute graft-
versus-host disease (GvHD); a frequent and severe complication of stem cell or bone 
marrow transplantation which often entails significant tissue destruction within the 
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gastrointestinal tract, necessitating an immediate increase in therapeutic 
immunosuppresion. Diagnosis currently requires endoscopic biopsy, often in 
thrombocytopaenic patients. In Bojarski et al.’s pilot study eCLE displayed specific 
morphological changes (crypt dropout and apoptotic cells) in 14 out of 19 patients with 
rectal GvHD out of 35 patients who were referred with diarrhoea after stem cell 
transplantation[134]. Similar crypt necrosis appears to be evident with eCLE for GvHD 
of the stomach[135].  
It is worth highlighting that not all bowel diseases include mucosal changes, and by 
creating a breach in the mucosa it is possible to insert a pCLE probe to abut the 
submucosa and muscularis externa. Early work has concluded that the enteric neural 
network is particularly fluorescent with acriflavine; a finding that might have relevance to 
the understanding of functional and motility disorders[136, 137].  
 
2.9.2 Imaging the biliary tree with pCLE 
Early diagnosis of malignant biliary strictures remains imperative, especially in those 
patients who are fit enough for surgical resection. A false negative or delayed diagnosis 
may result in the window of operability being missed; conversely, incorrectly labelling a 
stricture as neoplastic may inappropriately subject a patient to a potentially highly morbid 
operation. However, it is often a challenge to differentiate malignant from benign 
strictures. Even when three intraductal methods of tissue biopsy are employed during 
endoscopic retrograde cholangiopancreatography (ERCP), (cytological brush biopsy, 
forceps biopsy, and fine needle aspiration) the sensitivity and specificity for detecting 
high grade atypia and malignancy is only 62% and 90% respectively[138], due to tumour 
either not invading the portion sampled (often because cholangiocarcinoma spreads up 
and down the duct mucosa rather creating a circumferential mass) or a desmoplastic 
reaction enveloping the tumour. More sophisticated processing of cytology using 
characterisation of DNA content with digital image analysis[139] and fluorescent in-situ 
hybridization[140] may only moderately improve sensitivity. In 2008, Meining et al. 
described, with a sensitivity of 83%, the appearance of irregular vessels and a reduced 
signal to noise ratio in the pCLE images from malignant strictures[141]. Benign 
epithelium featured a fine reticular pattern of narrow dark bands; ex vivo research 
suggests this reflects healthy lymphatics[142]. Other small studies have had similar 
findings (Figure 2.6) [143, 144]. The “Miami classification” has suggested that where two 
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or more suspicious features are present: thick white bands (tortuous vessels >20µM), 
thick dark bands >40µM, dark clumps, or epithelial structures, there is an improved 
sensitivity of 97%, but with a trade off in specificity at 33% due to false-positive cases 
from benign inflammatory strictures[145]. A recent attempt has been made to characterise 
those pCLE image abnormalities that are caused by benign strictures, in an attempt to 
improve specificity[146]. This study identified three factors which may contribute to false 
positives: a) a malignant looking ERCP clouding pCLE interpretation – during protocols 
entailing on-line pCLE interpretation, b) poor quality videos and c) recent dilatation or 
stenting of the ductal lesion in question causing fluorescein leakage.  
The only work has so far to have been done on pCLE examination of ampullary lesions of 
the distal bile duct suggests that pCLE endoscopists struggle to agree on the image 
interpretation[147], a theme which is common to indeterminate biliary strictures 
elsewhere, with interobserver kappa agreements regarding the “Miami classification” 
ranging from poor to fair[148]. 
Future work is needed to correlate somewhat vague image findings with known histology.   
 
Figure 2.6 A stricture within the common bile duct is demonstrated using ERCP (A). pCLE 
images of healthy bile duct show thin dark bands (B), whereas large black cells and tortuous 
fluorescent vessels are evident in malignant areas (C and D)[143, 144]. 
 
2.9.3 Barrett’s oesophagus and pCLE 
The incidence of oesophageal cancer is rapidly increasing in the developed world. In the 
United Kingdom in 2008, 8170 people were diagnosed with it, rendering it the 9th most 
common cancer[76]. Mainly due to its often advanced stage at presentation, it has a 
dismal prognosis: the 5 year survival is less than 10%[149, 150] overall, but in those with 
early stage cancer it has been reported as high as 81%[151]. Early diagnosis is therefore 
essential, and as the main risk factor is Barrett’s oesophagus (chronic acid reflux causing 
metaplastic transformation of the normal stratified squamous epithelium of the distal 
oesophagus into the secretory columnar epithelium typically seen lining the intestines), 
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Barrett’s patients need identifying, in order to be offered screening endoscopy to identify 
areas of neoplastic transformation. Standard surveillance includes four quadrant pinch 
biopsy at 1-2cm intervals for the length of the Barrett’segment[152]. High grade 
dysplasia is treated with more intensive surveillance, radiofrequency ablation, 
submucosal endoscopic removal or surgery, whereas invasive cancer usually requires 
surgical resection. However, rigorous biopsy protocols have the dual problem of low 
yields, that still manage to miss high grade dysplasia owing to high grade dysplasia and 
early cancer frequently looking macroscopically normal[153]. To improve both the 
accuracy of surveillance, and the yield of biopsy, high resolution endoscopy, 
chromoendoscopy, autofluorescence endoscopy, narrow band endoscopy and optical 
coherence tomography have all been suggested. 
In 2006, Kiesslich et al. showed that the goblet cells of Barrett’s oesophagus were easily 
identifiable on eCLE, and trialled its use for eCLE detection of Barrett’s neoplasia, 
thereby using analysis of vessel and cellular architecture to formulate the Mainz 
criteria[154]. In the Mainz criteria, neoplasia is revealed by irregular capillaries that leak 
fluorescein into the lamina propria, contrasting against prominent dark cells that have 
irregular shapes and borders (Figure 2.7). In this initial study, using blinded retrospective 
reporting of the images, neoplasia was diagnosed with 93% sensitivity and 98% 
specificity. A subsequent small prospective crossover study suggested that in patients 
with Barrett’s associated neoplasia, suspected (but unlocalised) during prior white light 
endoscopy, the yield of neoplasia with a standard four-quadrant protocol every centimetre 
was 17%, but this doubled to 34% when mucosal biopsies were only taken from areas 
indicated as suspicious on eCLE; furthermore, 59% fewer biopsies were required for the 
diagnosis with the more selective approach[155].  
Barrett’s is relatively easily diagnosed with pCLE also[156], and therefore the Mainz 
criteria have been variously modified, generally requiring the presence of two of five or 
six parameters to denote neoplasia: an inhomogeneous gland lining, irregular epithelial 
lining width, presence of “dark areas” on the epithelial border, fusion of villi and glands, 
an irregular vascular pattern and absence of obvious goblet cells[157-159]. Pohl et al. 
showed that two independent endoscopists experienced in pCLE provided a 75-89% 
sensitivity and 75-91% specificity to detect high grade neoplasia/early cancer at 
retrospective image review[157]. By briefly training and then testing eleven experienced 
gastroenterologists, Wallace et al. suggested an overall sensitivity of 88% and specificity 
of 96% was achievable for neoplasia detection using the more recent high definition 
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pCLE probe with improved resolution, and also showed that the doctors who were 
previously acquainted with pCLE performed better[158]. Prior experience seemed to 
offer no advantage in the study of Gaddam et al. who, after systematically assessing the 
individual prognostic power of 9 image features, were unable to create a significantly 
improved classification system, with a sensitivity of 76% and specificity of 85% for 
diagnosing neoplasia[159]. Of note, this study showed that if the endoscopist was 
confident of the diagnosis, the accuracy was 98%, highlighting the importance of 
providing clear video sequences, and raising the possibility that in the future only those 
areas where the pCLE diagnosis is not clear need pinch biopsying.  
Whilst investigators used blinded offline image evaluation in the above evaluations of 
pCLE in Barrett’s, an obvious attraction of optical biopsy is real-time diagnosis. Spot 
diagnosis in vivo has inherent time pressures which could negate the potential advantages 
of being able to interpret the pCLE video sequence in the context of the patient and the 
mucosal white light image. In a prospective multicentre study enrolling 68 patients with 
Barrett’s, the sensitivity for realtime detection of neoplasia per biopsy was a 
disappointing 12%, with a specificity of 95%[160]. Post-procedure image review only 
improved these figures to 28% and 97%. High grade dysplasia or cancer was only present 
in 8.3% of the patients studied, but in reality this is a more realistic prevalence for a 
Barrett’s surveillance population. It was particularly salient in this study that this 
prevalence mirrored the seemingly high negative predictive value of 92%; which is 
essentially the same as the pre-test likelihood of absence of neoplasia. Also, the 
specificity of predicting neoplasia on a per-patient basis, fell from a respectable 95% to 
59% when the investigators were blinded to the endoscopic findings, supporting the 
French philosopher Henri-Louis Bergson’s quote that, “The eye sees only what the mind 
is prepared to comprehend”; in the context of mucosa with a macroscopically healthy 
appearance, an endoscopist may easily dismiss a few slightly abnormal video frames as 
spurious rather than score them as reflecting dysplasia.  
The only randomised controlled trial to date has suggested that with an “enriched” study 
population (31% had high grade dysplasia or cancer), when pCLE is combined with high 
definition white light endoscopy, it has a sensitivity of 62.5% and specificity of 
92.7%[161]. Though this significantly improved the biopsy yield, the sensitivity is still 
inadequate to obviate the need for conventional biopsy.  
The classification systems described are obviously somewhat subjective, and a more 
quantified approach to the assessment of morphological differences may aid 
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interpretation. For example, computational analysis of pCLE frames has shown that 
whilst the mean vessel diameter remains similar, dysplastic Barrett’s has a significantly 
greater mean vessel density than its non-dysplastic counterpart (24% versus 14%)[162]. 
Iguchi et al. demonstrated an 85% accuracy for observers to use specific microvascular 
pattern recognition to differentiate between Barrett’s oesophagus, high grade 
dysplasia/intramucosal cancer, and more deeply invading cancer on eCLE[163]. They 
also showed in a more quantified fashion that the mean microvessel diameters increased: 
11.4µm, 17.8µm, and 20.7µm respectively for the three groups (non significantly 
between the last two groups but there were only 15 patients in the study).    
As with colorectal polyp imaging, in Barrett’s, efforts have been made to interrogate 
cellular metabolism and function with confocal microscopic imaging. Following on from 
the paradigm of injecting radioactively labelled glucose analogues to screen for metastatic 
foci with positron emission tomography (PET), if ex vivo oesophageal mucosa biopsies 
are incubated in a fluorescently labelled deoxyglucose such as 2-NBDG, the uptake 
within the glandular epithelium, as determined by mean fluorescence intensity, is greater 
where high grade dysplasia or invasive cancer are present[164]. Similar results are seen 
with ex vivo EMR specimens[165]. Similar to that described for the colon, future 
developments will undoubtedly include fluorescently labelled peptides or antibodies that 
selectively bind proteins such as EGF-R, survivin (involved in mucosal protection)[166], 
and antigens that are expressed in neoplastic transformation[167, 168].  
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Figure 2.7 In (A), argon plasma coagulation marks the Barrett’s segment of the distal oesophagus 
to enable optical and pinch biopsies to be obtained from the same site, immediately above the burn 
marks. On the end of the endoscope, the transparent mucosectomy cap is visible to enable suction 
stabilisation[157]. The pCLE appearance of regular columnar epithelium in non-dysplastic 
Barrett’s mucosa, interspersed with mucin filled goblet cells is shown in B[158]. Features of 
dysplasia or cancer include epithelial inhomogeneity with large dark cells, and fluorescein leakage 
(C&D) [157, 160]. Desktop confocal microscopy images of non-dysplastic (E) and, as denoted by 
hyperfluorescent glands, high grade dysplastic oesophageal pinch biopsies (F) incubated in 2-
NBDG[164]. 
 
Gastroenterologists generally agree that whilst larger studies in non-selected patients are 
required, the diagnostic power of neither confocal endomicroscopy system is adequate at 
present to replace the classic Seattle pinch biopsy protocol. Clearly a thorough Barrett’s 
surveillance with CLE ultimately needs to 1) identify virtually all neoplastic areas with a 
level of certainty to allow immediate therapy, 2) be able to diminish the risk of neoplasia 
to a clinically acceptable level (from < 10% pretest to perhaps < 1% after a negative 
examination, and 3) identify low-grade dysplasia to enhance risk stratification and guide 
follow-up endoscopy frequency[169]. 
Ablative therapies such as photodynamic therapy, radiofrequency ablation (using devices 
such as the HALO system), or cryotherapy, as well as local endoscopic removal, known 
as mucosal (or submucosal) resection (EMR), are now being offered as far less invasive 
and morbid alternatives to oesophagectomy in cases of high-grade dysplasia and early 
cancer (suggested on biopsy and endoscopic ultrasound to be only stage T1a LPM or MM; 
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intramucosal, thus breaching basement membrane but still confined to lamina propria or 
muscularis mucosa)[170]. The advantage of local resection is that the histopathologist can 
provide staging information on the extent of invasion, and confirm that more aggressive 
treatment is not required, but the larger the area of tissue removed, the greater the chances 
of perforation or oesophageal stricturing. An obvious niche for confocal endomicroscopy 
is therefore to delineate the extent and margins of disease during these procedures, and to 
confirm the lateral adequacy of resection/treatment. Furthermore, in theory, if all areas 
requiring treatment are identified and dealt with at the same sitting, there is less chance 
for the unavoidable resulting fibrosis to hamper subsequent local resection, and similarly 
if biopsies are avoided, it has been suggested that subsequent EMR is easier[163].  
The feasibility of using confocal endomicroscopy to identify the exact location of high 
grade dysplasia as identified on previous biopsy, during the EMR procedure has been 
demonstrated with eCLE[171]. In the Dunbar et al. paper previously described, two 
patients underwent immediate EMR solely on the basis of eCLE suspicion[155]. In a 
retrospective series of seven patients with Barrett’s neoplasia undergoing EMR with 
narrow band imaging and pCLE, the area resected was frequently adjusted owing to the 
pCLE findings[172]; clearly larger prospective studies are required to assess whether it is 
useful in this context. 
 
2.10  Assessment of the Urological Tract with pCLE 
Perhaps the most necessary function of an optical biopsy probe in the urological tract is to 
differentiate non-papillary neoplasia from inflammatory regions of bladder epithelium 
(urothelium) during white light cystoscopy, and to delineate the boundaries of these 
lesions for transurethral resection. White light cystoscopy only has moderate sensitivity 
and specificity for identifying early lesions, so along with narrow band imaging, ramon 
spectroscopy, photodynamic diagnosis with hexylaminolevulinate (HAL) fluorescence 
imaging, and optical coherence tomography, pCLE has been licenced for this purpose. 
Using intravenous or intravesical fluorescein, Wu et al. have proposed a representative 
image library from 66 patients, intended to enable differentiation between normal 
urothelium, inflamed urothelium, and low/high grade urothelial cancer (Figure 2.8)[59]; 
as well as to suggest typical images of prostate and urethral mucosa and (ex vivo) the 
upper urological tract. This, and a similar feasibility study[51] interestingly noted that 
blood flow was discernible even with topical/intravesical fluorescein administration; a 
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finding not replicated in other tissues. Chang et al. showed that after a two hour tutorial, 
there was substantial interobserver agreement regarding four out of six imaging features 
in a heterogeneous set of 31 fluorescein pCLE videos of bladder regions[173]. Non-
clinical CLE novices picked up the technology as quickly with similar agreement. 
However, translating these observations into a diagnosis, only produced an accuracy for 
identifying cancer similar to that of white light cystoscopy. Clearly, more rigorous 
clinical trials are required to establish if cellular crowding, pleomorphism and distortion 
can be interpreted with sufficient consistency to provide adequate sensitivity and 
specificity to clinch a diagnosis of neoplasia. Similar to an endoscopic workflow of 
chromoendoscopy before CLE of the colorectum, pCLE may have a role after a technique 
such as HAL photodynamic diagnosis has provided regions of interest (HAL is an ester 
dye that accumulates preferentially in tissues with high metabolic rates, such as areas of 
neoplasia, and fluoresces red under blue light, though HAL fluorescence with the 488nm 
light of pCLE only highlights cytoplasm; fluorescein pCLE appears to correlate better 
with histology)[174].  
 
 
Figure 2.8 Healthy urothelium is shown in (A) in the form of a single pCLE image, also expanded 
into a panoramic mosaic. These “umbrella” cells appear more crowded in low-grade carcinoma 
(B), and display increasing pleomorphism in (D) which is taken from high-grade carcinoma. In 
(F), taken from chronically inflamed urothelium, there are small monomorphic cells. (C), (E) & 
(G) are the equivalent haemotoxylin and eosin stained histology images. Adapted from Wu et al. 
2011[59]. 
 
2.11  Gynaecological Targets for pCLE 
Early ovarian cancer is highly curable but notoriously difficult to diagnose; unfortunately, 
most women present with stage III or IV disease which has a 5 year survival of around 
20%. This forms the justification for the development of a confocal microlaparoscope 
which has been used to image the surface of ovary in vitro and in vivo (Figure 2.9)[175]. 
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Tanbakuchi et al. are yet to quantify the accuracy of interpretation of its images in vivo, 
but using topical fluorescein and then the topical nuclear contrast agent acridine orange, 
the size and distribution of the distinct epithelial nuclei became more heterogeneous in 
adenocarcinoma. Apart from the obvious concern that many tumours will develop from 
epithelium within the body of the ovary and thus remain inaccessible to the 
microlaparoscope, (images of the ovarian parenchyma have been obtained with a needle 
confocal which is subsequently discussed[67]),there are three challenges highlighted by 
their study:  
• The issue of ideal contrast agent is present; only by using topical acridine orange 
were distinct images possible, but owing to the theoretical risk of mutagenesis it 
is unlikely that this could ever be used where stained tissue could be left in the 
body (oophorectomy was being performed immediately afterwards in this study).  
• The epithelial coating of the ovary is fragile and easily denuded where 
manipulation of the organ and pressure of the thin imaging probe is difficult to 
control.  
• In vivo, awkward ergonomics renders consistent pressure tricky, and dark areas 
on the image represent partial loss of contact. 
Computer aided identification has been explored in many biomedical spheres. Early work 
by Srivastava et al. on images from the same group has suggested that it may improve 
accuracy and even outperform humans in terms of accuracy of detecting neoplastic 
ovarian tissue in CLE images, with a sensitivity of 98% and a specificity of 90%. 
Computational analysis of the subpatterns within the image (texture analysis) was 
employed using a) standard statistics from the normalised histogram of the image, b) 
spatial gray-level matrices, and c) spatial frequency based features[176]. Better accuracy 
was especially evident when compared against gynaecologists with little experience of 
CLE image interpretation. 
The other obvious gynaecological target is the uterine cervix where the commonly 
performed Pap smear can miss lesions during screening but more often overcalls lesions, 
resulting in unnecessary colposcopy which often requires multiple tissue biopsies to 
exclude disease. A rigid handheld CLE probe with topical acriflavine has been used to 
detect cervical intraepithelial neoplasia (CIN) with a sensitivity of 97%, though 
differentiating the different grades (1-3) was more challenging[177].  
The brief history of probe-based confocal endomicroscopy 
39 
 
 
Figure 2.9 A schematic showing a novel device for confocal image acquisition during laparoscopy 
is shown in (A). Ovarian images obtained using this microlaparoscope were superior using topical 
acridine orange (C-F) compared to topical fluorescein (B). The distribution and size of nuclei are 
more heterogeneous in adenocarcinoma (D) than in healthy epithelium (C). Epithelium can be 
easily denuded with accidental mechanical scraping during imaging (E) and when the device is 
used in vivo, uniform contact is more difficult to achieve (F). Cervical CLE with topical 
acriflavine can easily differentiate healthy epithelium (G) from CIN3 (I) on the basis of nuclear 
density, but distinguishing CIN1 (H) from healthy epithelium is more problematic. Adapted 
from[175] and [177]. 
 
 
2.12  A role for pCLE in the Respiratory Tract? 
2.12.1  Recent biophotonic developments in bronchoscopy 
White light videobronchoscopy is commonly used for rapid macroscopic examination of 
the large and medium airways, but has a low sensitivity for the detection of small 
superficial mucosal abnormalities and areas of intraepithelial neoplasia[178]. This has led 
to the development of modalities such as autofluorescence bronchoscopy (AFB)[14-16], 
narrow band imaging (NBI)[11, 12], high magnification bronchoscopy[17], optical 
spectroscopy[179], and optical coherence tomography[27], which are being studied as 
adjuncts to white-light bronchoscopic imaging and tissue biopsy. Endobronchial 
Ultrasound (EBUS) is an increasingly utilised tool for imaging beyond the mucosal 
surface. High frequency (20MHz) radial ultrasound probes have a resolution of <1mm 
and can distinguish certain histological characteristics of the airway wall[180] and of 
peripheral lesions[26, 181], but even at this resolution biopsies are still required for a firm 
diagnosis to be made.   
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In general these modalities can improve the sensitivity for highlighting disease, but their 
specificity to differentiate neoplasia from inflammation or dysplasia is insufficient to 
obviate the need for tissue biopsy. Furthermore, they are unable to image beyond the 
larger airways to add diagnostic information during the investigation of parenchyal lung 
diseases (PLDs); even the thinnest commercially available bronchoscope is the Pentax 
FB-8V® with a diameter of 2.7mm[182].  
To accurately diagnose many PLDs or solitary peripheral lung nodules, a 
multidisciplinary assessment is required[183]. This combines information from the 
clinical presentation, interpretation of the high resolution computed tomography (HRCT) 
images, and microbiological, cytological, and histopathological clues provided by 
bronchoscopy. Microscopic examination of cells from bronchoalveolar lavage (BAL) can 
cause dyspnoea, pleuritic pain[184] and fever/flu-like symptoms[185].  Histopathological 
analysis has the greatest influence upon establishing a diagnosis[186],  but it does not 
always provide a definitive answer[187], sometimes requires biopsies from several 
bronchopulmonary segments[188], and is not free from risk. Indeed, a blind 
transbronchial biopsy (TBB) carries a 1-12% risk of pneumothorax[189-192], and a 2-9% 
risk of bleeding[190, 193, 194]. Consequently, despite many parenchymal diseases 
progressing histopathologically (as well as clinically and radiologically) over time[195], 
repeated biopsies require good justification. For lesions that are inaccessible to TBB, the 
risks of percutaneous or video assisted thoracoscopic biopsies are greater still[187, 196].  
 
2.12.2  Adaptation of pCLE for the lung 
pCLE has been used for bronchoscopy; the only commercial system being the Cellvizio-
Lung® (Mauna Kea Technologies, France). It can image both the airways and the 
peripheral lung/lobule. In peripheral pCLE the probe is inserted blindly beyond the 
videobronchoscopic view until it is lodged and a relatively fixed alveolar image is 
obtained. The potential for tissue mosaicing is greater in the less constraining central 
airways, but the gentle and smooth manipulation which is required remains 
ergonomically challenging, due to cardiorespiratory and patient movement, and similar to 
what has been described in the gastrointestinal tract, the understanding that good imaging 
requires the sometimes awkward task of perpendicular probe abutment with the tissue.    
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For all CLE target organs described thus far, topical or intravenous administration of 
exogenous fluorescent contrast agents is required. However, elastin acts as an endogenous 
fluorophore when excited with a 488nm confocal laser beam, and elastin is abundant both 
within the basement membrane of the bronchial tree (Figure 2.10), and as a structural 
connective tissue component of the alveolar walls. Analysis of the spectral emission 
shape has demonstrated that these structures are responsible for the images created by 
pCLE without exogenous contrast during bronchoscopy[47].  
 
2.12.3  pCLE of the upper airways 
In 2007, by imaging healthy, premalignant and malignant bronchial mucosa in 29 patients 
and healthy ex vivo bronchus, Thiberville et al. described five apparently distinct lattice 
arrangements of the predominantly longitudinally orientated connective tissue fibres of 
the subepithelial lamina reticularis (deeper layer of the basement membrane) in separate 
areas of the bronchial tree, with small round/oval openings (up to 400µm in diameter) 
present down to the lobar divisions, representing bronchial gland openings [47]. These 
regular structures tended to become disorganised, and the spectral intensity of the 
fluorescing signal diminished (the probe used was actually a prototype combining 
imaging and spectroscopy) when overlying malignant, pre-malignant or even metaplastic 
epithelium was present. It was also suggested that non-malignant disease may affect the 
basement membrane appearance during pCLE; for example, the bronchial carina of a 
patient with sarcoidosis produced a granulomatosis like image, and a patient with 
Mounier-Kühn syndrome (atrophy of the airway smooth muscles and elastin causing 
infections and tracheobronchomegaly) displayed no pCLE autofluorescence. These 
alterations to the basement membrane appearance may be due to disease states altering 
the epithelial thickness, preventing the basement membrane falling in the plane of 
imaging, or may be due to damage to the membrane itself. Examples of Thiberville’s 
descriptive conclusions are shown in Figure 2.10, and illustrate the need for rigorous 
future study to determine accuracy and agreement amongst observers.  
Recently, Yick et al. in a very small study compared the pCLE appearances of the 
basement membrane at the bronchial carina between seven asthmatics and seven control 
subjects[197]. All pCLE images and histological slides were categorised into either 
“lamellar”, “whispy”, or “mixed”. There was close agreement between pCLE and 
histological category, and surprisingly, whilst there was no association between asthma 
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and any one particular category, those with a “laminar” pattern had a significantly poorer 
lung function (forced expiratory volume over 1 second post inhaled bronchodilator). 
To image the respiratory epithelium overlying the basement membrane, a contrast agent 
must be used: early work suggests that bronchial mucosa sprayed with physiologically pH 
buffered cresyl violet and imaged with a modified Cellvizio-Lung pCLE employing a 
561nm yellow laser[198], penetrates cytoplasm and demonstrates the cell nucleus, and 
therefore provides better resolution than 488nm excitation and intravenous 
fluorescein[199]. Standard cresyl violet has been used for pCLE imaging of the 
bowel[63] but its high natural acidity could be enough to provoke dangerous 
inflammation in the lung. However, whilst limited in vivo study suggests that it is 
possible to discern differences between dysplastic and normal (pseudostratified columnar) 
epithelium (based around homogeneity and seemingly cellular discernibility), 
categorising degree of disease (mild, moderate or severe dysplasia) is impossible[198] 
(Figure 2.10 J, K & L). At 660nm, topical methylene blue has also been tried as an 
alternative agent for imaging bronchial epithelium[200]. 
 
Figure 2.10 The arrangement of the elastin network beneath the airway epithelium autofluoresces 
and, it has been suggested, characteristically in different areas; dense, homogeneous without 
crosshatching in the anterior trachea (A), compact cross hatchings close to bronchial gland 
openings near lobar carinae (B), increasingly loose cross-hatchings of membranous trachea (C), 
and distal airways (D and E), and a “ringlike” appearance to noncartilagionous bronchioles (F). 
Disrupted basement membrane appearance is shown with carcinoma-in-situ (G), metaplasia (H) 
and sarcoidosis (I).  Using topically applied cresyl violet in vivo at 561nm, it is possible to 
differentiate between normal epithelium (J) and dysplasia (K&L), but not between grades of 
dysplasia; mild (K), and severe (L).  Adapted from [47] and [198]. 
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A “distal scanning” bronchoscopic 488nm confocal endomicroscope prototype was 
recently constructed[201]. At 6.2mm diameter without facility for white light imaging it 
requires rigid bronchoscopy under general anaesthetic but has been used to image 
endobronchial mucosal abnormalities of larger airways using intravenous fluorescein. As 
previously described, a major advantage of distal scanning devices over pCLE is that the 
distal optics allow the Z-depth of imaging to be altered during the procedure; in this case 
0-200µm below the surface, from individual ciliated epithelial cells down to submucosal 
smooth muscle and microvessels.      
   
2.12.4  pCLE of the peripheral lung 
As has been shown in the biliary tree, a key advantage of pCLE over eCLE, is size; a 
1.4mm diameter stiff pCLE probe can be deployed to the periphery of the lung to 
microimage small blood vessels and the fluorescent elastin scaffold of the lobule, creating 
a realtime image of the arching elastic fibres forming the backbone of alveoli.  
In 2009, Thiberville et al. performed pCLE bronchoscopy, using topical anaesthesia 
without sedation, in up to eight bronchoalveolar areas of 41 healthy subjects;  there were 
no complications (chest radiographs were performed before and after all procedures to 
exclude pneumothorax) although there was transient pain when the probe tip was close to 
the pleura[48]. All bronchopulmonary segments were accessible except for the apical and 
posterior segment of both upper lobes (B1 and B2[202]) due to the stiff probe impairing 
the ability of the bronchoscope to flex adequately. Lobular microanatomy could not be 
identified in only 23 out of the 215 bronchial segments cannulated with the probe. Whilst 
the published images do not provide entirely convincing evidence that consistent 
geometric and structural measurements can be obtained for each image, post-procedure 
the authors measured the mean alveolar mouth diameters as 278±53µm, the mean elastic 
fibres forming the lobular scaffold as 10.05±2.71µm, and the mean extra-alveolar 
microvessels as 104±48µm (Figure 2.11). Only the latter measurement was not normally 
distributed owing to positive skew from occasional large vessels. Cyclical changes in the 
size and shape of the structures during the breathing cycle were evident. Alveolar 
autofluorescence increased with age of subject. The presence of highly fluorescent 
macrophages during pCLE examination was also relatively specific to the 17 smokers in 
the study, creating greater overall fluorescence intensity within the alveoli of smokers. 
There was also a positive correlation between number of cigarettes smoked per day and, 
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a) mean macrophages of size >30µm present per field of view and b) presence of mobile 
macrophages. Absorption of tar by the macrophages is the likely cause of the 
fluorescence[203]. For the many current smokers who undergo bronchoscopy, these 
bright macrophages potentially act as an additional endogenous fluorophore.  
Thiberville observed that the probe could create alveolar distortion through the exertion 
of a pressure effect on the lobular geometry, and therefore only performed morphometric 
examination of those images which were recorded immediately prior to a loss of contact 
as the probe was gently withdrawn after finding its initial destination. In particular, if the 
probe was deemed to be entering the lobule down the axis of the alveolar duct, axial 
pressure upon the elastin structures created the illusion of increasing the working distance 
by compressing the first plane of focus against the backplanes. 
If adjacent images can be readily tracked during steady probe translation, the field of 
view (FOV) can, in theory, be increased using the device’s “mosaicing” software[57, 58].  
So far, there are few reports of pCLE imaging parenchymal disease. A case study 
suggested that the globular lipoproteinaceous material that formed within the alveoli of a 
smoker with the rare condition pulmonary alveolar proteinosis (PAP) was visible and 
distinct from alveolar elastin and macrophages[204].  Short abstracts have suggested that 
a) pCLE at 660nm will provide intracellular resolution if methylene blue is  squirted 
down an extended working channel to coat the lobular structures beforehand[205], b) 
there are “specific alterations” such as thickening of alveolar walls and structural 
disorganisation in patients with diffuse or focal interstitial lung diseases[206], and c) in a 
small study of patients either awaiting or having received lung transplant[207], the mean 
alveolar diameter of the 5 patients with end-stage emphysema was 389±127µm with 
alveolar wall thickness of 22±21µm; for the 5 with idiopathic pulmonary fibrosis, the 
mean alveolar diameter was 190±71µm, with alveolar wall thickness of 16±7µm; the 
same dimensions within the 10 transplanted lungs were comparable to Thiberville’s 
results in healthy subjects. Recently, Thiberville’s group have suggested that amiodarone-
induced lung toxicity can be differentiated from other interstitial lung diseases by the 
presence of large (>20µm), aggregating, strongly fluorescent cells within the acini[208]. 
These are presumed to be macrophages, and therefore as a diagnostic imaging test this 
could only be specific in non-smokers, although the addition of pCLE in-situ fluorescence 
spectroscopy appears to enable differentiation between fluorescent macrophages created 
by tar from smoking, and from amiodarone related pneumonia. 100µm diameter round 
highly fluorescent opacities have been described in the alveoli of two non-smoking 
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Belgian sisters with pulmonary alveolar microlithiasis; a rare form of parenchymal 
calcification[209].  
pCLE was inserted through transthoracic catheters to abut the pleura in a porcine model 
of acute lung injury (ALI), created by repeated surfactant washout, to evaluate the volume 
air index (VAI) as a computed parameter of alveolar recruitment[210]. VAI decreased 
following the induction of ALI, and only in the lower lobes could this be attenuated by 
increasing the positive end expiratory pressure. Intravenous fluoroscein was required for 
this, along with a similar transthoracic computational airspace analysis in mice[211].  
Whilst the transthoracic approach is unlikely to have relevance in the clinical setting of 
ALI, if similar results could ever be obtained with bronchoscopy, it could be a useful tool 
in the critical care environment. Ultimately, as proposed for the gastrointestinal tract, and 
assuming safety concerns have been addressed, it may be feasible to use functional 
fluorescent markers to evaluate processes occurring during ALI. Chagnon et al. used the 
Five-1 (Optiscan, Notting Hill, Australia), a rigid handheld pen-like distal scanning CLE, 
to compare transthoracic parenchymal images from healthy rats, to those from which ALI 
had been induced by bleomycin or hyperoxia[212]. Amongst the contrast agents used, 
fluorescent labelled ricinus communis agglutinin (RCA-1) binds galactose residues on 
type 1 epithelial cells, and, administered via the trachea, it demonstrated that ALI rats had 
increased parenchymal thickness. In other rats, neutrophils were harvested and labelled 
with green fluorescent PKH2 and then tracked. There was a 28-fold increase in the 
number of labelled neutrophils sequestered into airspaces pre-treated with bleomycin. 
Intratracheal or intravenous administration of the fluorescent molecular marker YO-PRO-
1 demonstrated increased apoptosis in ALI lungs. Finally, by imaging 5 minutes after the 
intravenous injection of fluorescent labelled dextran (at 77kDa it tends to stay 
intravascularly) it was possible to show the increased microvessel leakiness brought on 
by hyperoxia induced ALI.  
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Figure 2.11 Confocal alveoscopy in a non-smoker demonstrates (a) the elastin scaffold of the 
lobule with a green arrow showing the alveolar mouth diameter, and (b) a microvessel. The 
alveolus is stuffed with autofluorescent macrophages in healthy smokers (c), and in amiodarone-
induced interstitial lung disease (d). In PAP 100-300µm lipoproteinaceous globules are present (e). 
In rat models of bleomycin induced ALI, the parenchymal walls are thickened, as illustrated by 
type 1 epithelial cell fluorescent labelling in normal lung (f) and bleomycin induced ALI (g). 
Fluorescent labelled neutrophils are also drawn into the peripheral lung in ALI; healthy (h) and 
ALI (i). Adapted from [48, 204, 208, 212] 
 
In another rodent transthoracic study, the diagnosis of pulmonary aspergillosis (fungal 
pneumonia secondary to aspergillus fumigatus) was addressed with immunoendoscopy 
(Figure 2.12). A timely diagnosis is of critical clinical importance in these often 
immunocompromised patients, but it is often unfortunately delayed. FITC (fluorescein-
isothiocyanate) labelled peptides that relatively specifically bind to a. fumigatus were 
injected intravenously into immunodeficient rats previously inoculated with the organism, 
and pCLE images over aspergillosis foci on the lung surface showed a diffuse stromal 
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fluorescence, and with a sensitivity and specificity of nearly 95%, approximately 80% 
greater fluorescence intensity than that recorded without the peptide or with other fungal 
microabscesses or chronically inflamed areas[213]. It is possible that peptides for the 
targeting of other disease antigens could be used, but in vivo in situ translation into 
patients would require many things including proven safety of the peptides, and the 
transbronchial approach to be as accurate (it would be necessary to differentiate between 
the fluorescence created by acinar elastin and and the fluorescence from the label on the 
peptide; switching from 488nm to 660nm would be a possible solution).  
 
 
Figure 2.12 Transthoracic pCLE signal in rats showing no discernible fluorescence over a healthy 
area even after peptide injection (A). When imaging an aspergillus microabscess small specks 
were evident before peptide injection (B), becoming larger fluorescent patches after peptide 
injection (C). A similar appearance to (B) was seen overlying inflammatory areas, and Geosmithia 
argillacea microabscesses before and after peptide injection[213]. 
 
 
 
2.13  The Peritoneal Cavity and pCLE 
2.13.1 The evolution of peritoneoscopy 
The rigid laparoscope has become an essential diagnostic tool in minimally invasive 
surgery. Laparoscopy of the peritoneal cavity is widely used for diagnosis (and potential 
treatment) of endometriosis[214], chronic abdominal pain[215], unexplained sepsis in 
critical care[216], and it is employed as a vital staging procedure prior to resection of 
upper gastrointestinal or pancreaticobiliary malignancies[217]. Though the abdominal 
scars and physical trauma created by diagnostic laparoscopy are smaller than those of 
open surgical exploration, recent technological advances in the form of Single Incision 
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Laparoscopic Surgery (SILS), or flexible endoscopic approaches such as natural orifice 
transluminal endoscopic surgery (NOTES) aim to further reduce the physical and 
psychological burden, and reduce peri-operative mobidity and analgesic requirements. 
Indeed, NOTES peritoneoscopy has been explored clinically as an alternative to 
diagnostic laparoscopy[218-221]. 
 
2.13.2  The integration of optical biopsy into peritoneoscopy 
Concominant with the evolution of these minimally invasive approaches to examine, 
biopsy and potentially operate on the intraabdominal viscera, several of the probe based 
imaging technologies outlined in chapter 1 have been developed and experimentally 
integrated into the laparoscopic/endoscopic workflow. These include near infrared 
fluorescence[222], optical coherence tomography[223], and endocytoscopy[224]. These 
are particularly relevant in the context that staging laparoscopy can only prevent up to 
half of unresectable gastrointestinal malignancies, initially thought to be resectable on 
CT, undergoing fruitless laparatomy[225]. Von Delius et al. showed that pCLE provides 
interpretable images of the surface of the peritoneum and liver during porcine transgastric 
NOTES peritoneoscopy using intravenous fluorescein [52].  Splenic surface images only 
showed a few non-specific vessels. The 10µm depth “s” miniprobe was used for 
peritoneum, and the 100µm depth “z” miniprobe for the liver and spleen. Challenges 
highlighted included a) inaccessibility of particular areas of the peritoneal cavity with 
spatial disorientation; themes common to all NOTES research, b) movement artefact 
created from the pig breathing, although this was reduced by tilting the pig head down, 
and c) an inability to delineate nuclei with fluorescein; a feature which may be vital in 
identifying malignant deposits within the peritoneal cavity.  
 
2.14  Confocal Endomicroscopy of Solid Viscera 
To image slightly deeper, alternative fluorophores can be employed, which require 
excitation by a longer, and thus more penetrative, wavelength of confocal laser beam. For 
example, during liver laparoscopy of 22 patients under conscious sedation, fibrosis and 
steatosis were predicted correctly in 90% and 81% respectively using a prototype rigid 
eCLE, imaging to a depth of 350µm with 780nm light (near infrared) with intravenous 
indocyanine green[226]. Nevertheless, in contrast with the gastrointestinal lumen or 
bladder, solid abdominopelvic viscera may contain deeper areas of suspicion still that a 
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CLE probe merely abutting the surface could never interrogate. Needle based CLE 
(nCLE) has been proposed as a solution: a hollow 19 or 22-gauge endoscopic needle is 
first inserted into the organ of interest, through which a probe similar to the 0.85mm 
diameter cholangioflex used for biliary pCLE is passed. Via either a 
transgastric/transigmoid NOTES approach, or through the gastric wall with endoscopic 
ultrasound (EUS), Becker et al. were able to produce images of variable interpretability of 
the deep parenchyma of liver, spleen, abdominal musculature, and ovary in ten pigs[67] 
(Figure 2.13).  Whilst there was no bleeding of clinical significance, bleeding tended to 
impair imaging by absorbing light or extravasating fluorescein requiring probe 
repositioning. Sentinel lymph node imaging within the bowel mesentery (using patent 
blue dye for identification) was also feasible; a potentially useful tool for cancer staging, 
though the images were not especially convincing. Via the transigmoid or EUS approach, 
in 8/10 pigs it was even possible to access the pancreas with the nCLE, though owing to 
instability of the probe or perhaps insufficiently identifiable morphology, only 40% of the 
pancreatic image sequences could be evaluated. Konda et al. performed EUS FNA with 
nCLE in 18 patients (16 cystic and 2 solid lesions)[227]. On a Likert scale, only 10/17 
image sequences were graded as very good or good. Blood vessels were visible in 6 
lesions, papillary proliferations were observed in 3 out of 7 cases of intraductal papillary 
mucinous neoplasia (IPMN), and 3 cases showed a reticular network similar to that 
observed in ERCP pCLE of ductal epithelium. Otherwise, non-specific cellular structures 
were speculated upon. With around 10% of EUS FNA/core needle biopsies failing to 
provide a diagnosis in patients with indeterminate pancreatic cystic lesions[228] and 
difficulty arising from the differentiation between chronic pancreatitis and 
malignancy[229], pancreatic nCLE could clearly have a niche if the ergonomics and 
imaging quality were adequate. It could also enhance safety by reducing the number of 
traumatic passes into the pancreas to achieve a diagnosis and even allow single stage 
diagnosis and treatment, such as chemoradiotherapeutic ablation of cystic 
neoplasms[230]. 
 
The brief history of probe-based confocal endomicroscopy 
50 
 
 
Figure 2.13 The nCLE consists of a probe similar to a cholangioflex deployed through a 19 or 22 
gauge needle (A). nCLE images of porcine liver (B), appear to delineate sinusoids shown with 
H&E staining in (C). nCLE of the pancreas after EUS sometimes shows a reticular pattern similar 
to that found with biliary pCLE, suggesting the pancreatic duct has been abutted (D). A non-
mucinous pancreatic neoplasm (E), and an intraductal papillary mucinous neoplasm showing 
papillary proliferation (F&G) are shown. The highly vascular histology of a mixed serous/acinar 
cell pancreatic cystadenoma is shown in (J) with corresponding blood vessels (H) and acinar cells 
(I) demonstrated on nCLE. Adapted from [67] and [227]. 
 
 
2.15 CLE for the Assessment of Vasculature 
The potential utility of CLE to provide dynamic images of blood vessels and flowing 
blood within them cannot be overemphasised. Microvascular assessment frequently 
features in the classification systems here described for CLE of many organs, because 
neoangiogenesis with irregular leaky vessels is such a key component of the development 
of most cancers; indeed for a tumour to exceed 1-2mm in size, it must produce vascular 
endothelial growth factor (VEGF) and induce “angiogenic switch” to acquire enough new 
vessels for an adequate nutrient supply[231]. VEGF expression is also positively 
correlated with tumour progression and negatively with prognosis. VEGF is therefore 
another in vivo immunohistochemical imaging target. Foersch et al. used anti-VEGF 
antibodies labelled with AF488 (a similar fluorophore to fluorescein) with the FIVE-1 
(Optiscan) (a rigid handheld version of the CLE) to delineate colorectal tumours in vivo 
in both mouse models of colorectal cancer (both genetic knockout and human xenograft), 
and in ex vivo surgical specimens[232]. Antibodies were injected into the mouse tail vein 
or applied topically onto the surgical specimens. Computed fluorescent intensity and 
VEGF positive cell counts significantly increased in regions of interest (ROI) 
representing colorectal cancer, indicating relatively specific binding (mostly within the 
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cytoplasm). In the surgical specimens VEGF labelled cell counts were positively 
correlated with histological grade. 
Assuming the anti-VEGF antibodies could be safely used in humans there may be 
potential for improving colonosocopy (immunoendoscopy). Alternatively, Bevacizumab 
(Avastin®) is an expensive monoclonal antibody which inhibits VEGF, now licensed for 
use in metastatic colorectal cancer. However, only half of patients respond to it, it has 
side-effects, and its enormous expense has provoked controversy. Therefore, if CLE 
could quantify tumour VEGF expression at baseline and during treatment it may identify 
the cohort of patients that may benefit from this and other drugs. Alternatively, it may be 
preferable to quantify microvascular architectural changes before or during treatment 
with chemotherapeutic/antiangiogenic agents directly either with a conventional 
intravenous fluorophore, or with something that binds more selectively to endothelium. 
This has recently been done with eCLE (ex vivo) using AF488 labelled anti-PECAM-1 
antibodies, showing that tumour blood vessels were subjectively more tortuous and when 
measured were quantitatively wider than their healthy mucosal counterparts (13.5 ± 
0.7µm versus 8.5 ± 0.9µm) (Figure 2.5 F&G)[127]. 
Other interesting microvasculature discoveries courtesy of CLE include: 
• In a mouse cremaster muscle model there is excellent agreement between 
diameter of microvessels measured by intravital (in vivo) microscopy and by 
pCLE. Using FITC labelled albumin pCLE reliably picks up calibre changes 
courtesy of topically applied vasomotor compounds, and by injecting a 
fluorescent labelled macromolecule (FITC-dextran) and computing the changing 
mean gray level in the extravascular area, vessel leakiness can be assessed[233]. 
• pCLE has been shown to identify rogue blood vessels responsible for anaemia in 
angiodysplasia of the stomach[234]. 
• After subcutaneous injection of colorectal cancer cell lines into mice, pCLE has 
shown that the resulting xenografts feature an increasing proportion of grossly 
dilated chaotic vessels as they grow with decreasing permeation of the FITC-
dextrans fluorescent tracer[235]. 
• In a p53 knockout carcinogen exposed mouse model, the development from 
healthy colonic mucosa to adenoma to carcinoma is associated with increased 
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length and area of blood vessels. This change is partially reversed when the 
antiangiogenic agent sunitinib is used[236].  
• In the lamina propria of the colon, the capillary density decreases distally, which 
corresponds with the physiology of water absorption within the colon[237]. 
 
2.16  The Ergonomics of pCLE 
Regardless of the target organ, or the particular imaging device employed to manipulate 
high magnification optical biopsy probes such as pCLE, there are significant ergonomic 
hurdles[52, 226]. For example, using an endoscope intraluminally to create a panoramic 
pCLE mosaic or representative video sequence of a gastrointestinal mucosal lesion 
requires gentle and steady perpendicular probe contact, followed by slow and controlled 
translation over a few millimetres, created by twisting the endoscope or turning its 
wheels: a difficult task further hampered by bowel flacidity, peristalsis, cardiorespiratory 
movement, and in the case of pedunculated colonic polyps, a high degree of mobility. 
Patient agitation or poor compliance also hampers image acquisition with some evidence 
that different sedation regimens can affect the quality of the optical biopsies 
obtained[238]. The delivery of pCLE via a rigid probe makes perpendicular probe 
abutment difficult, as is observed with rigid cystoscopy, particularly of the anterior 
bladder wall[51]. 
In the seminal colonic polyp CLE paper by Kiesslich et al., movement artefact rendered 
30% of acquired images less than satisfactory[55]. More recently, in Hlavaty et al.’s 
eCLE trial in inflammatory bowel disease patients[103], there was disappointment 
regarding the ability to adequately anchor mucosal irregularities to obtain stable video 
sequence. Experience may play a role, and other series have included fewer raised lesions 
but the main issue in this study was that pedunculated polyps tended to flip over the tip of 
the endoscope, resulting in 2/30 flat and 30/70 pedunculated lesions not being amenable 
to eCLE imaging. Iguchi et al. found that 4/15 invasive oesophageal cancers could not be 
imaged with eCLE due to an inability to accurately negotiate the awkwardly placed 
viewing window of the stiff endoscope tip onto the centre of the curved lesion, especially 
if they were small and situated in the upper oesophagus[163]. Using pCLE, Van den 
Broek et al. were similarly hampered by mobile lesions[106], and it appears that video 
mosaic quality may be hindered by imperfect ergonomics that contribute to movement 
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artefact[101]. Movement artefact from instability is certainly exacerbated by flaccidity in 
the bowel, and by cardiorespiratory movement in the distal oesophagus[239]; a 
particularly problem for eCLE with its slower frame rate of 1.4 frames/second.  
In the distal oesophagus, even with 30-60 seconds of pCLE imaging per target, Pohl et al. 
found that between 6% and 18% of sequences were so poor as to be uninterpretable[157]; 
it is likely that awkward ergonomics contributed to this. Prior to attempting a 
retrospective diagnosis with each pCLE video sequence, Gaddam et al. asked subjects to 
rate video quality; less than a third were rated as “high quality”, and importantly subjects 
were 20% more accurate with these sequences, demonstrating a far superior interobserver 
agreement[159].  
It is a self-evident and frequent observation that clear images and videos yield better 
diagnostic accuracy and interobserver agreement[108], and greater challenges with 
tissue/probe abutment may be a reason why diagnostic accuracy was reduced in a study 
with smaller polyps where only 72% of the pCLE videos were deemed to be “high 
quality”[100].  
Such awkward manipulation is also a likely contributing factor to endoscopic procedures 
being far slower when confocal endomicroscopy is incorporated: by adding targeted 
pinch biopsies to the conventional random quadrant biopsy screening colonoscopies of 
patients with inflammatory bowel disease, Günther et al. found 10 minutes was added 
when chromoendoscopy was used for targeting, versus 25 minutes when eCLE was 
employed[104]. Similarly, in the oesophagus, Dunbar et al. found that eCLE for Barrett’s 
surveillance took a median of 18 minutes: twice as long as conventional four quadrant 
biopsies[155]. This clearly poses issues for both cost and patient comfort.  
Some endoscopists find that for both ends of the gastrointestinal tract [100, 157] a 
transparent mucusectomy cap fitted over the distal end of the endoscope enables the 
mucosa to be anchored under suction prior to deployment of the pCLE probe; however 
the cap’s benefits may be limited[240]. This stabilises the surface, and creates a more 
tangential angle of approach for the probe; if the intention is to create mosaics, it enables 
controlled translation between tip and tissue.  An intravenous bolus of hyoscine-N-butyl-
bromide (buscopan) can also limit peristaltic artefact[101].  
With endobronchial pCLE, the optimum images of the fairly stiff bronchial wall are 
certainly obtained with perpendicular probe contact; this is not always straightforward, 
particularly with cardiorespiratory movement[198]. With the slower scan rate of 
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endobronchial eCLE (0.7-1.2 frames/sec), even under general anaesthetic 60% of images 
were impaired by motion artefact[201]. Even when the lesions of interest are in the 
pharynx and being inspected with a rigid eCLE probe, movement artefact from instability 
and respiration is troublesome[241]. 
Where an endoscope is used to manipulate a pCLE probe outside of the constraining 
boundaries of the gastrointestinal tract lumen, during diagnostic inspection of the 
peritoneal or thoracic cavities for example, there are further ergonomic hurdles to 
overcome. Here, the endoscope is beset with the issues of instability, counterintuitive 
movement and disorientation that the NOTES community has been keen to overcome 
with robotic devices. The potential advantages of precision robotic actuation of optical 
biopsy both intraluminally and especially extraluminally over the awkward, somewhat 
crude control, provided by flexible endoscopes is clear when considering that maintaining 
steady probe apposition with consistent pressure is even problematic with close handheld 
manipulation of a confocal probe during open surgery[242]. Furthermore, robotic 
actuation may avoid variations in the contact force between tissue and optical biopsy 
probe. This may have implications for safety, as well as for maintaining the consistency 
of the images acquired and the information gleaned during optical biopsy[243-245].   
If the interpretation of CLE imaging is hampered by excessive instability and movement 
causing flitting of the video frames, mosaicing can create a smooth panorama, and 
improve the ability to identify important regions of interest[59]. However, at present, this 
is a task that is currently optimally performed offline post-procedure; this is inadequate 
for intraprocedure diagnosis and decision making, but might become realtime with more 
stability and precise translation. Mosaicing is significantly impaired by tissue 
deformations during translation, and a recent study has understandably demonstrated 
better mosaics on a tissue phantom with a precise industrial robot than with a prototype 
handheld actuator, but that the handheld actuator can produce mosaics of up to 1600 
images blended together by employing “visual servoing”[246]. 
The ergonomic clumsiness of confocal endomicroscopy may also have relevance to its 
safety, in the sense that repeated inelegant manipulation of a stiff narrow tipped probe 
may create damage; indeed the requirement for multiple imprecise deployments, 
manoeuvrings and extractions of the nCLE probe into pancreatic lesions to achieve 
satisfactory imaging is a possible reason for 2 out of Konda et al.’s series of 18 patients 
suffering from post-procedure acute pancreatitis[227]. 
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2.17  Tracking the pCLE Probe’s Tip 
In the peripheral lung, the blind insertion of a pCLE probe beyond the tertiary bronchiole 
enjoys no better manoeuvrability or targeting accuracy than that of a peripheral 
bronchoscopic forceps biopsy. The bronchoscopist can only estimate the location of the 
probe tip from the angle of deployment beyond the tip of the bronchoscope, the distance 
it passes, a knowledge of bronchial tree anatomy and any cross sectional imaging 
available for the patient.  
As CLE leaves no trace on the tissue, it is difficult to know exactly from where its images 
have been obtained. This poses a problem in several situations: 
1. If CLE is used to direct simultaneous tissue sampling, it is difficult to ensure that 
optical and pinch biopsies are obtained from exactly the same area; this is clearly 
a more significant problem in heterogeneous tissue. As an approximation, with 
pCLE, argon plasma coagulation can mark adjacent to the target. For eCLE, an 
approximation can be made by pinch biopsying to the left of the suction polyp 
created during stabilised confocal image acquisition[155], as the suction and 
confocal channels lie adjacent to one another. 
2. The endoscopist may be keen to perform all CLE within the colon or oesophagus 
prior to any therapeutic intervention (or pinch biopsy), because intravenous 
contrast agent decays with time, and constantly inserting and removing the probe 
is cumbersome and time-consuming. Unless each optical biopsy has been taken 
from a small lesion with a unique appearance, it may be difficult to relocate the 
correct target. In the oesophagus, a note of the circumferential position and 
distance from the incisors may be of help. With the deformability of the colon, 
this is a strategy that cannot be readily employed. 
3. Similarly, unless the diseased area is obvious, if diagnosis and therapy happen on 
different endoscopy sessions, relocation may be difficult. 
4. In the treatment of flat, macroscopically normal lesions, such as EMR/ablation 
for areas of Barrett’s dysplasia, or transurethral resections of non-pedunculated 
bladder tumours, in theory, CLE could precisely identify the transitions between 
normal and abnormal tissue and therefore map out the troublesome area for 
treatment[172]. Nevertheless, there is no guarantee of similarity between this, and 
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both the mental map that the endoscopist creates, and the resultant mucosal 
specimen removed.   
 
 
2.18  Conclusion 
The obvious potential of pCLE creates considerable academic drive to enhance it and 
identify its best applications. There were 200 participants from 17 countries at the 5th 
International Conference of Cellvizio Users in 2013. However, as discussed in this 
chapter, there are many reasons why it has not yet become a mainstream device.  
 
2.18.1  Enhancing the F.A.T.E. of pCLE 
This thesis will concentrate on four important challenges to pCLEs more widespread 
uptake and utilisation: force, accuracy, tracking and ergonomics. 
1. Contact Force  
Pressure induced changes to the diffuse reflectance spectra and the intensity of 
the fluorescence spectra occur when spectroscopy is the biophotonic technique 
employed, probably due to alterations to blood perfusion[244]. However, apart 
from the observation that probe pressure can distort the lobule of the peripheral 
lung[48], little is known about the effect of contact force on pCLE images. 
Contact force may affect the level of imaging, which has obvious implications 
when imaging epithelial surfaces that consist of cells that mature and change 
morphologically as they migrate away from the basement membrane. However, 
the way in which the images change with force may also provide diagnostic 
information. 
 
2. Insufficient Diagnostic Accuracy 
Despite high resolution probes, detailed classification systems, and optimisation 
of contrast agent protocol, pCLE is diagnostically inferior to pinch biopsy. 
Essentially, its ability to confidently identify worrisome pathology, and to 
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provide reassurance elsewhere, is inadequate. It cannot allow the operator to 
avoid pinch biopsying any colonic polyps, nor can it make four quadrant biopsy 
of Barrett’s oesophagus redundant. Perhaps the Ultimate Selling Points of pCLE 
require more exploitation. As examples, a) pCLE’s assessment of in vivo 
vascular structure and function is a concept unavailable to the world of 
conventional histology, and b) pCLE’s thin cross section allows examination of 
otherwise inaccessible regions of the body – in the biliary tree it is showing great 
promise, perhaps pathology within the peripheral lung could be as accurately 
identified. 
 
3. Probe Tracking  
As with other point-based biophotonic probes, pCLE probes image only small 
areas which may not be representative of the neighbouring tissue, do not create 
much visible trauma, and are often blindly deployed into narrow lumen. It is 
therefore important to know where the probe has been, and what it has been in 
contact with, to allow correlation between pCLE images and corresponding white 
light images, cross-sectional imaging and pinch biopsies, and allow sequential 
pCLE surveillance endoscopies to image the same area each time. Whilst partial 
solutions have been described with OGD eCLE in the form of transient suction 
polyps or argon laser marking, these approaches are limited. Scene 
recognition/clustering methods have been described[247], and the concept of 
augmenting the endoscopic view with labels indicating the sites that have 
undergone optical biopsy has been shown using a phantom model[248]. 
However, it remains to be seen whether this is feasible in a more chaotic in vivo 
situation. 
 
4. Awkward Ergonomics  
Minimal ergonomic evolution of the endoscope has occurred since Hopkins’ 
flexible fiberscope of the 1950s, a device which was not designed to manipulate 
cellular resolution optical biopsy devices. Elaboration of this problem, and 
solutions will be explored. 
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Chapter 3  In Vivo Experimental 
Assessment of the Challenges Facing 
pCLE 
 
3.1  Introduction to Both Studies 
In chapter 2, four major challenges to pCLE use were identified within the literature. The 
aim of chapter 3 was to experimentally assess the ubiquity of these and any other hurdles, 
through in vivo human pCLE examination of two different mucosal surfaces: 1) healthy 
and diseased endobronchium, and 2) healthy and diseased rectum. These hurdles may be 
partly illustrated by creating a small library of images for each organ.  
The discussion section at the end of this chapter places the findings of both studies in the 
context of the four challenges highlighted in the previous chapter. 
 
3.2  Introduction to pCLE for Endobronchial Disease Study 
The endobronchial pCLE knowledge base described in chapter 2 is thus far limited to a 
few papers, but no further justification is required for this work with a) endobronchial 
basement membrane elastin autofluorescence potentially obviating the need for 
exogenous contrast agents, b) lung cancer being the most common worldwide cancer and 
growing in incidence particularly in low income countries (and its outcome less bleak if 
diagnosed early), c) and epithelial induced basement changes being a key feature of 
several benign lung diseases[249].  
 
3.3  Methods for Endobronchial Study 
A single expert interventional bronchoscopist performed pCLE bronchoscopy in 16 
patients at the Royal Brompton Hospital immediately after performing diagnostic 
bronchoscopy for varied clinical reasons. All subjects were given verbal and written 
information about the study and gave prior written informed consent. The study was 
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approved by the Brompton, Harefield & NHLI Research Ethics Committee 
(09/H0708/18).   
 
3.3.1  Bronchoscopy 
Subjects had topical local anaesthesia applied to the back of the throat and were given 
conscious sedation if required (1-5mg intravenous midazolam). They were given 2 
litres/minute oxygen via nasal prongs and monitored with pulse oxymetry. The pCLE 
laser unit and probes were standard and commercially available (Alveoflex®, Cellvizio®, 
Mauna Kea Technologies, France; specification tabulated in chapter 2). Subjects were 
reclined at 45 degrees. As per the manufacturer’s recommendation, the laser unit was 
switched on for 15 minutes before recalibration, and the auto-power setting used. An 
Olympus 1T260 bronchoscope was used to perform the initial bronchoscopy; 
transbrochial biopsies and bronchoalveolar lavage were performed if required according 
to the situation. The central airways were then systematically evaluated with white light 
imaging, and then the probe was gently advanced through the bronchoscope beyond the 
distal opening of the working channel until it abutted the endobronchial wall. During 
normal respiration, 1-3 pCLE video loops were acquired of macroscopically healthy 
endobronchial regions (trachea or main bronchi), as well as abnormal regions, and where 
clinically justified, endobronchial biopsies were obtained. These biopsies were fixed in 
formalin, embedded in wax, and slides cut. Standard stains were used by an expert 
pathologist to provide a histopathological diagnosis. 
 
pCLE Video Assessment: Each dynamic video sequence was examined and a 
representative selection of the most clear and distinct frames selected for further 
inspection and subsequent illustration. 
 
3.4  Results of Endobronchial Study  
It was straightforward to touch normal and abnormal endobronchial targets with the 
pCLE probe. This was only perpendicular at the carinas, but the angle was usually 
sufficient to enable tissue abutment and the capture of autofluorescence sequences. There 
were no complications. 20 pCLE sequences were acquired during the bronchoscopies of 
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16 subjects; 12 from healthy endobronchial surfaces and 8 from diseased areas (Table 
3.1).  
Biopsy 
Number 
Likely Diagnosis 
of Endobronchial 
Area 
Bronchoscopic 
Appearance of 
Endobronchium 
Endobronch. 
biopsy 
Diagnosis 
Reason for 
Bronchoscopy/ 
other relevant 
pathology 
pCLE video/images 
Reticular 
Pattern 
Bronchial 
Glands 
1 Normal  Normal N/A 
Parenchymal 
infiltrates ++ + 
2 Normal Normal N/A COPD ++ ++ 
3 Normal  Normal N/A 
Fungal 
pneumonia + + 
4 Normal Normal N/A COPD ++ + 
5 Normal Normal N/A COPD ++ ++ 
6 Normal Normal N/A COPD + - 
7 Normal Normal N/A COPD + ++ 
8 Normal Normal  N/A COPD ++ ++ 
9 Normal Normal  N/A 
Peripheral 
sarcoma 
metastasis +/- +/- 
10a Normal Normal N/A 
CIS 
+ + 
10b Carcinoma-in-situ Inflamed 
Squamous 
cell 
carcinoma-in-
situ - - 
11a Normal Normal N/A 
COPD with 
endobronchial 
lesion on CT 
 
++ ++ 
11b 
Mucus 
hypertrophy/ 
inflammation  
Inflamed mucosa 
adjacent to lesion N/A + ++ 
11c 
Small cell lung 
cancer 
Nodular lesion 
right main 
bronchus 
Small cell lung 
cancer +/- +/- 
12a Normal 
Unaffected right 
main bronchus N/A Haemoptysis ++ + 
12b 
Tracheobronchial 
amyloidosis Nodularity 
Squamous 
metaplasia 
and amyloid Haemoptysis 
“cotton-wool” like 
appearance 
13 Mild dysplasia 
Mildly reduced 
autofluoresence Mild dysplasia 
Screening 
bronchoscopy + + 
14 Mild dysplasia 
Slightly inflamed 
on fluorescence 
Mild dysplasia 
& focal 
squamous 
metaplasia 
Screening 
bronchoscopy + +/- 
15 
Shrinking 
inflammatory 
nodules 
Small bronchial 
nodules 
Neutrophilic 
infiltrate 
(biopsy 
performed 
previously) 
Ulcerative colitis 
& bronchial 
nodules +/- - 
16 
Tracheobroncho-
pathia 
osteochondro-
plastica 
Anterolateral wall 
nodularity and 
plaques 
Dystrophic 
calcification 
with chronic 
active 
inflammation 
Haemoptysis, 
dypsnoea & 
weight loss 
“cotton-wool” like 
appearance 
Table 3.1 pCLE image description and interpretation of 20 different endobronchial surfaces. 
 
 
3.4.1  Healthy endobronchium  
Trachea or main bronchus with a normal appearance under white light bronchoscopy was 
optically biopsied with pCLE in 12 subjects (Figure 3.1). With retrospective analysis, 
every sequence included at least some frames displaying thin fibres, presumed to be 
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elastin, and apart from sequence 6, there was ubiquitous evidence of bronchial gland 
entrances. Nevertheless, obtaining recognisable morphology was not always immediately 
possible: for example, initial imaging in the trachea of sequences 4 and 9 provided poor 
and negligible autofluroescence respectively, requiring distal repositioning of the probe. 
Of note, the elastin fibres varied in their distinctiveness or discreteness (compare subject 
7 with subject 8), and during sequences there was variation in the visible appearance of 
the fibre orientation. This is illustrated in subject 8 which displays cross-hatched fibres at 
the beginning, and parallel fibres towards the end.  
 
 
Figure 3.1 Representative still images from pCLE video sequences in 12 subjects; all taken from 
endobronchium that appears normal during white light bronchoscopy. The yellow ovals indicate 
where bronchial gland ducts penetrate the elastin rich basement membrane. Sequence 11a 
demonstrates a short mosaic. 
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3.4.2  Inflammatory endobronchium  
Mucosal surfaces affected by four different inflammatory pathologies were imaged using 
pCLE (Figure 3.2). The most consistent images were obtained from two very rare 
conditions of endobronchial nodularity worthy of elaboration: tracheobronchopathia 
osteochondroplastica[250] (TBOP) and tracheobronchial amyloidosis[251] (TBA). The 
TBOP patient had sessile submucosal nodules with a cartilaginous/bony appearance 
protruding into the lumina of the anterior and lateral walls of his lower trachea and upper 
main bronchi. The posterior membranous portion of the trachea was 
characteristically[252] spared; this was evident with white light imaging as well as with 
pCLE. EBB confirmed active chronic inflammation of the affected areas with an 
eosinophilic infiltrate and dystrophic calcification. Whilst TBOP seldom requires much 
treatment, the patient with TBA has a much poorer prognosis, displaying characteristic 
circumferential nodular thickening and plaques on bronchoscopy which require debulking 
treatment. The TBA biopsies showed squamous metaplasia of the mucosal epithelium 
overlying extensive amyloid fibrosis containing scattered foreign body type giant cells. 
Congo red staining demonstrated extensive amorphous material displaying apple-green 
birefringence when viewed under high intensity cross-polarised light; the classical 
histochemical sign of amyloid[253]. pCLE imaging of the nodular excrescences in both 
patients (sequences 12b and 16) demonstrated a mottled “cotton-wool like” appearance, 
from autofluorescent calcifications and amyloid respectively causing disruption to the 
basement membrane.  
Two other inflammatory sites were examined: an area of mild inflammation and mucous 
hypertrophy close to a neoplastic lesion (sequence 11b), and an inflammatory nodular 
area as a very rare systemic manifestation[254] of ulcerative colitis (sequence 15). There 
was more heterogeneity exhibited within these pCLE sequences, and the fibres were not 
as clear or as consistent as those seen within the healthy sequences, but at least in part, 
elastin basement membrane fibres and bronchial glands were present. 
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Figure 3.2 pCLE images of inflammatory endobronchium. Yellow ovals once again highlight 
bronchial glands. The reticular elastin pattern appears to be at least partly preserved in mild 
inflammation or nodularity, but a “cotton wool” appearance is seen in the more dramatic  
nodularity of tracheobronchopathia osteochondroplastica and tracheobronchial amyloidosis. These 
conditions are illustrated in the CT scans and bronchoscopic images. Endobronchial biopsies of the 
mucosa affected by amyloid show acellular pink material underlying the respiratory epithelium 
after haemotoxylin and eosin staining; viewing this material with polarised light after congo red 
staining demonstrated apple-green birefringence. 
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3.4.3  Neoplastic endobronchium  
A long sequence imaging over the small cell lung cancer (SCLC) was mostly devoid of 
any recognisable autofluorescence (sequence 11c), though there was a brief normal 
reticular portion with bronchial glands (Figure 3.3). The autofluorescence was negligible 
in CIS (sequence 10b), but the reticular pattern was evident in the mild dysplasia 
sequences, though partially disrupted in sequence 14.  
 
Figure 3.3 pCLE images of endobronchium affected by dysplasia and neoplasia. To highlight the 
subtlety of these lesions sometimes, the arrow within the autofluorescence bronchoscopy image 
points to an area of mild dysplasia. 
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3.5  Introduction to Rectal Cancer Study - can pCLE identify Effects 
of Chemoradiotherapy? 
3.5.1  A background to predicting tumour response 
With recent developments in cross-sectional imaging, tumour characteristics such as size 
and shape, vascularity, and metabolic activity can be tracked during systemic treatments. 
It would be of enormous benefit if these highly variable responses could be predicted 
before treatment commences or early in the course of treatment. For example, it has been 
shown that the likely response to neoadjuvant chemotherapy in locally advanced breast 
cancer can be predicted using magnetic resonance spectroscopic imaging before and 
straight after the first dose of chemotherapy[255]. In locally advanced rectal cancer, 
neoadjuvant chemoradiotherapy is the standard of care as it improves resectability and 
disease free survival. However, whilst a complete pathological response (CPR) to 
neoadjuvant treatment (no viable tumour cells in the specimen) is associated with an 
improved outcome, this only occurs in 10-30% of patients with rectal cancer[256]; 
remaining patients have either some or no response, and therefore many will incur net 
harm from neoadjuvant therapy through delays to surgery and direct side-effects and 
unpleasantness of chemoradiotherapy. The ability to accurately identify responsive 
tumours during neoadjuvant therapy might lead to targeted treatments for patients. This 
might entail an adjustment of dose, or proceeding straight to surgery in those patients that 
are not predicted to respond. If it was possible to accurately predict or diagnose patients 
with a CPR without providing the surgical specimen, an option may then be for some 
patients to avoid significant surgical morbidity by having endoscopic resection, or simply 
attending for regular surveillance under the “watch and wait” strategy[257]. This is a 
management option that many feel is dangerous because of inadequate methods of 
proving complete disappearance of tumour[258].  
MRI alone can struggle to differentiate between active tumour and radiotherapy induced 
fibrosis, and the predictive value of changing tumour marker titres seems inadequate at 
present [259]. Unlike in breast cancer, current gene expression profiling cannot accurately 
predict responders[260]. At the conclusion of neoadjuvant treatment 18-
fluorodeoxygluocose FDG PET/CT can identify good responders[261], and several 
studies have suggested that some predictive information may be gleaned by performing 
the scan in the first or second week[262] when there is the potential for modification or 
interruption of the treatment offered. If PET/CT or optical biopsy techniques such as CLE 
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could provide adequate realtime virtual histopathological tissue assessment, this could 
stimulate a paradigm shift in colorectal cancer management. 
 
3.5.2  Pelvic radiotherapy side effects 
In the UK, approximately 17000 patients each year are treated with radiotherapy for a 
pelvic malignancy of the prostate, cervix, uterus and rectum, mostly with curative intent. 
Radiotherapy regimes are increasingly successful, but damage surrounding tissues. The 
oncologist’s aim is to treat the target organ with the maximum effective dose whilst 
simultaneously providing the greatest protection for adjacent tissue. This has resulted in 
evolutions of radiotherapy technology. For example, intensity-modulated radiotherapy 
(IMRT) is designed to make the treatment more selective for the prostate than 
conventional 3D conformal radiotherapy[263, 264]. Pelvic radiotherapy can exacerbate 
pre-existing conditions, it can damage neurological, enzyme-based and muscular 
functions within the region, but most obviously it causes proctopathy. These 
gastrointestinal injuries cause significant impairment in quality of life[265]. Prospective 
follow up data from 77% of survivors for more than 5 years in the Swedish Rectal Cancer 
Trial using preoperative high-dose (5x5 Gy) radiotherapy showed that 30% of the 
irradiated group had a significantly impaired social life because of bowel dysfunction, 
compared with 10% of the surgery-alone group[266].  
Based on clinical and pathological distinctions, this damage is divided into acute and 
chronic injury.  
 
3.5.3  Acute radiation proctopathy 
Acute radiation proctopathy occurs during the 5-6 week treatment regimen and usually 
subsides during the few weeks after treatment. Diarrhoea, abdominal cramps, tenesmus 
and less commonly bleeding are the main features. Sigmoidoscopy reveals an 
oedematous, granular, inflamed and friable rectal mucosa; the pathological changes are 
usually limited to the rapidly dividing cells of the superficial mucosa. Histopathologically 
there is cryptitis, crypt distortion and abscesses, a presence of inflammatory cells, a loss 
of superficial cell height, and a reduction in lamina propria lymphocytes[267-269]. 
Despite symptoms worsening throughout radiotherapy, histological changes are worst 
after the first two weeks of a 6 week course[268]. 
In Vivo Experimental Assessment of the Challenges Facing pCLE 
67 
 
3.5.4  Chronic radiation proctopathy 
Chronic radiation induced proctopathy occurs months or years after treatment; many 
authors define the earliest point at which it can be differentiated from acute radiation 
proctopathy is at 90 days[270]. Up to 80% of treated patients describe a permanent 
change in their bowel behaviour after radiotherapy[271], and a smaller number will 
endure serious complications of sepsis, fistulation, stenosis and severe bleeding. These 
gastrointestinal injuries cause significant impairment in quality of life[265]. The 
pathophysiology of chronic radiation proctopathy and the histological changes observed 
are thus far very poorly characterised. Endothelial cells are highly radiosensitive[272], 
and the mucosa and submucosa display vascular abnormalities such as focal distortion 
and destruction of small arteries and arterioles; those  vessels that remain display fibrosis 
of the tunica intima, thickening of the tunica media, and fibrin thrombi[273]. This chronic 
obliterative endarteritis leads to reduced vascularity of the entire bowel wall and 
associated mesenteries creating secondary ischaemic changes including fibrosis of the 
lamina propria[274], submucosal hyalinization/fibrosis, crypt distortion and focal 
mucosal ulceration[275]. Neovascularisation is a resultant feature of the ischaemia and is 
evident with congested dilated mucosal capillaries on histology and at endoscopy in the 
form of superficial telangiectatic vessels[274] which are the likely source of bleeding per 
rectum in these patients. Changes, not necessarily resulting from vascular damage, 
include changes to villi and goblet cells[273].  
 
3.5.5  pCLE and acute radiation proctopathy 
It would be a clinically important development to be able to predict at an early stage 
during or after radiotherapy treatment which patients will develop significant acute and 
chronic gastrointestinal toxicity. With no mainstream serum markers or metabonomic 
assays[276], a tolerated optical biopsy method of risk stratifying and diagnosing these 
problems would be invaluable. If patients at high-risk of fibrosis and chronic 
gastrointestinal problems could be defined accurately at an early stage during treatment, 
this would allow the radiotherapy prescription to be reconsidered.  If those at high risk of 
significant fibrosis were known soon after the end of treatment, it could allow early 
initiation of anti-fibrotic therapies.  
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3.5.6  Aims of rectal cancer study 
This was (owing to enormous recruitment difficulty) a single patient feasibility study to 
assess whether flexible endoscopic pCLE examination before, during and after 
neoadjuvant chemoradiotherapy for rectal cancer,  
1. may have a role in identifying chemoradiotherapy induced endomicroscopic 
changes to both the tumour and the healthy mucosa falling within the radiation 
field, and,  
2. is potentially acceptable to patients. 
 
3.6  Methods for Rectal Cancer Study 
In accordance with the ethical approval obtained from the NHS Regional Ethics 
Committee (Riverside: 10/H0706/6), the chosen volunteer was a 57 year old male with a 
T4N0M0 adenocarcinoma invading 3.2cm into the right seminal vesicle on pelvic MRI. 
The tumour covered 9cm in length of the right anterolateral wall of the rectum, from 4cm 
above the anal verge. He had presented with rectal bleeding, but had no other past 
medical history except for the endoscopic removal 7 years previously of a highly 
dysplastic rectal adenoma. 
The patient attended five endoscopy sessions: 1) at baseline, the week before the 6 week 
course of chemoradiotherapy commenced, 2) after one week of treatment, 3) after two 
weeks of treatment, 4) 5 weeks after the conclusion of treatment, and 5) 11 weeks after 
the conclusion of treatment during the week prior to definitive surgery. The large gap 
between sessions 3 and 4 was considered necessary to avoid unnecessary discomfort 
during the latter stages of radiotherapy. Standard “time to surgery” is 6 weeks; however 
the volunteer had been randomised to 12 weeks in a concurrent clinical trial. 
Chemotherapy entailed 6 weeks of oral capecitabine 825 mg/m2 twice daily, 5 days a 
week, with intravenous oxaliplatin 50 mg/m2 once a week. The patient also received 
concomitant radiation therapy to a dose of 50.4 Gray in 28 fractions. 
Prior to each of the 5 endoscopy sessions, a phosphate enema was administered to 
evacuate the rectum, and the patient was put into the left lateral position. Three sites were 
examined each time: the tumour itself, the healthy mucosa opposite the tumour within the 
radiation field, and mucosa outside of the radiation field above the rectosigmoid junction 
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at 20cm from the anal verge. After white light videoendoscopy footage had been 
recorded, 2.5ml boluses of 10% intravenous sodium fluorescein (Martindales, UK) were 
administered. pCLE videos of each site were then obtained using the Cellvizio-Coloflex 
HD (Mauna Kea Technologies, Paris, France) through the colonoscope; representative 
still frames were recorded and analysed.  
Four radiation toxicity scales were used to quantify proctopathy symptom severity for 
potential correlation to pCLE images. The endoscopist completed the simple but 
somewhat blunt EORTC/RTOG (Radiation Therapy Oncology Group) late proctitis score 
for the patient[277], and for greater insight[278] the patient completed a Vaizey 
Incontinence Score and a modified Inflammatory Bowel Disease Questionnaire (modified 
IBDQ) prior to their endoscopy session. The modified IBDQ is the Inflammatory Bowel 
Disease Questionnaire which has been developed for use in monitoring disease activity in 
Ulcerative Colitis and Crohn’s Disease[279], and 10 of its 32 questions provide an IBDQ-
B (bowel specific) score. The day after the procedure the patient completed a brief 
questionnaire using a Likert scale, covering acceptability and side effects. 
 
 
3.7  Results of Rectal Cancer Study 
3.7.1  Symptom severity and endoscopy procedure acceptability 
As expected, the patient’s gastrointestinal symptoms worsened during treatment being 
worst after 2 weeks of chemoradiotherapy, and generally eased afterwards (Table 3.2). 
According to the completed visual analogue scales the procedure was never even 
considered “uncomfortable” (Table 3.2).  
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Timepoint Toxicity Scale Acceptability 
(V.A.S.) 
RTOG 
0=asymptomatic 
5=death from 
DXT morbidity 
Vaizey 
0=perfect 
continence 
24=total 
incontinence 
IBDQ 
224= 
asymptomatic 
32=severely 
symptomatic 
IBDQ-B 
70=no bowel 
symptoms 
10=severe 
bowel 
symptoms 
“How was today’s 
endoscopic 
procedure (1-7)?” 
1=very comfortable 
4=uncomfortable 
7=very painful 
Baseline 1 1 209 64 3 
Week 1  1 6 204 62 3 
Week 2 3 8 (eg. 
wearing 
pad) 
193 57 2 
5 weeks 
post DXT 
2 6 205 63 3 
11 weeks 
post DXT 
1 5 200 61 1 
Table 3.2 Radiation induced side-effects during the study were most severe at week 2, but no 
endoscopy sessions were considered particularly uncomfortable by the patient. 
 
The patient’s urine was discoloured for a maximum of 24 hours after the procedure which 
he considered to be at most mildly inconvenient. Nausea was experienced on two of the 
five sessions but was only ever considered mild and lasted less than 3 hours.  
 
3.7.2  Serial endoscopies 
Over the 17 week period, the tumour macroscopically shrunk until it was a small recessed 
ulcer (Figure 3.4). To the unblinded observer, there was only very mild oedema of the 
posterior wall on the two endoscopy sessions at the start of treatment (less than even 
grade 1 on the Hanauer scale used for ulcerative colitis[280]). On each occasion, it was 
relatively straightforward to acquire pCLE videos of all three regions, although slight 
difficulty with endoscope advancement after 2 weeks of treatment meant the most 
proximal pCLE footage (outside the radiation field) was just above the rectosigmoid 
junction. 2.5mls of intravenous 10% fluorescein provided adequate fluorescence for 
image acquisition; a further 2.5mls towards the end of the procedure arguably made the 
glands more obvious.  
 
3.7.3  pCLE image interpretation 
Tumour: As expected, at baseline the tumour produced a heterogeneous collection of 
images containing long irregular epithelial ridges combined with amorphous areas. More 
normal morphology was seldom present, mostly at the tumour periphery, containing 
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recognisable circular glands and some distinct blood vessels. The endoscopy after 2 
weeks of treatment potentially demonstrated greater vessel leakiness/fluorescein spillage, 
but otherwise there were no clear changes during the study (Figure 3.4). Preoperative 
pCLE images of the contracted tumour still showed similar disorganisation to that of 
baseline.  
Healthy mucosa above and within radiation field:  Throughout the study, good 
definition videos/images were acquired from both regions (Figure 3.5 and Figure 3.6). 
Post-processing enabled mosaics up to 2.5mm in length to be created where gradual 
probe translation had been used. Glands of 70-90µm diameter were consistently 
observed, with 10µm vessels filled with moving erthyroctyes. Specific to the radiation 
zone, there was the unblinded observation of some thicker blood vessels, around 20µm, in 
the last three endoscopies. Irrespective of area, it was also apparent that despite selecting 
settings which varied the power to maintain relatively constant brightness, parts of video 
loops would vary between showing an excessively fluorescent lamina propria with good 
glandular contrast, or black glands with better lamina propria/vessel contast.  
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Figure 3.4 Representative pCLE still images and mosaics of the tumour during treatment 
demonstrating mostly disorganisation and loss of recognisable structure. Yellow and blue ellipses 
respectively highlight frames which include recognisable glands, and those containing vessels with 
flowing blood. The white light endoscopy images are taken with the endoscope retroflexed, and 
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show the tumour shrinking during treatment. (For simplicity, images from the fourth endoscopy 
session have been omitted). 
 
 
Figure 3.5 pCLE images of the posterior wall of the rectum during treatment. Blue ellipses 
highlight vessels; these are usually approximately10µm , but larger diameter ones are present after 
a couple of weeks of radiotherapy (20µm). 
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Figure 3.6: The glandular and vascular morphology of descending colonic mucosa (control) 
imaged with pCLE during neoadjuvant treatment did not seem to alter significantly. Blue ellipses 
once again highlight vessels. 
3.8 Conclusion  
These two short studies support previous declarations that pCLE within the upper 
respiratory tract and colorectum is well tolerated (even with marked inflammatory 
symptoms from local radiotherapy), and that fluorescein is well tolerated. Whilst the 
conclusions that can be drawn are limited by the size of both studies, they have examined 
the challenges that face pCLE: 
 
3.8.1  Force 
The manipulation, often up to a metre from its tip, of a flexible fine probe, which lies 
restrained within the narrow operating channel of an endoscope, would appear liable to 
create unpredictable variations in contact force. Greater probe resistance, and therefore 
even less probe control seemed available when the endoscope was contorted in the lungs 
or retroflexed within the rectum. In an in vivo situation, it is difficult to establish whether 
or how contact force variations affect the images acquired, perhaps through tissue 
deformation, imaging in different confocal planes, or the alteration of dynamic processes 
such as compression of microvasculature blood flow. It is possible that force variation is 
responsible for some of the heterogeneity within the videos; for example during imaging 
of a) healthy rectal mucosa, the unpredictable switch in maximum contrast between 
lamina propria and glands, or b) transient amorphous frames prior to characteristic 
reticular basement patterns in some healthy endobronchial areas (it is nevertheless 
appreciated that many of the “healthy” endobronchial regions were not confirmed on 
tissue biopsy and were not from otherwise healthy lifetime non-smokers; the 
endobronchial histopathological features of COPD include epithelial, goblet cell, and 
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bronchial gland hyperplasia creating mucus hypersecretion on a background of a 
thickened basement membrane, thus creating a significant likelihood of changes to the 
endobronchial pCLE morphology[249]). The implications of variable contact force on 
image acquisition are addressed in Chapter 5. 
 
3.8.2  Diagnostic accuracy  
Both studies corroborate published work attesting that pCLE can generate high resolution 
virtual histopathology of varied mucosal surfaces, enabling a reasonable degree of tissue 
phenotype differentiation between firstly endobronchial basement membrane whilst in 
health, affected by endobronchial nodularity, or affected by carcinoma/carcinoma-in-situ, 
and secondly healthy rectal mucosa, and that affected by invasive carcinoma. However, 
there are limits with pCLE’s specificity: the endobronchial diseases TBOP and TBA 
seem indistinguishable on pCLE; and with dysplasia, carcinoma-in-situ, and small cell 
lung cancer all displaying significantly reduced or negligible autofluorescence, this 
troublesome distinction between grades of neoplasia matches other work[198].  
The rectal cancer patient studied had more severe acute symptoms than average: Khalid et 
al.[278] described milder median toxicity scores (RTOG of 1, Vaizey of 5, IBDQ of 199, 
and IBDQ-B of 60), after pelvic radiotherapy for gastrointestinal cancers (after 5 weeks 
of treatment - when symptoms would be expected to be worse[268]). Therefore, it would 
appear that any microanatomical changes created by the chemoradiotherapy are likely to 
be subtle, and would clearly need to be more thoroughly investigated with a larger study. 
This was essentially a hypothesis generating study and it was hinted that within tumour, a 
greater degree of fluorescein leakage occurred following 2 weeks of treatment, and within 
the otherwise healthy radiation zone microvessel calibre increased after treatment.  
 
3.8.3  Tracking  
Despite the exclusion of all segments of endoscopic pCLE sequences which had been 
noted to include acquisitions from when the probe unintentionally tracked across more 
than one tissue type, there was marked heterogeneity in many videos, such as a few 
frames resembling healthy microanatomy within the typically significantly disrupted 
morphologies of both small cell lung cancer and rectal cancer. This might reflect the 
probe coursing the margin of the diseased area, or genuine microarchitectural 
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heterogeneity within the diseased region of tissue. The facility to accurately track, record 
and after the procedure display the path of the probe with corresponding pCLE footage 
would therefore be of major benefit. This would also make the longitudinal assessment 
(for the purposes of studying natural history or effects of treatment) of specific tissue 
regions using pCLE more accurate; for example, areas affected by radiation proctopathy 
or endobronchial dysplasia could be accurately followed-up. 
 
3.8.4  Ergonomics 
Obtaining videos and images is not difficult for a reasonably experienced endoscopist. 
Nevertheless, it is not clear how important perpendicular pCLE probe abutment with 
constant force is, and to what extent it might influence the heterogeneity in some video 
loops previously mentioned. In certain luminal areas such as during retroflexion within 
the lower rectum or within narrow bronchi this seemed more awkward. 
Currently there is no evidence to support the benefit of mosaics over individual frames or 
videos for pCLE interpretation. However, it can be expected that any pCLE role is likely 
to be enhanced by the facility for creating large mosaics. The post-procedure Cellvizio-
Viewer software was certainly able to create much longer mosaics of the roomier 
colorectum compared to the endobronchium, probably due to easier and less confined 
manipulation facilitating easier probe translation. 
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Chapter 4 Imaging Parenchymal Lung 
Diseases with pCLE 
 
4.1  Introduction 
A striking advantage of pCLE probes, over many other optical imaging devices is their 
potentially tiny cross section. This allows imaging within anatomical areas that are 
otherwise relatively inaccessible, including the biliary tree and cystic lesions of the 
pancreas, using the sub millimetre cholangioflex and nCLE, respectively.  
The peripheral lung is similarly isolated from conventional white light inspection, and 
with parenchymal lung diseases having greater prevalence than biliary strictures or 
indeterminate cystic lesions of the pancreas, chapter 4 seeks to explore a potential role for 
pCLE in diagnosing parenchymal lung diseases (PLDs). As described in Chapter 2, prior 
to this study, for pCLE of the peripheral lung, there has been little more than a description 
of the images and safety profile in 41 otherwise healthy smokers and non-smokers[48]. 
 
4.1.1  Hypotheses - assessing and maximising the accuracy of a new niche for 
pCLE 
1. The first hypothesis was that pCLE would detect morphological changes evident 
in specific PLDs.  
2. As previously discussed, unlike in the elastin rich lung, the gastrointestinal tract 
requires exogenous fluorescent contrast agents for imaging to delineate the 
cellular architecture of the glands embedded within the epithelium, and 
demonstrate dynamic in vivo blood flow. Therefore, the second hypothesis was 
that intravenous fluorescein would provide additional in vivo information in 
pCLE imaging of peripheral lung in health and disease. Despite some evidence 
from the literature, that topical agents which can penetrate the cellular membrane, 
such as acridine orange or acriflavine delineate microanatomy better, intravenous 
Imaging Parenchymal Lung Diseases with pCLE 
78 
 
fluorescein was used owing to its proven safety profile in the GI tract, and in an 
attempt to delineate microvessels prior to contrast extravasation. 
3. The third and final hypothesis was that pCLE would be safe in PLD patients.  
 
4.2  Methods 
4.2.1  Subjects 
pCLE was performed in 1) healthy non-smoker volunteers, 2) patients with chronic 
obstructive pulmonary disease (COPD) undergoing lung cancer screening bronchoscopy 
or endobronchial valve insertion for lung volume reduction, and 3) patients with PLD 
during their diagnostic bronchoscopy. The healthy subjects had no significant 
cardiorespiratory disease or bleeding diathesis. All COPD and other PLD patients had 
undergone HRCT scanning prior to bronchoscopy. Emphysema severity for each 
bronchopulmonary segement imaged with pCLE was ascertained from the HRCT scan 
closest to the investigation bronchoscopy by grading 0-4 (Table 4.1) [281] by an expert 
radiologist who was aware that emphysema was a likely component of many of the scans 
but was blinded to other clinical data.  
 
Grade Radiological Severity  
(percentage of lung affected) 
0 None/Trivial (<5%) 
1 Mild (5-25%) 
2 Moderate (26-50%) 
3 Marked (51-75%) 
4 Severe (>75%) 
Table 4.1: Quantification of percentage of lung affected by emphysema on HRCT 
 
All subjects gave prior written informed consent. The study was approved by the 
Brompton, Harefield & NHLI Research Ethics Committee (09/H0708/18).   
 
Imaging Parenchymal Lung Diseases with pCLE 
79 
 
4.2.2  Bronchoscopy 
Similar to the endobronchial study in chapter 3, subjects had topical local anaesthesia 
applied and were given conscious sedation if required (1-5mg midazolam). They were 
given 2 litres/minute oxygen via nasal prongs and monitored with pulse oxymetry. The 
pCLE laser unit and probes were standard and commercially available (Cellvizio®-Lung, 
Mauna Kea Technologies, France) producing a 600µm diameter FOV at 12 frames per 
second, imaging to a Z-depth of up to 50µm. Subjects were reclined at 45 degrees. The 
laser unit was warmed up for 15 minutes before recalibration, and the auto-power setting 
used. An Olympus 1T260 bronchoscope was used to evaluate the central airways and 
then advanced into the most distally accessible bronchi, whereupon the probe was gently 
advanced beyond the distal opening of the working channel until recognisable images 
were obtained of the acinus. During normal respiration, successive pCLE video loops 
were acquired of up to six bronchopulmonary segments (BPSs) named according to 
international nomenclature[202]. In each PLD patient, an attempt was made to optically 
biopsy areas of both maximal and minimal disease. Where clinically indicated, 
bronchoalveolar lavage (BAL) was performed using 100mls of 0.9% saline, and TBB was 
performed with Olympus EndoJaw disposable biopsy forceps (Model FB-211D). 
Diagnosis in two patients required subsequent CT-guided percutaneous biopsy. All 
patients undergoing transbronchial biopsies had post-procedure erect chest radiographs 
performed.   
For the first 5 patients who underwent BAL/TBB correlation, an extended working 
channel (outer sheath) was initially deployed through the working channel and blindly 
wedged distally in an attempt to improve the likelihood that pCLE, BAL and TBB were 
all obtained from the same location. 
Incremental doses of intravenous fluorescein (0.1ml-20ml of 1%) (Martindales, UK) with 
a saline flush were injected through a peripheral cannula towards the end of the procedure 
in five bronchoscopies during video acquisition. The same BPSs were then reimaged.  
 
4.2.3  BAL/TBB analysis and definitive diagnosis 
Differential cell separation, cytopathological examination, and microbiological culture 
were performed on all BAL fluid samples. Where there was spare BAL fluid, constituent 
cells were differentially separated, resuspended, and ex vivo pCLE imaging performed. 
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TBB samples were fixed in formalin, embedded in wax and 5µm sections were examined 
by an expert pathologist. In accordance with current guidelines[183], all available data 
was discussed at a multidisciplinary team meeting to reach a diagnostic consensus.  
 
4.2.4  pCLE image acquisition, processing and interpretation 
pCLE video loops were recorded for up to 30 seconds in each BPS until a consistent 
image had been obtained. At least five representative stills were created for each video, 
for subsequent qualitative appraisal by two observers (RN & PS) using Cellvizio Viewer® 
software (Mauna Kea technologies, France), including an assessment of the septal walls 
and vessels (autofluorescence intensity, regularity of structure) and any fluorescent 
cellular infiltrate. The Cellvizio Viewer® software’s mosaicing function was used to 
create automated mosaics. For each video sequence that enabled mosaic construction, the 
longest individual mosaic axis was recorded as a quantification of how well the FOV 
could be retrospectively increased. SPSS version 17 was used for statistical analysis.  
 
4.3  Results 
4.3.1  Subjects 
Bronchoscopic pCLE videos and still images were obtained from 4 control volunteers and 
1 lung-disease free patient (normal HRCT but cutaneous erythema nodosum) (mean age 
34.8 ± 9.7) (Figure 4.1 A-C), together with 37 patients (mean age 54.9 ± 11.8). TBB and 
BAL were performed in 21 and 23 patients respectively. Final diagnoses were COPD (13 
patients mean age 61.7 ± 6.8), or other PLD (24 patients mean age 48.9 ± 13.6) (Table 
4.2). The only two current smokers were PLD patients (sarcoid and respiratory 
bronchiolitis). The single chronic bronchitis patient had smoked until 2 weeks before 
bronchoscopy. RB1 and LB1/2 were the only BPSs that were not always possible to 
cannulate, but this occurred only during 4 bronchoscopies. Previously, cannulation of 
these BPSs has been regarded as impossible due to probe stiffness[48]. Each subject had 
1-6 BPSs optically biopsied creating 116 pCLE videos for analysis.  
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 Number of 
subjects (main 
diagnosis)  
Overall 
number of 
affected BPSs 
imaged 
Healthy 
Volunteers 4 19 
Nil abnormal  on CT, TBB & BAL, or 
remote from diseased area 
1 8 
 Subtotal 5 27 
 
COPD 
Grade 1 emphysema 2 2 
Grade 1 emphysema with partial collapse 1 1 
Grade 2 emphysema 0 3 
Grade 2 emphysema with mild infection 0 1 
Grade 3 emphysema 0 3 
Grade 3 emphysema with mild infection 1 1 
Grade 4 emphysema 8 15 
Chronic bronchitis 1 3 
 Subtotal 13 29 
 
Other parenchymal lung diseases 
Respiratory bronchiolitis 1 5 
Pulmonary sarcoidosis 4 12 
Mild radiotherapy damage 1 1 
Tuberculosis 1 4 
Pulmonary fibrosis with infection 1 1 
Drug-induced pneumonitis 2 3 
Peri-chemotherapy pneumonia 7 19 
Amyloidosis 1 2 
Peripheral non small cell lung cancer 1 1 
Bronchioloalveolar carcinoma 1 5 
Metastatic cancer (breast, endometrial or 
fibrosarcoma) 
4 7 
 Subtotal 24 60 
Total 42 116 
Table 4.2: The main diagnosis of the 42 subjects bronchoscoped, providing the 116 BPSs that 
were imaged. 
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Figure 4.1 Still pCLE images in A,B & C are from healthy BPSs and show fine undistorted septal 
wall elastin architecture (<10µm thickness), though age seems to play a role in the septal wall 
fluorescence intensity (A and B are from a 52 year old patient; C was aged 29). Mosaicing was 
able to increase the FOV in 64/116 BPSs: D shows the longest mosaic created (1268µm); the oval 
highlights a 150µm microvessel with a small branch (from a BPS with grade 1 emphysema). 
 
 
4.3.2  Safety and acceptability 
pCLE adds between 1 and 5 minutes to the bronchoscopy procedure depending on the 
number of BPSs being optically biopsied. Blood originating beyond the bronchoscope tip, 
along the path of the probe toward the lobule, was significant enough to spill proximally 
and impair the bronchoscopic or pCLE views in 3 patients before TBB. However, one of 
these patients had a clotting abnormality (prothrombin time of 19 seconds), and within 
the probed BPS of another patient was a metastatic breast tumour displaying microvessel 
invasion. Nevertheless, there was clear observation of a microvessel being snapped in 
vivo by the probe in three separate BPSs (Figure 4.2E). The probe causes some pleuritic 
pain during image acquisition, but there were no pneumothoraces. The largest fluorescein 
dose injected caused retching during the procedure in one healthy subject. Seemingly 
snapped elastic fibres of the septal walls flapped around on the video loops of 28 BPSs 
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(Figure 4.2A-D). This may be sometimes related to pre-existing disease; it was indeed 
more commonly observed in COPD BPSs than in areas that were affected by other PLDs 
or healthy lung. Nevertheless, direct damage from the probe was witnessed in 6 BPSs as 
septal walls snapped during image acquisition (Figure 4.2D).  
 
 
Figure 4.2: Free ends of septal walls, observed on video loops to flutter loosely, were apparent in 
28/116 BPSs (highlighted with circles in A, B, C and D). This phenomenon could be partly 
illustrative of the primary disease, however, in 6 BPSs, individual septal walls were observed to 
fracture, separate and then their blind ends swing freely, presumably from the axial pressure of the 
probe (demonstrated in C, and in D across 3 sequential frames; each separated by 83ms). 
Microvessels were also observed to snap under axial pressure in 4 BPSs (highlighted by an oval in 
C, and sequential frames shown in E). A is from a grade 1 emphysema BPS, B, C and E are from 
different grade 3 and 4 BPSs, and D is from a patient with respiratory bronchiolitis. 
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4.3.3  Mosaic function 
The automated mosaic function was used on the Cellvizio Viewer®software. Mosaics 
were creatable for 64/116 video loops, but the mean maximum mosaic length was a 
modest 760± 124µm. Video loops with bright distinct images, where there was some 
controlled movement of the probe tip tended to yield longer mosaics (Figure 4.1D).  
 
4.3.4  Basic analysis of emphysema 
It is evident from studying the 116 video loops and representative stills, that the 
appearance of copious, regular, 10µm elastic fibres within the alveolar septal wall 
structure previously described in healthy subjects[48], and illustrated in Figure 2.11, 
becomes variably disorganised in peripheral disease (Table 4.3). For example, pCLE 
highlights some of the morphological alterations in severe emphysema, the main one 
being a loss of the number of septal walls (Figure 4.3). In many cases there is distortion 
of the remaining septal walls, or thickening that leads to an inability to distinguish septal 
wall from microvessel (Figure 4.3G & Figure 4.5). In two emphysematous BPSs 
containing large bullae, a sudden black image was followed by a fine reticular pattern, 
suggesting the possibility that the inner surface of the visceral pleura had been reached 
via a bulla (Figure 4.3 I&J).  
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Figure 4.3: A schematic (A) shows the loss of of alveolar septal wall density in emphysema, often 
in the apices. White light microscopic images of emphysematous (B) and healthy (C) 
transbronchial lung biopsies are shown. The number of visible septal walls on pCLE tends to 
reduce as emphysema worsens: grade 1 emphysema (D&E), grade 4 (F). G and H are images near 
large bullae. The ellipse in G highlights probable distorted thickened septal wall that on 
discrimination by thickness could be confused with a microvessel. H shows a probable vessel but 
minimal septal wall. I and J are images of pleura beyond bullae. 
 
4.3.5  pCLE images of PLD 
In most parenchymal lung diseases other than emphysema, the pCLE architecture 
becomes unrecognisable (Figure 4.4 and Figure 4.5F). The autofluorescence is reduced 
and the images become indistinct and noisy. The most radiologically affected areas tend 
to display the most disruption and loss of autofluoresence in their corresponding pCLE 
images. However, whilst BPSs exclusively affected by emphysema have a smaller 
number of septal walls per FOV, creating the appearance of “holes”, they do not appear to 
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lose autofluorescence intensity, and the elastin scaffold of the lobule tends to retain its 
distinctiveness even in severe disease, even if sometimes vessels become 
indistinguishable from septal wall.  
Whilst the septal wall structure was more distinct in healthy volunteers than in subjects 
with marked disease, the autofluorescence was generally weaker than healthy or 
emphysematous areas of older patients. This effect of age on autofluorescence has 
previously been described[48].   
 
Observation Healthy/Normal 
(N=27) 
COPD 
(N=29) 
Other PLD 
(N=60) 
↓ autofluorescence of 
individual elastic structures S 
12/27= 44.4% 1/29 = 3.4% 19/60 = 31.7% 
Unrecognisable structure & 
↓ distinctiveness NS  
7/27 = 25.9% 5/29 = 17.2% 45/60 = 75% 
Distorted septal wall 
morphology S 
1/27 = 3.7% 22/29 = 75.9% 35/60 = 58.3% 
Snapped septal walls or 
vessels S 
2/27 = 7.4% 15/29 = 51.7% 11/60 = 18.3% 
Autofluorescent 
macrophages (15-30µm & 
mobile) S 
0/27 = 0% 3/29 = 10.3% b 10/60 = 16.7% a 
Mucus globules/bubblesNS 9/27 = 33.3% 11/29 = 37.9% 21/60 = 35% 
3µm specksNS 6/27 = 22.2% 8/29 = 27.6% 26/60 = 43.3% 
Are mosaics creatable?S 6/27 = 22.2% 26/29 = 89.7% 32/60 = 53.3% 
Mean maximum mosaic 
length (µm) NS 
709 ± 78 811 ± 134 800 ± 90 
Table 4.3: A summary of the observations and measurements from the 116 BPSs analysed. Whilst 
the elastin scaffold morphology with emphysema is most likely to appear distorted, structures tend 
to be vivid and brightly autofluorescent. Diminution of both autofluorescence and recognisable 
distinct structure is common in other PLDs.  The few BPSs displaying autofluorescent 
macrophages were from the only two current smokers in the study, both with PLDs a, and a COPD 
patient who had only quit smoking 2 weeks previouslyb. (Using ANOVA for mosaic length, and 2-
sided chi-square tests for the other observations p<0.05S, p≥0.05NS) 
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Figure 4.4: Many PLDs cause a non-specific loss of fluorescence and distinctiveness. This is 
demonstrated with a peripheral metastatic fibrosarcoma deposit (A), an organising pneumonia (B), 
and an area of lung affected by a lymphocytic infiltration secondary to a peri-chemotherapy 
pneumonia (F). In a patient with bronchioloalveolar carcinoma, HRCT showed severely affected 
upper lobes (D), and pCLE provided virtually no recognisable autofluorescence within the right 
upper lobe (C) whereas the spared right lower lobe showed distinct alveolar structures with greater 
autofluorescence (G). E was acquired from maximal distal cannulation of LB6 in a patient with 
tracheobronchial amyloidosis: the “cotton wool like” autofluorescence was similar to that observed 
in pCLE of endobronchial amyloid deposits[282]. 
 
Figure 4.5: In health, differentiation between microvessels and septal walls (Figure 2.11A&B) is 
done on diameter and shape characteristics[48]. This is not as straightforward in diseased BPSs, 
and here the circles show indeterminate structures from diseased BPSs which cannot be identified 
as either structure on the basis of their shape or intermediate calibre. A-E are from emphysematous 
BPSs (grades 2, 3, 3, 4, and 4 respectively) and F is from a BPS with drug-induced pneumonitis. 
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4.3.6  Inflammatory cells 
The appearance of undetermined 3µm specks (particularly on approach to the acinus), 
mucus globules/bubbles or even faint inflammatory cells is a non-specific finding to 
healthy and diseased areas (Figure 4.6). However, brightly autofluorescing 15-30µm 
cellular infiltrates were exclusively observed in the BPSs of the only 2 current smokers in 
the study (respiratory bronchiolitis and sarcoid), as well as one recently ex-smoker with 
chronic bronchitis. The 3 other sarcoidosis patients were non smokers and their in vivo 
pCLE and ex vivo BAL pCLE images had no visible inflammatory cell infiltrate. 
Differential cell separation of the 2 current smokers’ BAL fluid demonstrated that the 
responsible cells were autofluorescent macrophages. The subject with chronic bronchitis 
had endobronchial washings only, which displayed no ex vivo fluorescent cells. 
 
 
Figure 4.6: Bright indeterminate 3µm specks are common on approach to the acinus regardless of 
smoking status (A is from a patient with pneumonia). Apparent mucus blobs or bubbles are non-
specific (B is from a resolving pneumonia, and C is from a BPS with grade 3 emphysema). Whilst 
some very faint cells are suggested even in non-smokers, brightly autofluorescing alveolar 
macrophages are exclusive to smokers (or those with a recent smoking history) regardless of 
disease (D&E are from RB4 and RB6 of a recently quit heavy ex-smoker with chronic bronchitis). 
F shows that these macrophages sometimes “drown out” the alveolar walls (respiratory 
bronchiolitis). 
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4.3.7  Intravenous fluorescein 
Incremental doses of 1% fluorescein were administered intravenously in 3 healthy 
volunteers and 2 patients with emphysema. 0.25mls was the minimum required to 
observe a change. This change consists of a hyperfluorescent foreground containing non-
fluorescent bubbles; it appears within a few seconds of drug administration and is not 
initially confined to the microvessels (as might be expected) (Figure 4.7). Therefore, there 
is no discernible increase in the autofluoresence of the septal walls, microvessels or cells 
during incremental administration of the drug.  
 
 
Figure 4.7: Compared to standard biopsy, there is reduced resolution/diagnostic information with 
conventional elastin autofluorescence pCLE: from the same sarcoid BPS, compare the H&E 
stained TBB (autofluorescent microscopy x200) (A) of a pathognomonic non-necrotising 
granuloma to the non-specific disruption seen with pCLE (B). Could the administration of 
intravenous fluorescein help? It causes a general white appearance of the mucus/surfactant (C 
shows a healthy BPS following injection of 5ml of 1%) with bubbles displacing the contrast agent. 
All other acinar structures are disguised. Even when tiny quantities are used (such as 0.4ml of 1% 
in D), the microvessels (marked by the ellipse) are no more distinct, but bubbles are still evident 
where the newly fluorescing mucus is being disturbed. 
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4.4  Conclusion 
A previous study has demonstrated that pCLE accurately displays the morphology of the 
elastin microskeleton within the healthy acinus[48], which has led to speculation that 
pCLE may provide diagnostic clues in peripheral lung diseases[199, 205, 283]. This study 
has described the feasibility and findings of pCLE imaging in a group of patients with 
varied diseases.  
 
4.4.1  Contact force and safety 
It suggests that in this context, pCLE is safe for patients not suffering from bleeding 
diatheses. Whilst the probe causes pleuritic pain, no pneumothoraces were identified 
during the study. However, damage to the delicate pulmonary lobule cannot be excluded. 
For example, the terminal and respiratory bronchioles are substantially narrower than the 
1.4mm diameter probe[284]. Whilst grossly magnified, free ended swaying septal walls 
were observed in 28 BPSs. Sometimes, this may be the product of lung disease, (more 
were observed in the emphysematous BPSs) but the probe was shown to be the likely 
culprit in several videos where traumatic tearing of vessels and delicate septal walls was 
observed in real time. Whether this has any minor clinical significance remains to be 
established, but the trauma should still be less than for TBB.   
 
4.4.2  Accuracy of pCLE  
Regarding image interpretation and the diagnostic potential of pCLE, the best case 
scenario was that alterations to elastin would be specific to individual diseases and 
provide unique image features such that, for example, non-necrotising granulomas were 
visible in sarcoidosis[285], and the fibrotic zones of dense collagen found in pulmonary 
fibrosis were enough to specifically alter the elastin appearance[286]. However, the 
pathognomonic features of specific diseases, observed under standard haemotoxylin and 
eosin histopathological microscopy are unlikely to match the changes occurring to the 
elastin. Nevertheless, elastin structure and production is known to alter in lung 
disease[287-290], and the most salient image finding from this series is the degree to 
which many peripheral diseases (emphysema excluded) are able to create a non-specific 
attenuation of the stunning highly recognisable images of healthy acini. The observed loss 
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of distinctiveness and autofluorescence in the non-emphysematous diseases within this 
study may be due to elastin destruction, alveolar collapse or substances such as collagen, 
blood, inflammatory infiltrate or mucus impeding the incident laser light and emitted 
autofluorescence.  
Predictably[48], the autofluorescence intensity of individual fibres was greater in the 
older subjects; the healthy volunteers were young and whilst their individual septal walls 
were generally distinct, they displayed consistently weaker autofluorescence than from 
older non-diseased BPSs, or those BPS only affected by emphysema.  
It appears that severe emphysema is often evident on pCLE imaging with dark holes and 
a reduction in the number of septal walls visible in each frame. Residual elastin is often 
thickened or disrupted. This is perhaps logical, considering that a major feature of COPD 
is fragmentation and loss of alveolar elastin[291]. The next section of chapter 4 looks at 
the reliability of these diagnostic findings, and whether milder disease is adequately 
demonstrable. If so, pCLE could be employed to grade the severity of emphysema for 
trials, or to assess the efficacy of interventions. Currently, subclinical COPD in 
asymptomatic smokers is screened for using spirometry[292] but whilst much more 
invasive, pCLE could have an additional diagnostic role, particularly if it had greater 
sensitivity for detecting early morphological damage which was predictive for future 
symptomatology. However, centrilobular emphysema tends to be heterogeneous which 
will inevitably create sampling bias; a particular problem in alveolar pCLE where to 
image a new area, mural restraint of the probe necessitates blind reinsertion into the BPS 
in the hope of cannulating a different terminal bronchiole. Conversely, the homogeneity 
of panacinar emphysema in alpha-1-antitrypsin deficiency makes early diagnosis difficult 
using HRCT; this provides a possible niche for pCLE.  
In this current study, it should also be highlighted that two patients with bullae 
inadvertently had what is likely to be the first described in vivo bronchoscopic imaging of 
the inner surface of the elastin rich visceral pleura[293]. 
Thiberville et. al. bronchoscoped 41 healthy volunteers and confidently measured the 
septal walls as being 10±2.7µm and the microvessels as 90±50µm[48]. However, in the 
diseased BPSs, discrimination between these two image components was often 
impossible. This is likely due to pathological disruption of the elastin architecture 
forming the septal walls and microvessels[294-296], along with in many BPSs, the 
disease related reduction of image distinctiveness and autofluorescence described. 
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Using the mosaicing software, the standard 600µm FOV could only be modestly 
increased in just over half of the BPS overall, and only two BPS yielded mosaics >1mm. 
Unlike pCLE in less constrained areas, such as the proximal endobronchium or the 
gastrointestinal lumen, the probe cannot easily be translated, and within the acinus gentle 
withdrawal or further advancement does not always provide adjacent images to stitch 
together. The mosaicing function was likely impaired by fainter septal walls in the 
younger subjects, and distinct feature loss in non-emphysematous disease.  
Whilst this series included only three current or recently quit smokers, the previous 
finding in healthy subjects that bright autofluorescent macrophages are specific to 
smokers or ex-smokers[48], seems to remain true in disease. Whilst there was a 
suggestion of similarly sized faint cells in the acinae of several subjects, the inflammatory 
cells in the video loops from the current and recently quit smokers were very bright and 
clearly independently mobile and therefore distinct from the septal walls they were 
within. The smokers’ BAL fluid uniquely demonstrated fluorescent cells (macrophages). 
The fluorescence imparted upon alveolar macrophages from cigarette smoking takes 
years to fully diminish[203] and there is in vitro evidence that air pollutants have a 
similar effect on macrophage fluorescence[297]. These factors could explain any less 
obvious fluorescent cellular infiltrates. Further work is needed to elucidate the identity of 
the mucus globules/bubbles and the bright 3µm specks. 
 
4.4.3  The role of fluorescein  
Intravenous fluorescein is the modus operandi for pCLE in the GI tract by highlighting 
the calibre, course and leakage of microvessels[239], as well as providing fluorescence of 
the epithelium and glands. For this study, it was postulated that intravenous fluorescein 
might facilitate the discrimination between microvessels and septal walls, and therefore 
might have a role in diagnosis. However, there was no concentration that provided a 
useful role in peripheral lung pCLE imaging as there is “white-out” of the image before 
delineation of any microvessels can take place. A recent small study using only a fixed 
dose of IV fluorescein has suggested there may be subtle differences in the dark bubbles 
in health and disease, though this was not our finding[199] (it also showed that imaging 
of the epithelium of central airways is hampered by intravenous fluorescein). In this 
current study, severe nausea and wretching was induced by the fluorescein in one patient, 
but this has been previously well described during gastrointestinal pCLE[70]. Whilst 
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fluorescein would not preferentially outline microvessels, additional information for 
acinar pCLE imaging may be gleaned in the future by using topical contrast agents as has 
been briefly described in the upper airways[198] and peripherally[205]. 
An in vivo instrument such as pCLE has theoretical advantages over conventional 
histology. We observed both cyclical movement related to respiration within the acinus, 
and mobile cells. There were no serious complications and there was no delay or 
alteration (from histological preparation) to the structure observed. However, with the 
exception of emphysema, there is significant diagnostic information lost with pCLE as 
compared with histopathology. Whilst this study provides a basis to develop pCLE for 
PLD imaging, further work is needed to realise the goal of providing accurate diagnosis 
without tissue biopsy. Safe topical contrast agents that penetrate the cell wall may have a 
role[205]. pCLE imaging of endogenous structures other than elastin may also be realised 
by employing combinations of confocal wavelengths to provoke simultaneous 
autofluorescence from multiple endogenous sources such as collagen[298], or by 
combining fluorescence lifetime imaging with confocal endomicroscopy[299].   
 
4.4.4  Tracking  
The prediction or retrospective estimation of probe destination remains an issue. Even in 
Thiberville et al.’s healthy cohort, over 10% of cannulated BPSs did not yield an alveolar 
image[48], presumably because of an inability to adequately deploy or position the probe 
beyond the respiratory bronchiole. In severely diseased BPSs it was difficult to ascertain 
if a reduction in image quality represented this incomplete deployment, or if the probe 
was imaging a bulla/diseased area. Similarly, it is not possible to confirm that the pCLE 
image was taken from exactly the same location as the diagnostic TBB and BAL. An 
extended working channel was used in the first five patients but this had to be abandoned 
owing to it impairing the ergonomics of the procedure. Whilst this should not be a 
concern in widespread homogenous disease, focal patchy disease may cause difficulty 
with reliable correlation. 
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4.5  Quantification of Emphysema Severity: the Accuracy of pCLE 
Compared to HRCT 
4.5.1  Introduction 
As discussed within the introduction, COPD is a significant worldwide health burden. In 
the United Kingdom alone there are estimated to be 3.7 million people with the 
disease[300] and 30,000 deaths per year are attributed to it[301]. Assessing lung function 
with spirometry remains the mainstay of diagnosis and longitudinal observation in the 
900,000 who obtain a formal diagnosis[302]. Where indicated, HRCT provides fast, high 
resolution images of the anatomical destruction, hyperexpansion and bullae. However, 
with these modalities, early diagnosis is not always possible, and moreover with HRCT 
only providing a resolution of approximately 100µm[303] there is no means of providing 
imaging of individual alveolar walls. A method of providing in vivo images of individual 
alveoli could be useful for identifying early disease and evaluating any therapeutic 
modality for tissue regeneration[304]. 
Section 4.3.4  Basic analysis of emphysema) demonstrated that when severe emphysema 
is present, the pCLE images reflect this, with a destruction of the regular morphology 
and, in particular, areas where the elastic fibres are more scant in the FOV. However, it 
was not clear after lengthy unblinded inspection of the video loops and stills if this was a 
reliable feature (Figure 4.8), or perhaps more usefully, if the images could be used to 
predict the degree of emphysema in the less severe areas.  
 
4.5.2  Objectives and hypothesis 
This sub-study aimed to compare the accuracy, interassessor reliability and intraassessor 
reproducibility of trained assessors determining emphysema severity according to the 
modified NETT classification for HRCT (Table 4.1) using pCLE imaging presented in 3 
different formats[281]. The hypothesis was that pCLE would accurately classify 
emphysema.  
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Figure 4.8 A few of the unenhanced collated still images (CSI) selected from the pCLE video 
loops of the BPSs of healthy and emphysematous BPS. Whilst it would appear that the most 
abnormal/destroyed lobules on pCLE fall within the worst two radiological classifications, there 
do seem to be multiple “false negative” grade 4 images that have good septal wall density 
compared to the destruction evident upon HRCT. 
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4.5.3  Methods 
Using data from the first 15 subjects bronchoscoped in the last section, from 35 BPS, 35 
representative sets were compiled of a) 20-30 second video sequences (VS), b) collated 
still images (CSI) and c) collated enhanced still images (CESI). CESI were produced by 
inputting CSI through brightness equalisation and a low pass filter to eliminate noise; the 
rationale for CESI was to improve the delineation of the septal walls within the FOV. 
Normal areas were obtained from 3 healthy volunteers and from radiologically unaffected 
areas of the first 12 patients with lung disease. As previously described, emphysematous 
areas were ascribed severities based around the modified NETT classification described 
in the last chapter. Overall, 18 BPS were grade 0 (normal parenchyma), 5 BPS were 
treated as grade 2 (26-50% of BPS being affected), 2 BPS grade 3 (51-75%) and 10 BPS 
grade 4 (>75% involvement) (Figure 4.10A). No grade 1 BPS were available/used at the 
time. 
As many representative individual greyscale JPEG snapshots as possible were acquired 
from the pCLE video loops from each BPS selected for the analysis. The “shadow 
remove” function was used where offered and an attempt was made to avoid images with 
motion artefact, bubbles, inflammatory cells or microvessels. Snapshots from the same 
optical location were a minimum of 4 frames apart on the pCLE video loops to avoid 
repetition. No mosaics were used. 
Using Microsoft PowerPoint, 5 assessors (4 clinicians and 1 image scientist) were each 
given an individual 10 minute tutorial on the basics of pCLE in the peripheral lung with 
an explanation of the elastin-containing structures that can be observed (septal walls and 
microvessels). One example of each of the 4 emphysema severities (0, 2, 3 & 4) was then 
provided in each of the three formats for training and for subsequent reference (Figure 
4.9). The assessors (blinded to the prevalence of disease severities) were then asked to 
grade all the 31 remaining BPS, first in VS format, then all in CSI, and finally in CESI, 
presented in a different disarranged order for each format series. For the CSI and CESI 
formats, the individual frames from each BPS were presented on a single PowerPoint 
slide, similar to that seen with the training slides. To evaluate the stability of assessor 
classification, the same observers reclassified some of the VS (14) and CSI (13) one week 
later. The assessors were asked to provide their degree of confidence with each 
classification, and asked for feedback on the exercise. 
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Figure 4.9: Prior to being asked to grade the BPS on each of the two occasions, each assessor was 
given general background information about the essence of emphysema and pCLE, and shown 
examples on slides of G0, G2, G3 and G4 emphysema in the form of VS (A), CSI (B) and CESI 
(C). 
 
For the week 1 interobserver reproducibility and week 2 intraobserver reliability, Fleiss 
and Cohen’s weighted Kappa coefficient for multiple observers and multiple classes was 
used [305] and interpretation was performed according to the guidelines of Landis and 
Koch[306]. Kappa values can range from -1 to +1 (perfect disagreement to perfect 
agreement), with a value of 0 equating to random agreement. Values of 0.81–1.00 
indicate excellent agreement, 0.61–0.80 substantial agreement, 0.41–0.60 moderate 
agreement, 0.21–0.40 fair agreement, 0.00–0.20 poor agreement, and < 0 no agreement. 
SPSS Statistics (Version 17, Chicago, IL, USA) with the MKAPPASC.SPS macro was 
used together with an online kappa calculator[307]. Values were expressed with 95% 
confidence intervals. 
 
4.5.4 Results 
The assessors spent approximately10 minutes having instruction and studying the VS, 
CSI and CESI. The comprehensive week 1 assessment and interrogation of intraobserver 
reliability at week 2 took around 1 hour, and 30 minutes respectively. The accuracy for 
exactly classifying HRCT severity with pCLE was only 13.6% (9.04-19.8) when 
classification was demanded from the VS; 19.31% (13.7-26.5) for CSI; and 11.72% 
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(7.45-18.0) for CESI (Figure 4.11A). Whilst there were examples of both substantial 
underscoring and overscoring, every assessor on average overscored the severity with 
each imaging modality. For example, as shown in Figure 4.10B, the mean overscoring for 
VS was 0.73, 0.63 for CSI and 0.61 for CESI.  
 
 
Figure 4.10 A shows the prevalence of BPSs identified for the study of each different NETT 
emphysema grade. Over half of the BPS were of normal density, perhaps contributing to the 
assessors overscoring them by a mean of 0.73, 0.63, and 0.61 grades for VS, CSI and CESI 
respectively (B). 
    
According to the weighted Kappa coefficients, the interassessor agreement was fair for 
CESI (0.31), but poor for both VS (0.13) and CSI (0.19) (Figure 4.11). At the week 2 
reassessment, the mean intraassessor reliability was judged as moderate for CSI (0.48) 
and fair for VS (0.21) (Figure 4.11).   
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Figure 4.11: In each format there was a disappointing accuracy for the assessors correctly 
predicting the actual emphysema grade of the BPSs (A). B shows the interobserver agreement 
coefficient for each format, and C shows the intraobserver reliability. 
 
4.5.5  Conclusion 
With this limited data set, the ability of five previously pCLE naive assessors briefly 
trained with a very small training set to predict the emphysema severity as determined by 
HRCT was generally disappointing. There was a little intraassessor reliability 
(particularly for CSI) indicating slight stability for individual assessor’s response. 
However, there was less interassessor agreement and none of the 3 formats enabled pCLE 
interpretation to accurately categorise emphysema severity. The “best” agreement was 
seen with intraassessor agreement for CSI and this was still only a “moderate” 0.48.  
It is important to note that this level of agreement is very poor in comparison to levels 
that would ever be considered acceptable for a diagnostic investigation. Kripperndorf 
suggested more conservative cutoffs than Landis and Koch, with values <0.67 being 
being discountable, values between 0.67 and 0.8 requiring scepticism, and values >0.8 
being required for firm agreement to be concluded[308].  
In addition to the small number of training and data sets, and assessors, there are multiple 
limitations to this study. The training was brief, although with other organ targets the 
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learning curve for pCLE is short, with one or two sessions enabling proficiency[65, 66]. 
There is no pCLE classification available so the training was very basic and limited. 
26/31 of the BPS for post-training categorisation by the assessors were either normal or 
severely diseased - grade 0 or grade 4: a more even spread, including some grade 1 
emphysema would have been desirable. Many of the grade 0 subjects were younger and 
therefore known to display less autofluorescence and therefore more noise, and many of 
these “normal” BPS came from lungs with disease elsewhere; therefore mild non-
emphysematous disease may have affected the results. Whilst it was hoped that one 
benefit of computational enhancement of the images might be to better delineate elastin, 
CESI images were not more accurately interpreted.  
A recent study has shown that even in healthy lung transplant patients having similar 
pCLE bronchoscopies 3 months apart, there are only moderate coefficients of correlation 
for measurements of septal wall thickness and lobular diameter between the two 
bronchoscopies[309]. This likely relates to factors mentioned such as dynamic movement 
of the acinus, and the the subsegment of lung imaged on each occasion being slightly 
different geographically, but still not adequately representative of the region. Clearly if 
the data consistency is limited in clinically stable patients, it is likely to be worse in lung 
which is affected, often heterogeneously, by disease. 
Tracking the Probe Location: It is possible that the heterogeneity of centrilobular 
emphysema often results in the pCLE probe advancing through micro-bullae until 
relatively normal elastin structure is reached, imaged and therefore inaccurately 
interpretated as normal lobule. Furthermore, a relatively blank screen could be a micro-
bullous or the probe not having reached the lobule; without an understanding of the 
whereabouts of the probe at any one time this is difficult to establish when cropping 
videos or selecting stills for assessment.       
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Chapter 5 The Significance of Contact 
Force during pCLE Imaging 
5.1  Introduction 
Little is known about any effects that the optical biopsy technique may have upon the 
images acquired. The angle of approach of the device, the degree of spread of the tissue, 
and the contact pressure of the probe may all exert influence. Experience suggests that 
variations in angle of approach of the device seem to be countered to some degree by 
tissue deformation and accommodation of the probe. The degree to which an epithelial 
surface is contracted or stretched out will be affected firstly by multiple biological 
factors, and secondly by inflation pressures (for those targets which depend upon the 
insufflation of gas to create a working space, such as the peritoneal cavity and moreover 
the floppy gastrointestinal lumen). As discussed in chapter 2, the contact force of an 
imaging probe may also play a role; it certainly affects spectroscopic signals [244], and 
pCLE probe pressure can distort the lobule of the peripheral lung[48]. From pCLE 
imaging of the respiratory tree and colorectum in chapter 3, it appears that image quality 
and consistency is not always the same even in healthy tissue, and that small probe 
movements can rapidly alter the field of view or image; it is feasible that probe contact 
pressure could be partly attributable.  
An example of the potential importance of geometry in the interpretation of confocal 
endomicroscopic images was highlighted by Li et al. who found that eCLE images of 
ulcerative colitis mucosa showed a quantifiably reduced number of crypts per image, with 
increased distances between crypts and enlarged crypt openings[129]. However, the 
accuracy of any potential assessment of colitis using a CLE device would be 
compromised if this geometry was unpredictably disturbed by tissue stretch or the angle 
or pressure of the probe itself. Early work into computer aided diagnosis has begun with 
“content-based image retrieval”, using automated detection and interrogation of simple 
glandular features to discrimate between eCLE images from colonic mucosal surfaces 
affected by different conditions[310]. By assessing (amongst other things) the 
compactness, roundness, border size and separation of glands and crypts of a particular 
image, it is possible to search a large library of optical biopsies that have been previously 
correlated with histopathology and provide similar images to aid the endoscopist. This is 
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known as content-based image retrieval; clearly its potential will be limited if probe 
contact pressure affects these simple parameters. 
A very simple preliminary test is shown in Figure 5.1 to explicate the concept. A 2.5mm 
gastroflex pCLE probe was used manually, first with minimal contact force 10 times, and 
then with significant contact force (approximately 3N with a force torque sensor) 10 
times to perpendicularly image four different materials. Topical 1% fluorescein was 
dropped onto lamb kidney and lamb liver; this was not required for the natural sea 
sponges as their collagenous fibres are autofluorescent at 488nm. 80 images were 
acquired; each from a new site. The firmer contact force upon both densities of sponge 
produced a more crowded cluster of filaments, perhaps as fluorescent fibres were 
squashed together into the plane of imaging. Any qualitative effects of contact force upon 
the kidney and liver images were very subtle; perhaps some spreading out of the tissues 
was observable. However, the force changes were crude, and subtle differences could 
easily be missed owing to the lack of distinctive features. 
 
Figure 5.1: The effect of contact force alterations to pCLE images was mostly evident upon sea 
sponge. 
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5.1.1  Initial hypotheses 
The first two hypotheses tested in this chapter were that the morphology of colonic glands 
would be influenced by two different ergonomic factors: the degree of inflation of the 
bowel, and variations in the static contact forces of the probe.  
 
5.2  Methods 
5.2.1  Colon inflation study 
A 70kg landrace pig under general anaesthetic for an unrelated minimally invasive non-
survival gynaecological experiment underwent midline laparotomy and bimanual 
evacuation of the rectum. 3.5mls of 10% fluorescein was injected intravenously. A 
2.5mm diameter standard resolution gastroflex pCLE probe was immediately deployed 
through a gastroscope which was navigated above the peritoneal reflection into the colon. 
With the probe gently abutting the tissue and undergoing slow translational movement, 2 
minute pCLE video sequences were recorded with the bowel a) collapsed, b) inflated to 
4cm diameter, and c) hyperinflated to 6cm  with the aid of an occluding doyen intestinal 
clamp (Figure 5.2D). From each video sequence 20 representative still images were 
extracted: the maximum diameter across each gland was measured using the Cellvizio 
Viewer software, and the number of complete glands per image was recorded (Figure 
5.2E). The study was undertaken under Home office licence PPL 80/2297. 
 
5.2.2  Static force study 
A rigid aluminium board was bolted vertically to an optical breadboard. 4x4cm pieces of 
fresh full thickness distal large intestine from a contrast agent naive pig were irrigated 
with saline to remove mucus and faeculent residue. They were then suspended against the 
aluminium board, but separated and cushioned from its rigid surface by clamping a piece 
of full thickness porcine stomach in between (Figure 5.2B). The same gastroflex pCLE 
probe was used; its smooth distal tip consisted of flat glass constrained by an encircling 
metallic tube lying flush. The topical nuclear staining contrast agent 0.02% acriflavine 
was applied to each sample of colonic tissue immediately before imaging (as intravenous 
contrast was not feasible for this study, a nuclear staining contrast agent was found to 
offer better discrimination of mucosal morphology than topical fluorescein). The probe 
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was clamped 3cm from its tip into a force-sensitive linear servo mechanism that has been 
described in detail for a different application[311]. In summary, a bespoke LabVIEW 
programme (National Instruments, Texas) enables a DC motor to linearly drive a rack and 
pinion system attached to the clamped probe until a predetermined contact force between 
probe tip and tissue is achieved (Figure 5.2A).  
The probe was driven perpendicularly into fresh tissue regions of healthy bowel only, 
until a contact force of 0.005N, 0.05N, 0.1N, or 0.5N was achieved. 0.005N was the 
minimum programmable contact force required to ensure contact, and the acquisition of 
an image. Twenty good quality still pCLE images were acquired and analysed for each 
force. As for the in vivo experiment, the number of complete glands per image was 
counted, and the maximum diameter was measured across each gland.      
 
 
Figure 5.2: For each image, every gland was counted and its maximum diameter measured (E). 
Imaging conditions were altered in an ex vivo experiment by changing the contact force using a 
bespoke programmable actuator to drive the probe into porcine colon (A, B & C), and altered in an 
in vivo experiment by changing the colon diameter using occluded insufflation.  
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Statistics: Owing to gland number and diameter being slightly non-parametric, 2-tailed 
mann-whitney tests and Kruskal-Wallis analysis of variance tests were used. 
 
5.3  Results 
5.3.1  Colon inflation study 
For collapsed, inflated, and hyperinflated distal colon respectively, the mean number of 
complete visible crypts per field of view decreased: 23.8 (±3.1), 14.0 ((±2.1), and 8.1 (± 
0.7) (p<0.0001). Similarly, the mean crypt diameter increased: 65.4µm (± 2.2), 85µm (± 
2.1) and 95.6µm (± 2.8) (p<0.01) (Figure 5.3). It was also apparent that in the collapsed 
bowel, fluorescence was obvious in the centre of the gland, appearing to pool in the crypt.  
 
Figure 5.3: The result of colonic inflation on gland density and diameter.  
 
5.3.2  Static force study 
In total, 80 still pCLE images were acquired, at one of 4 pCLE probe contact forces 
(0.005N, 0.05N, 0.1N, or 0.5N). Only a few had to be repeated, either due to residual 
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mucus causing an unrecognisable image, or in the case of 0.005N images because of 
shadow artefact (Figure 5.4). Analysing the complete glands per field of view and 
maximum diameter across each gland was straightforward, though the gland boundaries 
were not always as distinct in 0.5N images (Figure 5.4).  
 
Figure 5.4 The number of glands and their maximum diameter was easily calculated for each 
image although a few of the 0.005N images had to be repeated due to shadows, perhaps due to 
incomplete contact (A). Some of the 0.5N glands had less distinct boundaries (C) than those 
observed at the smaller forces (B). 
 
It was evident that greater contact forces produced images with fewer glands per field of 
view (Figure 5.5): 18.9 ± 2.6 at 0.005N, 10.3 ± 3.6 at 0.05N, 9.6 ± 1.6 at 0.1N, and 6.6 ± 
1.6 at 0.5N (p<0.01 for all except 0.05N versus 0.1N). Similarly, the images acquired 
during firmer probe contact resulted in those fewer mucosal glands being wider across 
their maximum diameter: 44.6 ±10.5µm at 0.005N, 68.5 ± 25µm at 0.05N, 73.3 ± 21.6µm 
at 0.1N and 92.7 ± 35.8µm at 0.5N (p<0.01 for all except 0.05N versus 0.1N).  
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Figure 5.5: The effects of contact force on gland density and diameter in an ex vivo set-up. 
 
5.4  Conclusion  
These two studies have shown that bowel inflation and probe contact force are able to 
affect gland density and apparent diameter of the glands, at least in the extremes that were 
created in this experimental set-up. This may have important implications for 
standardising image acquisition protocol during endoscopic pCLE to ensure 
morphological alterations to crypts can be exclusively attributed to tissue differences. 
In the in vivo study, the most striking observation was that in the collapsed bowel the 
number of glands per image was almost three times that of the hyperinflated bowel. The 
gland diameter was 46% greater in the hyperinflated bowel. During endoscopy, fully 
collapsed bowel would be challenging to image, and hyperinflated bowel would cause the 
patient severe pain; the endoscopist inflates a lumen such as the colon “just enough”, and 
further work would need to be done to ascertain what the variation in colonic inflation is. 
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Having shown fluorescein in the crypt lumens of the collapsed colon, if intercryptal 
fluorescein remains a marker of disease[129] it may also be important to ensure bowel is 
adequately inflated. Future work would also have to find a way of maintaining a constant 
contact force independent of bowel dilatation, and be performed on more than one 
animal. Though imaging at all three inflations only took a few minutes, image quality 
begins to deteriorate 8 minutes after contrast injection[74], and therefore it would be 
important to alternate the order in which the sequences at different inflations are acquired.  
In the static force experiment it was found that the mean gland diameter at 0.5N was over 
twice the value observed at a “just touching” value of 0.005N.  At the higher force there 
were, on average, less than half as many observable glands per field of view. It is likely 
that the greater the contact force, the more the probe flattens the mucosa and stretches out 
the glands and epithelium; this creates wider glands and squeezes some of them out of the 
field of view. With gland and crypt morphology being an important part of pCLE disease 
classification and understanding[109, 129], this finding in itself may have clinical 
relevance, with contact force being difficult to accurately control endoscopically. With 
manual deployment through an endoscope, the pressure at which the pCLE probe abuts 
the tissue during clinical examination is likely to be between the extremes, but this would 
require further analysis. Our data (unpublished) suggested that, depending on position 
(from straight to retroflexed), between 0.1 and 0.6N respectively of axial force was 
required simply to overcome resistance through the working channel of a colonoscope in 
order to begin to advance the probe toward a tissue target. This suggests that the current 
ability to carefully control the contact pressure is probably limited. On the basis of this 
work, as a first step towards controlling the contact force distally, our laboratory has 
developed a handheld device incorporating force and position sensors with linear voice 
coil actuator to grasp a pCLE probe and ensure a consistent contact force with 
tissue[243]. 
Measurement was made harder by fuzzier edges at higher forces and greater inflation 
pressures; it is possible that a high definition probe may help in future, together with the 
arguable benefits of using intravenous fluorescein (in vivo) over topical acriflavine (ex 
vivo). As future force adjustment study translates into the in vivo environment, it will be 
interesting to see if blood flow through the microvessels is affected. If the mucosal 
capillary blood pressure between arteriole and venule is assumed to range between 
1.3KPa and 4KPa respectively [312], a 2.5mm diameter probe would need to exert a force 
between 0.026N and 0.079N to obstruct the flow. 
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5.5  Introduction - a Study in Dynamic Force  
5.5.1  Diagnosis through assessment of a tissue’s mechanical phenotype 
5000 years ago, the Ancient Egyptians described digital palpation to elicit information 
about aneurysmal blood vessels in the Edwin Smith papyrus[313]. Palpation remains an 
important clinical skill for assessing not only the shape and texture of tissues and organs 
but their hardness and springiness. As the fingers attempt to deform and displace the 
tissue, pressure receptors provide localised information about the stresses that the tissues 
are exerting on the pads of the fingers, and the temporal variation of these stresses as the 
tissue deforms. Indeed, the palpation of hard, irregular tethered masses over soft, well-
circumscribed, mobile lesions tends to discriminate malignancy from benign processes in 
many organs such as during breast examination of a solitary lump, or during digital rectal 
examination of an enlarged prostate. Several technologies are able to more accurately 
extract similar information about the mechanical phenotype of a biological specimen, 
ultimately quantifying stiffness with Young’s Modulus, which is a ratio of the stress 
applied (force per unit area) over the strain (fractional change in length of the object). 
Perhaps the simplest method of comparing tissue stiffness in vivo was demonstrated by 
Carter et. al.[314] using a handheld compliance probe. Consisting of a fixed reference 
ring, surrounding a round tipped rod attached to a linear variable displacement transducer, 
it indented normal and less compliant cholestatic liver parenchyma to a maximum of 
5mm. A similar device has shown that the soft tissues overlying the metatarsal heads of 
diabetics is stiffer than in controls[315]. By employing a 5-50Hz cyclical stress upon 
chippings of benign prostatic hypertrophic tissue, Phipps et al.[316] were able to 
demonstrate that the amplitude ratio between the excitation force and the resultant 
displacement was dependent upon the smooth muscle content; smooth muscle being fairly 
elastic. Equally, they found that the phase difference between the two waveforms, as a 
positively correlated marker of tissue viscosity, was smaller in chippings from malignant 
prostates[317]. For the assessment of skin turgor, the cutometer is a suction technique that 
measures the force required to raise a pre-defined amount of skin[318]; similarly shear 
modulus can be measured with a twisting device placed on the epidermis[319].  
Assessment of mechanical phenotype can also incorporate modern imaging modalities 
such as “echopalpation” during B-mode ultrasonography; an area of interest is 
compressed either digitally or with the ultrasound transducer; in general, firm lesions 
(such as a thrombosed vein) move as a unit whereas soft lesions (such as a patent vein) 
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flatten. This effect is more elegantly displayed during ultrasound elastography where 
cross-correlation between pre-compression and post-compression radiofrequency 
waveforms enables the degree of tissue displacement to be calculated[320]. Derived from 
this are localised strain values: soft tissue has a high rate of change of displacement and 
is displayed brightly, whereas hard areas strain less and appear dark on the elastogram.  A 
study of transrectal ultrasound elastography with a water-filled balloon to create the 
necessary tissue movement produced an area under the receiver operator curve of 0.97 for 
differentiating adenocarcinomas from their softer pre-malignant adenoma precursor[321].   
On a nanotechnological scale, the atomic force microscope [322] can measure the 
stiffness of cells, with neoplastic cells invariably being more deformable[323, 324] owing 
to cytoskeleton changes. Of relevance to this current study however, tumours are 
generally hard, despite their constitutive cells being soft, owing to increased compression 
secondary to the rapidly expanding tumour mass[325], stiffening of the extracellular 
stroma from the desmoplastic fibrosis induced by the tumour[326], and increased 
interstitial pressure from damaged lymphatic drainage and leaky abnormal blood 
vessels[327].  
 
5.5.2  Aims and hypothesis 
The purpose of this section was to establish if pCLE can be used to assess the mechanical 
phenotype of tissue at a microscopic level, and whether the simulation of disease by prior 
chemical alteration of the tissues’ physical properties, can be detected by the way in 
which the pCLE morphology responds to a dynamic force. As discussed, the most 
commonly studied morphological feature of pCLE images of the bowel thus far, which 
has been repeatedly integrated into diagnostic criteria, has been the colonic glands which, 
if healthy, are regularly spaced across the en face image, and comprise small circular 
crypts lined by mucin secreting goblet cells; therefore, as with the colon inflation and 
static force studies, the glandular microanatomy was studied.  
The hypothesis was that the distortion observed during imaging with a cyclical force 
would be less in stiffened tissue than otherwise healthy ex vivo tissue. 
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5.6  Methods 
The experimental set-up with rack and pinion linear slider was similar to the static contact 
force study. The axial contact force was measured at 500Hz by an embedded force-torque 
sensor. Actual force values were recorded for retrospective confirmation of achievement 
of the desired cyclical forces, and also for overlying with the image analysis traces. 
The linear servoing mechanism was programmed so that the probe exerted a 0.43Hz 
sinusoidal contact force with a trough to peak amplitude of 0.07N (from the 0.005N 
required to ensure contact, to a maximum force of 0.075N). pCLE video sequences were 
recorded for nine healthy and seven stiffened pieces of tissue. Stiffened tissue, to mimic 
neoplastic transformation, was created by partial fixation of healthy full-thickness colon 
from the same pig (soaked for two hours in 10% formalin before rinsing in saline). For 
this study the analysis of the pCLE video sequences was more automated. Thus, for each 
video, the centre of every distinct gland was manually selected prior to the entire frame 
undergoing histogram equalisation and median filtering. This removed spurious noise, 
and improved the contrast between the poorly fluorescing boundaries of the glands and 
the fluorescent surrounding epithelium. A binary thresholding operation was applied to 
the filtered frame, with a threshold dependent on the intensity of the manually selected 
points and their immediate surroundings. Only connected regions containing the selected 
points were retained and their centroids calculated; this outlined the desired regions. For 
each frame, filtering and thresholding were automatically applied and the glands were 
temporally and spatially tracked by checking which connected regions contained the 
centroids computed at the previous frame. Under the assumption of smooth motion and 
medium to large crypt size, regions were tracked consistently and they were usually 
recovered from temporary occlusions. For each region tracked within the frame, 
information about its centroid, and average distance to the centroids of the other tracked 
regions was recorded. All glands that remained trackable for a minimum of three 
sinusoidal force cycles were included in the subsequent analysis for both mean gland 
surface area and mean intergland separation. Both these measurements were plotted as a 
moving average of the neighbouring three values, and overlain onto the waveform of 
contact force. For each gland analysed, the mean percentage change in area over two 
consecutive cycles was calculated (with the smaller area/trough used as the denominator). 
Data was taken from a trendline which averaged area and separation readings effectively 
over every quarter second. This method was also used for assessing the mean percentage 
change in separation between the centroids of the glands as the contact force varied.     
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Direct visual observation and the data from the static force study suggested that the 
greatest alteration to gland size and the number of glands per field of view/gland 
separation was occurring across forces less than 0.1N. This finding supported the choice 
of the minimum and maximum parts of the sinusoidal dynamic force as being 0.005N and 
0.075N respectively. 
 
5.7  Results 
From the videos of the 9 healthy/fresh bowel specimens, 29 glands were tracked and 
analysed. 36 glands were tracked from the 7 specimens that had been partially fixed and 
stiffened by formalin to mimic disease. The morphological changes in response to a 
sinusoidal force appeared to also be approximately sinusoidal for healthy and pre-treated 
tissue (see healthy example in Figure 5.6). The mean surface area of the glands during 
minimum probe contact force (0.005N), which was effectively baseline, was greater for 
healthy bowel (712 pixels ± 297 SD) than it was for stiffened tissue (379 pixels ± 196 
SD) (p<0.01).  
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Figure 5.6: An example of the temporal effect of a sinusoidal force on the mean separation of five 
tracked glands in a fresh piece of colon with the corresponding area of one of the glands (marked 
in red). Formalin pre-treatment toughens the tissue and appears to condense more glands into the 
field of view (bottom right). 
 
As the probe was pushed in and out of the mucosa to cyclically increase and decrease the 
contact force, the mean gland area rose and fell for both tissue types, but for the constant 
amplitude of force applied, the mean percentage change of mean gland area was greater 
for the healthy tissue compared to the less compliant stiffened tissue: 52.8% ± 47.4 SD 
versus 20.1% ± 14.2 SD (p<0.01).  
Though the glands selected for analysis in each video were picked on their trackability 
and not on their spatial relationship with one another, probably due to the formalin 
treatment, the glands analysed within the videos of stiffened tissue were closer together 
during the minimum probe contact force within the force cycle (0.005N) than the healthy 
glands: the mean centroid separation at this force was 11.7 (± 5.07 SD) kilopixels versus 
16.8 (± 7.61 SD) kilopixels (p=0.028).  
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As the probe was sinuisoidally driven in and out of the mucosa with the linear servo rig, it 
was evident that the glands in both tissue phenotypes were cyclically becoming more 
spread out before returning to their original position. Analysis of the percentage change in 
this intergland separation showed that the stiffened tissue contained glands which 
separated proportionally less than the healthy ones during the same cyclical force 
changes: the mean percentage change in intergland separation was 19.3% (± 23.3 SD) for 
healthy tissue versus 3.66% (± 2.12 SD) for stiffened tissue (p=0.045).      
 
 
Figure 5.7: Columns demonstrating that for the same additional axial force, the pre-treated 
tissue’s glands did not enlarge or separate to the same degree as the fresh tissue. 
 
5.8  Conclusion 
The ultimate aim for the multitude of in vivo optical imaging probes currently being 
trialled is to provide sufficient information for the clinician to safely make realtime 
accurate diagnoses and decisions about management without needing to biopsy, or at the 
very least to be able to take more focussed higher yield biopsies. To this end, pCLE has 
made enormous progress over the last decade, but in general, still only provides 
complementary information. For example, as discussed in chapter 2, screening for 
neoplasia in Barrett’s oesophagus has been the focus of most of its clinical research, but 
the sensitivity was as low as 12% in a recent multi-centre study[160]. Similarly, during 
screening endoscopy of the lower gastrointestinal tract of asymptomatic patients[91] (a 
procedure which is likely to put enormous burden on pathology services in the next 
decade) pCLE would be an invaluable tool if it could obviate the need for biopsy of every 
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small benign appearing mucosal polyp, but a current sensitivity of 88% is inadequate to 
do this safely[109]. Current diagnostic criteria for pCLE are predominantly based around 
qualitative architectural abnormalities, and as such are highly subjective.  
Therefore, the second part of this chapter aimed to establish whether the mucosal lining 
of the gastrointestinal tract provides other, more quantifiable clues as to its phenotype that 
could potentially be identified during elastographic assessment with pCLE. 
Computational analysis has shown that with the application of a sinuisoidal axial stress, 
the dark areas representing glands cyclically enlarge and shrink, but the proportional 
change in area of healthy glands is over double that of glands from stiffened tissue. The 
cyclical force also induces glandular dispersion and coalescence, and whilst this is 
minimal in the stiffened tissue, there is a 19.3% variation in interglandular separation 
over the force cycle in fresh tissue. It is interesting therefore that the stiffened tissue’s 
glands appear to expand their own area with greater ease than which they disperse; this is 
partly explained because a change in area is being compared with a linear dimension, but 
it is possible that their orifices or goblet cells are less affected by the stiffening than the 
epithelium and lamina propria. The sinusoidal input force was a similar shape to the 
strains produced, suggesting that both tissues were behaving approximately elastically. 
It is known that diseased cells and tissue present altered mechanical properties[314, 324], 
and that fibrotic or malignant tissue tends to be stiffer than its healthy precursor. 
Nevertheless, formalin immersion to create protein cross-linking and toughening is a 
relatively crude method of simulating the increased stiffness of neoplastic change within 
mucosal tissue, and indeed the baseline morphology is affected. Future work should aim 
to see if the elastographic response is affected by actual mucosal disease, and also to 
establish if the results demonstrated using topical contrast agent on flaccid mucosa with 
very gentle forces on a steady platform can be replicated endoscopically in vivo using 
intravenous fluorescein.  
It is likely that if probe contact force is ever to be adequately controlled or expoited some 
kind of robotic actuation will be required. This is presented next, in Chapter 6. 
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Chapter 6  Probe Manipulation – 
Improving the Ergonomics and Tracking 
of pCLE 
 
 
6.1  Introduction  
 
In chapter 2 the multiple ergonomic challenges of pCLE were discussed and have been 
further described in the intervening chapters. Essentially, to adequately exploit its high 
magnification and fine resolution, the pCLE probe must remain completely still, or 
translate very gradually and predictably over the tissue to avoid movement artefact. It 
must abut the tissues near perpendicularly, and not be fazed by tissue deformation, 
cardiorespiratory movement or peristalsis.   
 
The potential need for control of contact force has been highlighted, with extremes of 
axial force shown to alter the colonic gland diameter by a factor of two in chapter 5, with 
different elastographic responses obtained from stressing simulated diseased tissue. In 
chapter 4 it was shown that axial force may cause subclinical damage to delicate tissue, 
but back in chapter 3 it was observed that force control is not always straightforward with 
pCLE through a resistant endoscope working channel, especially if retroflexed.  
 
It was apparent in chapter 3 that, occasionally, marked heterogeneity is apparent in the 
pCLE sequences analysed post-procedure from what was seemingly a specific lesion or 
macroscopically uniform area of colorectum or endobronchium. This underscores two 
requirements: 
 
6.1.1  Probe manipulation for a larger optical biopsy 
Using breast lesions as an example, the more tissue that a histopathologist is presented 
with, the higher the chance of a firm diagnosis: a surgical biopsy provides more 
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information than a core biopsy, which is itself more informative in most situations than 
fine needle aspiration cytology. Similarly, small areas sequenced by pCLE do not 
necessarily represent adjacent tissue characteristics and a more accurate impression 
should be gleaned if pCLE examines a larger area to illustrate the heterogeneity more 
accurately, with longer video sequences or preferably a large mosaic. Therefore if a larger 
area is to be scanned quickly and consistently, one solution could be to incorportate 
robotic actuation. This could ultimately enable mosaics to be constructed in a more 
structured way such as a raster pattern or outward spiral; along with the potential benefits 
of easier navigation of the pCLE probe to the optical biopsy target, and more controlled 
contact force. 
 
 
6.1.2  Precise tracking of probe tip location 
It is not realistic to assume microarchitectural homogeneity of all examples of 
endobronchial nodularity or rectal carcinoma, with distinct borders that the translating 
probe will never stray across. Nor is it possible to accurately identify the geographical 
target of a pCLE sequence acquired following blind deployment of a probe into perhaps 
the biliary tree or ureter, or more particularly the peripheral lung with its extensive 
branching. Chapter 4 illustrated the point that negligible autofluorescence on screen 
during peripheral lung pCLE may represent the probe having not yet reached the lobule, 
or be indicative of a large bullous. It is also difficult to guarantee that optical and pinch 
biopsies are taken from exactly the same target in the lung. Hence, for a diagnosis to be 
ever feasible from a pCLE image, the clinician must know the area from which it was 
taken.  
In the peritoneal cavity or bowel lumen a macroscopic image can be saved of the specific 
point/s that the probe has touched, although precise co-registration of pCLE and white 
light endoscope imaging would be of great benefit for post-procedure analysis. If there 
are local features to put the site in context, it may be possible to revisit almost the same 
place for subsequent follow-up imaging or treatment, especially if a tissue biopsy has 
been performed and has not completely healed, as was found in the rectal cancer patient 
in chapter 3.  
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However, during peripheral lung bronchoscopy, accurately linking an individual pCLE 
video sequence with a site (essentially its corresponding CT image) is sometimes difficult 
due to the inherent problems of establishing where the tip of the probe has been blindly 
deployed to - without using fluoroscopy.  
The bronchial tree comprises over 20 generations. When the bronchoscopist advances the 
probe blindly from beyond the bronschope tip, at perhaps the 3rd or 4th generation, into an 
area of peripheral lung, is it even possible to predict where the probe will travel to? 
Perhaps, analogous to a locomotive following the path of least resistance determined by 
the setting of the points on the track, the physical constraints of the bronchial tree dictate 
that the probe can only ever end up in one place: factors like speed, angle of insertion, 
relationship within breathing cycle are irrelevant and the probe’s destiny is pre-
determined. This would lead to the exciting possibility of the CT scan or the resistance 
experienced during deployment of the probe providing sufficient information to predict 
where the probe’s image is being acquired from without using fluoroscopy. It may also 
allow the MDT to establish if access to a lesion with pCLE (or indeed TBB) would ever 
be feasible bronchoscopically, or whether diagnosis would be expedited by a 
transthoracic approach from the outset.  
However, this suggestion is contradicted by an individual case report taken from the 
peripheral lung pCLE imaging study in chapter 4. A 67 year old ex-smoker presented 
with a spiculated mass in the upper segment of the left lower lobe (LB6). Subsequently, 
transthoracic biopsy showed that it was a non-small cell lung carcinoma. During pCLE 
bronchoscopy, the bronchoscope was navigated as far distally as possible down the 
tapering bronchial tree before blind probe deployment distally into the opening of the 
corresponding segmental bronchus of the lesion. Initial insertion yielded a video sequence 
with surprisingly relatively normal density fluorescent septal wall appearance (Figure 
6.1). Two subsequent deployments into the same bronchial orifice produced video images 
with attenuated autofluorescence and diminished structural distinctiveness. It was 
hypothesised that these sequences were from structurally dissimilar regions of the lung, 
and potentially identifiable variables in the workflow were responsible for the probe 
having more than one terminal destination. 
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Figure 6.1: LB6 was cannulated with the probe (A), in an attempt to image the circled lesion on 
CT in (G). It is suspected that the probe was able to pass either inferiorly (B) and image relatively 
normal lung (C&D) or pass superiorly (E) to image abnormal parenchyma (F&G). 
 
 
6.1.3  The aims and hypotheses of the robotic manipulation and tracking 
studies 
Two studies were performed and are described in turn in the following sections, with an 
overall discussion at the end of the chapter.  
1. The manipulation study looked at the feasibility of robotic actuation for pCLE 
optical biopsy. Considering the specific ergonomic and technical challenges 
posed by pCLE probe tip manipulation within the peritoneal cavity, with its lack 
of luminal restraint and irregular geometry, a projection was made of how a 
multi-articulated robotic endoscope would safely perform transvaginal pCLE 
peritoneoscopy, using an estimated workspace derived from patients’ computed 
tomography (CT) scans. A porcine study was then performed to assess the 
feasibility of this ergonomically more sophisticated method of acquiring 
interpretable targeted pCLE optical biopsies. 
2. The aim of the tracking study was to assess any predictability of probe tip 
destination in an ex vivo lung porcine model. The hypothesis was that for 
peripheral lung pCLE, as the probe tip is deployed beyond the starting point of 
the most distally visualised bronchial divisions, there are multiple potential 
terminal destinations.  
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6.2  Methods - Robotic Manipulation Study 
6.2.1  Articulated robotic endoscope 
The articulated robotic endoscope has been previously described[328, 329]. In summary, 
it provides seven independently controllable degrees-of-freedom from five serially 
connected segments attached to a rigid aluminium shaft. Proximal to the distal and middle 
segments are universal joints each providing ±45° pitch and ±45° yaw, whereas the 
proximal three joints provide ±45° yaw only. Combined, the endoscope’s distal tip can 
pan ±90° vertically and ±225° horizontally. The 500mm length shaft, 44mm proximal and 
middle segments, and 36mm distal segment are all 12.5mm in diameter and therefore 
compatible with existing trocar ports. The device is insulated and protected by a bellowed 
latex sheath. 
Each of the degrees-of-freedom is actuated by an embedded Ø4mm Brushless DC 
micromotor (Namiki Precision Jewel Ltd, SBL04-0829) with a 337:1 planetary gearbox. 
The rotary motion of the motor is converted to joint rotation via an internal mechanism. 
The device features three internal channels: a Ø1.8mm internal channel to pass power and 
signal lines for the motors; a Ø3mm channel to pass an IntroSpicioTM 115 Micro CCD 
video camera (Medigus Ltd, Israel); and a Ø3.5mm channel through which standard 
endoscopic instrumentation can be passed. In this study, the latter channel was used for 
the pCLE probe. The device is controlled via a thumbstick embedded within a handheld 
controller[329]. 
 
Figure 6.2 The 7 degrees-of-freedom robotic articulated endoscope (a) has two operating channels 
for the camera and interchangeable instruments (eg. pCLE probe). In the linear translation 
mechanism schematic (b), the components which translate to servo the probe (rack, slider, clamp 
and pCLE probe) are shaded in red. 
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6.2.2  Imaging probe and deployment 
A standard 2.5mm diameter Gastroflex pCLE probe was inserted through the 3.5mm 
operating channel of the articulated endoscope.  
To simplify the ergonomics of engaging the pCLE probe with target tissues, and to enable 
the operator to manually maintain effective contact between probe tip and tissue 
regardless of tissue movement and distal joint movement, a linear translation mechanism 
is attached to the proximal end of the robot’s shaft (Figure 6.2). Where the probe exits the 
robot proximally, it is clamped into the translation mechanism which utilises a 6V 
brushed DC motor and a rack and pinion slider to manually advance or retract the probe 
at a fixed speed based on a switch on the handheld controller. Note that in chapter 5 the 
translation device produced a prescribed force; this was not feasible with the robot, as the 
probe tip was substantially further away from the transducer and the probe was variably 
contorted along the articulating endoscope shaft. Nevertheless, the aim of this 
mechatronically-assisted approach was to allow the operator to both steer the distal tip 
and engage the probe using a single hand, thus simplifying the overall deployment of the 
pCLE probe when compared to a conventional endoscope.  
 
6.2.3  Estimation of clinical workspace 
To predict how the robot would perform pCLE peritoneoscopy clinically, an estimated 
average pneumoperitoneum workspace was required. Whilst it is known that the 
diaphragm is raised 2-3cm caudally by a pneumoperitoneum[330, 331], and external 
elevation of the abdominal wall fascia prior to insufflation raises the umbilicus by 
approximately 8cm[332], there is a paucity of data on the shape and size of the 
pneumoperitoneum created for intraperitoneal procedures. 
The shape of the workspace was therefore obtained from the CT scan of a patient with a 
pneumoperitoneum secondary to a perforated colon: the extraluminal air provided a 3-
dimensional mesh shape which was then smoothed across the deep surface.  
The mean maximum length and width of the potential space of the peritoneal cavity was 
obtained using ten consecutive outpatient female abdominopelvic computed tomography 
(CT) scans. The length was measured from the most cranial part of the diaphragm to the 
parietal peritoneum lying immediately deep to the most anterior aspect of the pubic 
symphisis (319.5mm +/- 21.3mm); for the workspace, 25mm was added to this for 
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insufflatory diaphragmatic elevation[330, 331]. The width was calculated across the 
peritoneal cavity at the widest part of the iliac crests (235mm +/- 22.3mm). From the 
inferior tip of the pneumoperitoneum the posterior colpotomy for the transvaginal entry 
point was a mean of 20mm +/-8.2mm craniocaudally and 58mm +/-13 anteroposteriorly. 
The 3-dimensional mesh was then shrunk to these dimensions creating a 
pneumoperitoneum depth of 93mm. 
 
6.2.4  Projection of robotic pCLE in workspace 
An optimisation algorithm was developed to establish the proportion of the mesh surface 
that could be touched by the probe tip, to a tolerance of 1mm, at various different 
probe/tissue angles, using all possible robot configurations for every point on the visceral 
and parietal workspace surface. The software was implemented in Matlab®. In the 
projection, the robot was treated as having eleven degrees-of-freedom. These arose from 
a) the seven degrees-of-freedom shown in Figure 6.2, b) translation in and out of the 
patient, c) roll about the robot axis, d) 30 degrees of tilt in the sagittal plane, and e) 30 
degrees of sideways yaw. Yaw and tilt were pivoted at the posterior colpotomy. The 
pCLE probe tip was assumed to lie 10mm beyond the distal tip of the robot.  
 
6.2.5  Study animal and in vivo imaging procedure 
An adult large white landrace crossbread female pig (70kg) was anaesthetised with 
intramuscular ketamine 5mg/kg and xylazine 1mg/kg. After endotracheal intubation 
anaesthesia was maintained with oxygen, nitrous oxide and isofluorane, and at the 
conclusion of the procedure, the animal was euthanized with anaesthetic overdose using 
sodium pentabarbitone (Lethobarb). The study protocol was approved by the home office 
under the Home Office Animals for Scientific Procedure Act 1986, (number 80/2297).  
Intravenous fluorescein sodium 10% (Martindale’s, UK) was used as a contrast agent.  
0.05ml/kg body weight[73] was used with a saline flush, 5 minutes before pCLE 
imaging[74].  
Pneumoperitoneum was created through a 10mm umbilical port and maintained at 
14mmHg; this port accommodated a laparoscope which was used to record footage of the 
robot during the procedure. Transvaginal access was via a bespoke 30cm trocar inserted 
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through a posterior colpotomy. The rigid proximal end of the endoscope was manipulated 
by the surgeon, and the articulated distal end was navigated between pre-determined 
anatomical regions of the peritoneal cavity using the handheld controller. At each target, 
with the distal tip of the endoscope 10-20mm from the tissue surface, the axial 
deployment mechanism was switched on to advance the probe until tissue contact was 
made. pCLE videos were then recorded as the probe was translated across the tissue 
surface using controlled motion of the distal tip. Once acquisition was complete, the 
probe was retracted back into the channel using the deployment mechanism. 
Cellvizio Viewer software (Mauna Kea Technologies, Paris, France) was used after the 
procedure to create mosaics from the video sequences. Images were compared with 
known histology.  
 
6.3  Results - Robotic Manipulation Study 
6.3.1  Workspace analysis 
The algorithm calculated that 88% of the estimated workspace mesh surface could be 
reached (Table 6.1).Over half of the workspace could be contacted perpendicularly.  
 
Contact angle between 
probe and tissue 
Percentage of mesh surface that probe tip 
can touch within 1mm with transvaginal 
approach 
0-90° (any angle) 88% 
≥45°  83% 
≥60° 78% 
≥70° 70% 
≥80° 61% 
90° 53% 
Table 6.1: The proportion of the workspace mesh surface that would be reached for different 
angles of the pCLE probe. 
 
By examining the heatmaps generated from this analysis, it is clear that the only 
unreachable surfaces (12%) are within the workspace pelvis, especially on the deep 
visceral surface (Figure 6.3). Here, the robot is retroflexed, rendering its transvaginal 
forward translation unhelpful for closing in on the probe’s target. It is also evident that 
the recesses of the workspace and some areas of the irregularly contoured visceral surface 
can only be reached at angles shallower than 90°.  
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Figure 6.3: The top diagram projects the configurations required by the robot to target three 
regions of the pneumoperitoneum workspace during transvaginal deployment. Underneath it are 
heatmaps which illustrate the areas of the workspace that could be pCLE biopsied at particular 
angles (proceeding downwards is a lateral view from the left; a view of the parietal peritoneum 
from the outside; and a view of the visceral surface from below the workspace). Dark blue, lighter 
blue/yellow, and red areas can be abutted at a maximum of 90°, 45-90° and <45° respectively by 
the probe. 
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6.3.2  pCLE peritoneoscopy 
The operator was able to systematically navigate the articulated endoscope throughout 
predefined regions of the abdominal cavity using the onboard camera. It took 3 minutes to 
provide adequate onboard views of the main viscera. After switch operated deployment of 
the probe, providing an optical biopsy took a further 1-2minutes for each organ. The 
deployed pCLE probe was able to translate sufficiently slowly under active control of the 
distal joint to provide artefact free videos and therefore mosaics up to 2mm in length to 
effectively increase the image field-of-view of parietal peritoneum, liver, and spleen 
(Figure 6.4). Movement from positive ventilation provided enough translation between 
probe and serosal surface for imaging of some areas of liver and spleen. It was necessary 
to increase the probe deployment length to image pelvic surfaces. Tissue deformation 
frequently enabled imaging at shallower angles than 90°. There was no evidence of tissue 
damage from the probe. 
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Figure 6.4: The robot was inserted transvaginally and navigated around the abdominopelvic cavity 
(a). Optical biopsies were obtained of spleen (b), peritoneum of anterior abdominal wall (c), and 
liver (d). (e) shows the onboard camera view of the liver during pCLE imaging. 
 
6.3.3  Interpretability of robotic actuated optical biopsies 
Whilst the images from the stomach surface had no recognisable features, the robot 
enabled recognisable stills and mosaics to be acquired of other organs (Figure 6.5).  
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Figure 6.5 Robotically acquired pCLE optical biopsies of peritoneum, liver and spleen. Courtesy 
of slow and controlled movements of the distal robotic joint, it was possible to use mosaicing 
software to expand the field-of-view by up to 4 times (approximately 2mm) to create more 
representative and interpretable optical biopsies (a, d & h show the expansion). The parietal 
peritoneum of the anterior abdominal wall shows 10 to 100µm blood vessels (a-c). The liver 
images show distinct features of liver parenchyma, with mildly fluorescent hepatocytes contrasted 
against dark sinusoids (particularly prominent in (g)), arranged into hexagonal lobules (d-f) each 
surrounded by fluorescent vascular septa with highly fluorescent branches of the portal vein at the 
hepatic triad present at each lobule corner (marked by circles). The splenic parenchyma shows 
dark cords of billroth surrounded by extracellular space containing fluorescent blood. Larger 
diameter sinusoids are clearest in j. The 100µm vessel in i is likely to be a penicillar arteriole (a 
straight arteriolar branch of one of the central arteries)[333]. 
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Peritoneum: In the parietal peritoneum of the anterior abdominal wall, fluorescein was 
observed to course through the straight and angularly bifurcating vessels deep to the 
mesothelial monolayer. These vessels ranged from 10µm (capillaries) to 100µm 
(arterioles and venules). 
Liver: With the porcine liver capsule reported as being less than 100µm thick[334], the 
recognisable features of liver parenchyma deep to the capsule are compatible with the 
100µm confocal imaging depth. In the porcine model, each 1-2mm hexagonal liver 
acinus/lobule is surrounded by thick, vascular, well developed connective tissue septa that 
branch from the capsule[335]. Under pCLE these were highly fluorescent and delineated 
the edges of the lobules. Furthermore, enhanced fluorescence was seen at the highly 
vascular portal triads present at each corner of the lobule, and a characteristic mottling 
was present within each lobule from dark sinusoids lined by mildly fluorescent 
hepatocytes.  
Spleen: Some areas of the spleen provided minimal fluorescence and it is likely that the 
confocal imaging depth was within a relatively avascular area of the 50-165µm[336] 
splenic capsule. Elsewhere there was a unique appearance from the fluorescent blood 
filled spaces of the splenic parenchyma under the capsule. It can be surmised that these 
structures are part of the red pulp and comprise tortuous 20µm sinusoids (modified 
endothelial lined venules) together with a narrower network of blood filled extracellular 
space surrounding the cords of billroth.  
  
6.4  Discussion - Robotic Manipulation Study 
pCLE is a new in situ imaging technology where potential diagnostic tissue targets are 
being continually expanded. However, regardless of optical biopsy location, cellular level 
resolution brings the need for careful ergonomic control. Still images can be created when 
the probe is stationary relative to the tissue. With steady, slow movement over a couple of 
millimetres, a more representative area can be imaged, and the resultant increased field-
of-view mosaics may enhance the interpretability for the operator[101]. The 
instrumentation available to perform these sometimes awkward manoeuvres is 
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limited[52]; the first aim of this chapter was to establish whether robotic control could be 
the solution. 
By estimating the clinical workspace provided by a pneumoperitoneum in the average 
female, it was calculated that a 7 degrees-of-freedom robotic endoscope, when introduced 
transvaginally with the benefits of manual roll, tilt, yaw and translation movements, 
would allow 88% of the peritoneal cavity to be abutted by a pCLE probe that had been 
deployed by 10mm. If the optimisation algorithm was adjusted to permit longer 
deployment of the probe, it is probable that much of the unreachable pelvic region could 
be contacted. Perpendicular probe abutment is preferable for consistent images, but only 
53% of the cavity would be abutted at a minimum of 90°. Nevertheless, deformable soft 
tissues tend to pucker, enabling shallower angles to often achieve adequate results.  
In the subsequent feasibility study we demonstrated that control via an articulated robotic 
endoscope would enable simple pCLE optical biopsy in a transvaginal porcine NOTES 
setting. The robotic endoscope was navigated around the peritoneal cavity and after the 
probe had been deployed using the linear translation mechanism, small yaw movements 
of the distal joint enabled mosaics of up to 2mm to be constructed.  
There were specific features representing the architecture of healthy liver, spleen and 
peritoneum. If metastatic deposits display characteristic pCLE features, clinical 
translation for assessment of suspicious peritoneal nodules in patients merits further 
evaluation. It is likely that novel fluorescent biomarkers which are switched on by 
malignant tissue[337], or that target specific peptides which are expressed in cancer[126] 
will help with this.   
It should be noted that there are limitations to the workspace estimation used in this 
paper. For example, the shape reflected a single pathological pneumoperitoneum, where 
consciousness and abdominal muscular contraction secondary to peritonism may have 
created a different contour compared to a surgical pneumoperitoneum. During surgery, 
12-16mmHg pressure is often used (though there is some evidence that the workspace is 
not altered by lower pressure[338]), but the pressure of the pathological 
pneumoperitoneum could not be measured. Nevertheless, abdominal compartment 
syndrome (ACS) occurs above 20mmHg, and, excluding iatrogenic endoscopic injury, 
acute visceral perforation is a rare cause of ACS[339], which suggests that a pathological 
pneumoperiteonum is at relatively low pressure, and therefore of no increased volume. In 
practice the workspace may well be intentionally increased and deformed intraoperatively 
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by intraoperative patient positioning and manipulation of the intestines, providing even 
more space for the robot.  
If translatable, there are numerous potential clinical applications for this ergonomically 
enhanced intraperitoneal pCLE. For example, in chronic renal failure patients undergoing 
peritoneal dialysis (PD), establishing the cause of ultrafiltration failure sometimes 
requires a peritoneal biopsy. Encapsulating peritoneal sclerosis is a potentially fatal 
complication of PD with inadequate early diagnostic investigations[340]. Nevertheless, 
there is a correlation between decreased ultrafiltration and a submesothelial thickening 
with vasculopathy. These vascular changes include neovascularisation, vessel wall 
thickening and dilatation[341]. Experimental chapters 3, 4, and 7 confirm that pCLE 
provides high resolution images of the microvessels and could therefore have a role in the 
future in longitudinal study of the membrane, particularly if minimum invasive access 
could be developed – such as through NOTES, or a wide diameter PD catheter[342]. 
Perhaps a device such as has been described could provide rapid and simple in situ 
diagnosis of ultrafiltration failure in real time. However, it is likely that cancer staging, 
and diagnosis of liver disease would be the main targets for robotically controlled pCLE 
peritoneoscopy [226, 343], and its precise movements may have a role in making nCLE 
of solid organs safer[227, 344].  
The addition of automated control of the distal probe tip contact force could potentially 
make the ergonomics even more straightforward, increase safety and improve image 
consistency. It might require the use of a distal force transducer, or a means of indirectly 
assessing the distal contact force by adjusting the values measured at the proximal 
translation device according to the conformation of the flexible endoscope. 
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6.5  Methods – Tracking Study 
A balloon cuffed size 15 endotracheal tube was inserted into the left main bronchus of a 
fresh left pig lung. It was connected to a continuous positive airways pressure (CPAP) 
machine (Resmed Sullivan® S6 elite) and placed “supine” in a non-restrictive perspex 
tray secured with zip ties around the trachea (Figure 6.6). After 15 minutes of continuous 
flow to ensure maximum inflation, 20 radioopaque fiducial markers (3mm Suremark® 
V30 spheres) were attached to the visceral pleura using Loctite® superglue adhesive. The 
inflated lung was then imaged with HRCT using 0.5mm slices with subsequent resolution 
into transverse, sagittal and coronal sections. 
With the lung tray then anchored at 45 degrees supine, a lubricated 6mm Olympus BF10 
bronchoscope was inserted through the endotracheal tube and navigated sequentially to 
all of the most distally navigable bronchial branches. At each of these bronchoscope tip 
locations, the pCLE probe was deployed with constant gentle force until a subpleural blue 
glow was visible. The probe was then reinserted several times until all possible 
destinations had been found. Where feasible, this process incorporated different angles of 
approach and positions of the bronchoscope with respect to the bronchus being 
cannulated. For each of the probe tip’s supleural terminal destinations, the straight line 
distance to the three nearest fiducials on the relevant pleural surface was measured by 
ruler. 
 
Figure 6.6 The argon blue laser light appearing subpleurally after probe deployment down a dorsal 
branch of the pig’s left caudal lobar bronchus is circled in white (left). Fiducial markers, circled in 
yellow, were stuck to the inflated lung (middle). An axial slice of the mid pig lung is viewed from 
below (right). 
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The coordinates of the probe tip destinations were retrospectively estimated by iterative 
optimisation using Praxis software. In essence, after establishing the fiducial coordinates 
on the CT scan images using the MRIcroN viewer, the sum of squared differences of the 
unknown point to the fiducials was minimised[345, 346]. Estimates were disregarded for 
any further assessment if they required the algorithm to change any of the measurements 
to a fiducial by more than 11mm. These were regarded as a software calculation flaw. 
Where a bronchoscope tip location produced more than one probe tip destination, the 
maximum distance between these estimated points was calculated. The distance between 
each starting point and optimised terminal destination was measured on CT (rather than 
simply via length of probe deployment). 
 
6.6  Results - Tracking Study 
Whilst the size and volume of porcine lungs is comparable to human lungs[347], the 
anatomy differs markedly. For example, there are four lobes on the right (the right apical 
lobar bronchus to the right apical lobe stems from the trachea) but only two on the 
left[348]. This study only used the left lung and the CPAP machine inflated it with a 
constant 20cmH2O. Its height was comparable to an adult human’s at 489mm from the 
most caudal part of the caudal lobe to a point level with the apex of the apical lobe. With 
the stiff probe contained within the biopsy channel, it was not possible to flex the 
bronchoscope sufficiently to cannulate the apical lobe via the apical bronchus off the left 
principal bronchus.  
A systematic inspection of the left caudal lobe with the bronchoscope revealed 28 tertiary 
and quarternary bronchi branching from the caudal lobar bronchus where the pCLE but 
not the bronchoscope could fit (starting points) (Figure 6.7). Awkward bronchial branch 
angles prevented pCLE deployment from 7 starting points, and in 2 further cases the 
probe stopped before its blue haze was visible. Therefore, 19 starting points yielded 
recordable terminal destinations of the probe. After multiple insertions from each of these 
starting points, it was concluded that 10 had a single possible destination and 9 had 
multiple destinations (3 had 2 destinations, 3 had 3 destinations, with 3 starting points 
even having 4 possible terminal destinations) (Table 6.2). The mean distance between the 
multiple terminal destinations was 33.98mm ± 21.43. The mean distance from the starting 
points to the terminal destinations was 57.4mm ± 15.5. There was no significant 
difference between this deployment distance when comparing the group comprising 
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starting points yielding multiple destinations with the group yielding single destinations 
(data not shown).  
 
Figure 6.7: A schematic representation of the pig lung’s bronchial tree at bronchoscopy with the 
number of terminal destinations possible (in parentheses) for each starting point 1-19. 
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Number 
of 
Starting 
Point 
Resulting 
Number of 
Destinations 
Distance from Starting Point to 
Destination(s) (mm) 
 
Maximum Distance Between 
Any Two Terminal 
Destinations of Probe (mm) 
10 4 70.1   
 
xˉ = 65.2 
 
 
44.11 
64.2 
52.5 
74.19 
18 
 
4 82.41  
 
xˉ = 64.6 
 
 
75.03 
66.02 
45.51 
3 4 Difficult to assuredly state starting 
coordinates on CT 
16.62 
11 3 63.15  
xˉ =63.2 
 
35.06 60.38 
65.94 
17 3 21.98   
xˉ = 38.4 
 
45.27 38.07 
55.28 
9 3 37.73 xˉ = 45.6 22.63 
53.37 
1 2 72.8 xˉ = 71.5 5.12 
70.2 
15 2 73.89 xˉ = 63.2 28.02 
52.56 
19 2 25.33 ~11 but ignored 
2 1 43.07 N/A 
6 1 77.96 N/A 
7 1 47.75 N/A 
8 1 80.62 N/A 
12 1 53.3 N/A 
4 1 Difficult to assuredly state starting 
coordinates on CT 
N/A 
5 1 Difficult to assuredly state starting 
coordinates on CT 
N/A 
13 1 62.2 N/A 
14 1 72.4 N/A 
16 1 44.3 N/A 
 Mean ± SD = 57.4 ± 15.5 Mean ± SD = 33.98 ± 21.43 
Table 6.2 A table outlining the length of probe deployment from each starting point to terminal 
destination, and the maximum distances between possible probe tip terminal destinations (the 3 
destinations 9a, 18b, 19a were removed from the data table as their computed coordinates would 
have required their measurements to fiducials to change by ≥ 11mm). 
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6.7 Discussion - Tracking Study 
This study supports the hypothesis that a pCLE probe will not always arrive in the same 
acinus after peripheral deployment into the most distally visualised part of the bronchial 
tree. In a simple, carefully controlled test environment of a pig lung, only about half of 
the most distally bronchoscopically visualised openings for pCLE deployment have a 
single route that the probe passes down; the other openings have two or more potential 
routes of passage.   
For a given bronchial tree, the path of a probe of fixed diameter and stiffness will depend 
upon the angle and position that the probe approaches the bronchus at, as well as levels of 
endogenous lubrication, possible trauma from previous cannulations, and in vivo the 
respiratory cycle phase as the probe “chooses” its path at each bifurcation. Where there 
are bifurcations, branches and therefore “options” for the probe beyond the visual limit of 
the bronchoscopist, the maximum distance that the resultant terminal destinations will be 
separated was 34mm on average in this model, although the maximum was 75mm when 
the probe was deployed from the most caudal lateral branch of the caudal lobar bronchus 
(number 18).  
This uncertainty compromises the reliable interpretation of attempted pCLE imaging of a) 
solitary pulmonary nodules (SPNs) discovered on computed tomography (CT) but not 
visible at bronchoscopy, as demonstrated by the case report on page 119, and b) 
bronchopulmonary segments heterogeneously affected by parenchymal lung diseases.  
This issue of imprecise peripheral pCLE navigation mirrors the variable diagnostic yield 
from attempted transbronchial lung biopsy (TBB). The yield is only 19-62% for 
SPNs[349, 350], though positively correlated with both size and centrality[351]. For TBB 
of parenchymal lung diseases the yield is better, but nevertheless it diminishes where 
there is sparse radiographic involvement[352]. Other methods designed to improve the 
accuracy of lung biopsy without resorting to surgery include X-ray[353] and CT-
fluoroscopy guided TBB[354], endobronchial ultrasound-guided TBB[355], TBB using 
an electromagnetically guided steerable bronchoscope[356] and CT guided transthoracic 
needle aspiration[357]. However, a diagnosis cannot always be provided by these 
methods and there are added issues such as pneumothorax and bleeding risks from 
biopsy, and the additional radiation exposure during any fluoroscopic guidance.  
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SPNs are by most definitions 10-30mm diameter on CT[358] and are a major target for 
TBB and, perhaps in the future, pCLE. Therefore, without a means of predicting and 
tracking its course, pCLE could easily miss an SPN if human lung starting points provide 
similar divergence from multiple available paths1. 
It would perhaps be logical for those starting points furthest from the pleura to have more 
potential for divergence of the probe but the deployment distances were no different 
between the single destination and multiple destination groups. This could be that the 
deployment distances were insufficiently dissimilar between the two groups or, perhaps 
less likely, that the bifurcations responsible for the multiple destinations occur distally. 
There are limitations to this study beyond any inherent errors in the computations of 
terminal destination coordinates from the fiducial measurements and the arguable need 
for repetition of the results in more pig lungs. Whilst porcine and human lungs are 
comparably sized[359], and the subgross anatomy is similar[360], the lobes are different 
as previously discussed, and the mural cartilage extends more distally within the 
tracheobronchial tree providing the pig lung with cartilage to within three bronchiole 
generations of the acinus versus ten in the human lung.[361] The pig lung is susceptible 
to deformation from both dehydration (between the CT scan and the end of the extended 
bronchoscopy) and from necessary tilting of the Perspex tray to measure the terminal 
destinations on the posterior surface. Furthermore the probe might behave differently in 
continuously inflated lungs, with positive pressure, and with less external restraint than a 
thoracic cavity. Only two paths yielded invisible terminal destinations; fluoroscopy or 
adaptation of the probe with tracking technology would be required to identify them.  
Even with careful insertion, in this porcine model where peripheral pCLE images are 
poor, false passages or deployment beyond the lobules might be possible. It was certainly 
apparent that without careful observation, subpleural skimming of the probe could create 
the illusion of additional terminal destinations. This would probably create an impression 
of there being more divergence of the routes than is the case. With unlimited resources, 
tracking the nuances of the probe path would be best performed by serial CT scan. 
                                                      
1 In the pig lung, the starting points were a mean of 57.4mm from the pleural destinations. This 
compares similarly with a mean of 82.2mm deployment in patients (data not shown in chapter 4 as 
only measured in 5 patients; range 65-125mm). (A longer deployment could lead to greater 
potential divergence, and thus error). 
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6.8  Conclusion 
The robotic probe manipulator is projected to have the ergonomic requirements to 
perform pCLE peritoneoscopy. In the porcine model it enables controlled, steady contact 
translations of a pCLE probe for safely acquiring distortion free characteristic near-
histological grade submesothelial images of viscera within the peritoneal cavity. Other 
future work will include assessing the device’s role for pCLE via transumbilical SILS, 
and directly comparing its ergonomics with conventional endoscopic pCLE within the 
abdominal cavity[17] and eventually the gastrointestinal lumen. Currently, the linear 
deployment mechanism is designed to initiate contact and maintain it during extensive 
probe translations, but with development dynamic force control should be possible. 
Future work should also identify whether the actuator can help maintain image 
consistency and actually produce larger controlled lateral translations to rapidly mosaic 
larger areas.  
This chapter has also addressed the significant issue of probe tracking, using the 
peripheral lung as an important example. It has found that if optical biopsy of the lung 
parenchyma with technologies such as pCLE is to develop without the targeting issues 
that affect TBB, a more accurate prediction of probe tip location will be required, perhaps 
using one of the technologies mentioned in the introduction to the chapter. A robotic 
manipulator such as the one employed in this chapter could be part of a more integrated 
approach to recording where the probe tip has been during pCLE and white light videos, 
and with the potential for the robot to incorporate more accurate probe contact force 
measurements towards its distal end, it could even have a role in parenchymal lung pCLE 
for predicting the route of the probe through the constantly altering resistance to 
deployment through the bronchial tree’s bifurcations. 
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Chapter 7  Chronic Radiation 
Proctopathy Assessment with pCLE 
 
7.1  Introduction 
7.1.1  pCLE and vascularity 
For pCLE to achieve its potential in terms of maximising its diagnostic accuracy and 
generating a clinical niche greater than that of an expensive experimental device, it is 
important for it to focus on its “Unique Selling Points”. One of these, as investigated in 
chapter 4, is its ability to access relatively restricted regions. Another is its ability to 
delineate blood vessels and dynamic circulation in vivo. As an illustration of the 
importance of blood vessel morphology in tumourgenesis, it was previously described in 
chapter 2 that CLE using topical acriflavine can easily identify a severely dysplastic 
uterine cervix but, similar to conventional colposcopy, struggles to differentiate between 
the lesser grades of abnormality[177]. Immunohistochemical analysis shows that as the 
dysplasia progresses from CIN1 to CIN3, and then into microinvasive carcinoma, 
microvessel density increases[362-364]. Similarly, as measured by eCLE, microvessel 
diameter quantitatively increases by half between Barrett’s oesophagus and 
dysplasia[163]. Measurement of the microvessel density may also help predict survival 
and the likelihood of recurrence in many cancers, and may also help guide treatment 
decisions[365]. pCLE has potential benefits over eCLE for this purpose; eCLE can 
identify microvessels and contrast agent leakage, but unlike pCLE, its inferior frame rate 
renders it incapable of assessing erythrocyte flow rate. In an in vivo animal model of 
pancreatic cancer, pCLE has been used to quantitatively show differences in microvessel 
diameter, density and fractal geometry, by developing a vessel segmentation and 
delineation algorithm[366]. A fluorescent agent (with molar mass nearly 700 times 
greater than fluorescein) was used to pool selectively within the blood vessels. 
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7.1.2  Radiation proctopathy 
As described in chapter 3, radiotherapy for pelvic malignancies is increasingly successful, 
but leaves many patients with unpleasant symptoms of chronic radiation induced 
proctopathy such as bleeding, urgency, frequency, and tenesmus. The pathophysiology is 
poorly understood, but involves ischaemia, fibrosis, and neovascularisation at least in part 
by the formation of fragile superficial telangectasia. 
There are many treatments for RP, but efficacy is less than ideal. Whilst hyperbaric 
oxygen may play a role in management[367], most medical therapies such as oral or 
rectal preparations of steroids, sucralfate, and 5-aminosalicylates have limited efficacy. 
Endoscopic therapies used to ablate rogue superficial vessels include formalin[368], 
Nd:YAG laser and argon plasma coagulation. Whilst efficacy of these treatments is 
currently judged upon symptom response using validated questionnaires of quality of life 
or symptoms, together with subjective assessment during follow-up endoscopy, a more 
objective assessment of the initial severity of disease and response at the tissue level is 
vital[270]. pCLE has the potential to provide such in vivo information, and may offer 
clues as to the pathophysiological processes involved. Whilst there are older technologies 
to quantify mucosal blood flow such as laser doppler flowmetry[369], tonometry[370], 
reflectance spectrophotometry[370, 371], pulse oximetry, and ultrasound flowmetry[372], 
pCLE may provide similar information but with morphological images at the same time. 
 
7.1.3  Aims and hypothesis 
Having demonstrated feasibility and tolerability for pCLE with marked acute radiation 
proctopathy in chapter 3, it was hypothesised that pCLE might provide insight, in vivo, 
into the vascular and epithelial disruption present in chronic radiation proctopathy, 
potentially enhancing longitudinal follow up of the disease and of any treatments. These 
pCLE morphology differences observed between healthy and diseased mucosa were 
correlated with conventional histology as well as white light endoscopy imaging (VRS), 
and symptom scores.  
To benchmark pCLE against histology, histology was correlated with white light 
endoscopic findings (VRS) and symptom scores. 
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7.2  Methods 
This was a prospective, non-randomised study. Recruitment was aimed at consecutive 
patients in an outpatient department fulfilling the inclusion criteria of adults who had 
finished external beam radiotherapy for a non-gastrointestinal pelvic malignancy at least 
six months previously that were, compared to before treatment, troubled by some degree 
of lower gastrointestinal symptoms assumed to be caused by radiation proctopathy. 
Exclusion criteria included patients with a history of previous bowel resection, 
inflammatory bowel disease, prostate brachytherapy, allergies to fluorescein or other 
intravenous contrast agent, known alternative causes for their new bowel symptoms (such 
as untreated bacterial overgrowth, bile-salt malabsorption or carbohydrate 
malabsorption), or those pregnant, breast feeding or unable to provide informed consent. 
The protocol was similar to chapter 3. After a phosphate enema, patients underwent 
flexible sigmoidoscopy with pCLE using 5mls of 10% intravenous fluorescein.  
From up to 3 areas of bowel in each patient (descending colon, upper rectum and lower 
rectum in an attempt to acquire sites within and outside the original radiation field), 1 
minute pCLE video sequences were recorded with gentle probe apposition, and analysed. 
Two correlative pinch biopsies were obtained, fixed in 10% neutral buffered formalin, 
embedded in paraffin wax, sectioned at 4µm, and examined using haematoxylin and 
eosin. 16 histopathological features (imperfectly categorised into 4 vascular, 7 epithelial, 
and 5 glandular) were recorded for each site through blinded analysis by a single expert 
histopathologist; plasma cells were absent in all biopsies so eliminated as a potential 
discriminator or pathological feature. Parameters were graded according to a predefined 
scale similar to that of Hovdenak et al.[268]. 
Each pCLE video was blindly assessed using the Cellvizio-viewer software by a single 
investigator for the categorical presence of blood vessels, the diameter of the largest 
visible blood vessel if present, and examined for morphological changes including 
fluorescein leakage, glandular and lamina propria disruption. Rather than using the 
Hanauer grade of proctitis (G0-3)[280], Wachter’s Vienna Rectoscopy Score of proctitis 
severity (VRS) was assigned via consensus opinion to each area (G0-5) [373]. VRS is a 
means of objectively and systematically describing the severity of chronic radiation 
induced damage on a 0-5 scale as judged by endoscopic examination evaluating 5 factors:  
• Telangiectasia: (grade 0, none; grade 1, single telangiectasia; grade 2, multiple non-
confluent telangiectasia; grade 3, multiple confluent telangiectasia). 
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• Congested mucosa: (grade 0, none; grade 1, focal reddening of the mucosa combined 
with an oedematous mucosa; grade 2, diffuse non-confluent reddening of the mucosa 
combined with an oedematous mucosa; grade 3, diffuse confluent reddening of the 
mucosa combined with an oedematous mucosa). 
• Ulceration: (grade 0, none; grade 1, microulceration – superficial, <1cm2; grade 2; grade 
2, superficial >1cm2; grade 3, deep ulceration; grade 4, fistualtion or perforation. 
• Stricture: 0, none; grade 1, >2/3 of regular diameter; grade 2, 1/3-2/3 of regular diameter; 
grade 3, <1/3 regular diameter; grade 4, complete obstruction. 
• Necrosis: grade 0, none; grade 1, necrosis.  
The highest grade of any one of 5 parameters provides the VRS score G0-5 (Table 7.1): 
VRS Congested Mucosa Telangectasia Ulceration Stricture Necrosis 
0 Grade 1 None None None None 
1 Grade 2 Grade 1 None None None 
2 Grade 3 Grade 2 None None None 
3 Any Grade 3 Grade 1 None None 
4 Any Any Grade 2 Grade 1 None 
5 Any Any Grade ≥3 Grade ≥2 Yes 
Table 7.1: The VRS score was provided for each area of mucosa. 
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Figure 7.1 The typical vascular pattern of normal colonic mucosa (G0) is demonstrated with 
normal descending colon in A, and undergoes pCLE optical biopsy in B. C shows G2 VRS 
proctopathy of the lower rectum with an oedematous mucosa containing multiple non-confluent 
telangectasia. G3 mucosa of the upper rectum with confluent telangectasia is shown in D. 
 
Patients were then asked to list their main symptoms, before completing a Vaizey 
Incontinence score and a modified Inflammatory Bowel Disease Questionnaire (modified 
IBDQ), prior to their endoscopy session, similar to chapter 3. Once again, the endoscopist 
completed an EORTC/RTOG (Radiation Therapy Oncology Group) late proctitis score 
for the patient and an acceptability questionnaire was completed the day after the 
procedure. 
 
7.2.1  Statistics  
For categorical variables such as the presence of vessels or the observation of fluorescein 
leakage at progressive VRS grades, two-tailed Chi-squared test (or Fisher’s exact test for 
small cell numbers) were used. The Kruskal-Wallis test was used to compare non-
parametric measurements between groups (such as maximum vessel diameter at different 
VRS grades); where two groups were present the Mann-Whitney U test was employed 
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(for example comparing the symptom scores of patients with and without visible vessels 
on pCLE imaging). Spearmann’s Rank Correlation Coefficient were calculated for the 
relationship between symptom score and widest vessel on pCLE.  
The ethical approval obtained for the study was from the NHS Regional Ethics 
Committee (Oxford: 11/SC/0036). Written informed consent was obtained from all 
patients before study registration.  
 
7.3  Results 
7.3.1  Patient cohort  
26 patients with symptomatic chronic radiation proctopathy participated and completed 
the study, with a median age of 68 (range 27-82). The main symptoms that the patients 
described included bleeding (16 patients); frequency, urgency or a change in bowel habit 
(16 patients); abdominal pain, borborygmi, flatulence or cramps (8 patients); faecal 
incontinence and mucus (7 patients); and tenesmus (6 patients). Their median modified 
IBDQ score was 180.5 (range 57 to 219), IBDQ-B score was 58.5 (range 21 to 69), 
Vaizey score 6.2 (range 0 to 19), and median late RTOG score 1 out of 4 (range 1 to 2) 
(see Table 3.2 for a recap of these classifications). They had completed external beam 
radiotherapy (± brachytherapy) a median of 23.5 months previously (range 7 to 73 
months). The primary diagnosis was either prostate (21), cervical (4), or vaginal (1) 
cancer. 5 patients had undergone treatment for their proctopathy other than enemas: 
topical formalin application (2), topical formalin application with argon plasma 
coagulation (1), and blinded participation in a randomised controlled trial with hyperbaric 
oxygen therapy (2). 10 patients were taking anti-thrombotic medications: aspirin (7), 
aspirin and clopidogrel (1), warfarin (1) and low molecular weight heparin (1). Of the 
participants, 5 were current smokers, 6 had never smoked, with the remaining 15 patients 
have stopped smoking a mean of 27.0 years previously. The mean body mass index was 
26.3.  
The procedures were well tolerated: on the same 1-7 visual analogue scale as chapter 3 
the mean score was 2.3, which is roughly midway between “very comfortable” and 
“uncomfortable” (range 1-6; though the “6” was by a patient who had undergone 
colonoscopy). Only urinary discolouration was noticed in 18 of the 26 patients which 
disappeared after a day or two, and there were two cases of marked nausea with no 
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complications. When asked within the questionnaire the day after the procedure “If this 
endoscopic procedure is shown to provide useful information to guide your treatment, 
would you recommend it to other suitable patients?” on a visual analogue scale from 1 
(definitely recommend) to 7 (definitely advise against), there was an average score of 2.3. 
 
7.3.2  Biopsy sites 
76 pCLE sequences were obtained with corresponding pinch biopsies from a potential of 
78; one descending colon and one upper rectum area were abandoned owing to apparent 
discomfort in two patients. Though possible, the accessibility of one lower rectum was 
ergonomically challenging owing to diffuse extrinsic luminal compression from pelvic 
fibrosis. Altogether, this produced 39G0, 25G1, 9G2, and 3G3 regions according to the 
VRS scale using white light endoscopy (Figure 7.2).  
 
 
Figure 7.2 The biopsy sites in the lower rectum were generally affected by the higher VRS grades 
of radiation proctopathy. Only one descending colon was macroscopically unhealthy (in a very 
symptomatic patient 72 months post brachytherapy and external beam radiotherapy for cervical 
cancer). 
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7.3.3  pCLE correlated with VRS 
Sequences from areas of higher grade VRS were more likely to have no visible vessels on 
pCLE: G0, 7.7%; G1, 8%; G2, 55.6%; and G3, 66.6% (p=0.0005) (Figure 7.3). 
Combining categories, vessels were absent in 8.47% of normal or mildly diseased 
sequences (G0&G1), versus 58.3% of more macroscopically damaged tissue (G2&G3 
sequences) (p=0.0001). Providing dark contrast within the microvessels against the 
hyperfluorescent lumen, individual red blood cells were observed flowing in many of the 
sequences independent of VRS grade; however a reliable measurement of red blood cell 
translational movement per unit time was deemed unfeasible. 
In those sequences where there were visible vessels, the mean (± SD) diameter of the 
widest vessel increased across the grades: G0, 15.0µm ± 4.7; G1, 20.0µm ± 11.4; G2, 
32.9µm ± 8.54; G3 37.1µm ± N/A). Despite the convincing nature of the images and the 
trend in calibre this phenomenon only approached significance, perhaps due to inadequate 
sequences (p=0.147) (Figure 7.4). In the G0 and G1 sequences, the red blood cells appear 
to pulse down the microvessels in single file, whereas several of the larger diameter 
vessels from G2 and G3 sequences appeared to contain several red blood cells squeezed in 
adjacent to one another. Furthermore, there were two examples of G3 sequences where 
large calibre vessels appeared to contain static red blood cells. 
 
Chronic Radiation Proctopathy Assessment with pCLE 
146 
 
 
Figure 7.3 A chart demonstrating that VRS G2 and G3 areas were much more likely to display no 
obvious vessels on pCLE videos. pCLE mosaics provide examples whereby external beam 
radiotherapy for prostate cancer appears to have disrupted the normal vascular appearance. 
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Figure 7.4 In proctopathic tissue, where vessels are seen, there is a (non-significant) tendency for 
the vessels to have a larger calibre; some examples are shown. 
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Morphological distortion of glandular structure and epithelium was more common in 
tissue affected by severe proctopathy, characterised by irregular shaped or thickened 
glands, a sloughy epithelium or irregular ridge-lined epithelial layer (p<0.0001). Marked 
irregular epithelial ridges were observed in all 3 of the G3 sequences. In the sequences 
where glands were apparent, fluorescein leakage into the centre seemed more common in 
proctopathic tissue, though there was no statistically significant difference in this 
observation across the VRS groups (p=0.25). 
 
Figure 7.5 Morphological changes appear more commonly in G2 and G3 disease. An irregular 
ridge-lined epithelial layer (p<0.0001) is more common. Fluorescein leakage seemed particular 
marked in the G2/G3 disease but its categorical presence was not statistically different across the 
groups (p=0.25).  Included are some examples of G3 disease displaying fluorescein leakage into 
the crypt lumen (A and B) and epithelial ridges (C and D).   
 
 
 
7.3.4  Histology 
One pair of lower rectum VRS G1 biospies did not survive processing so was removed 
from the analysis leaving 75 sites for histological assessment. One prostate radiotherapy 
patient had a macroscopically VRS G0 descending colon that displayed borderline 
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features of collagenous colitis with a thickened basement membrane. Otherwise, a 
summary of the findings for each of the 16 histological features is found in Figure 7.6. 
Overall, the most common deviations from a normal appearance were at least some 
degree of either vessel dilatation (61.3%), superficial epithelial loss (58.7%) vessel 
congestion (56%), or goblet cell loss (54.7%), or the presence to some degree of 
mucophages (58.7%) or  macrophages (57.3%). The least commonly found abnormalities 
were microthrombi (14.7%), crypt loss (25.3%), increased apoptosis (28%), fibrosis 
(29.3%), eosinophils (34.7%) or an abnormal proliferation pattern (34.7%). 
 
 
Figure 7.6: For each of the 16 histological features analysed, stacked columns showing the 
interpreted frequency of severity for the 75 biopsy pairs. 
 
7.3.5  Correlation between histology and macroscopic appearance 
For each VRS grade, the mean “score” attributed from histological examination was 
calculated; a mean absolute score was also calculated for “lymphocytes” and 
“proliferation pattern” where 1- was treated as 1+. 
Individually, only the presence of mucophages was statistically significantly different 
between VRS groups (although mucophages did not steadily increase in prevalence with 
VRS grade). Despite not reaching significance, more convincing trends were seen with 
gland morphology where there was an almost universal increase at every VRS grade in 
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crypt loss, crypt branching, goblet cell loss, apoptosis, and altered proliferation pattern, 
with the mean VRS G3 having a score 2-3 times greater than that of G0 for each of these 
histological factors. For epithelial histological observations only the presence of fibrosis 
and altered lymphocyte concentration seemed to increase consistently across the VRS 
grades, with G3 sites having a mean score 4-5 times greater than G0 sites although 
statistical significance was not approached for these factors individually. Amongst the 4 
vascular histological factors, only vessel dilatation convincingly increased across the 
VRS grades (although p=0.051).  
For each VRS grade, the mean combined score from all 16 criteria (0 to a potential 
maximum of 31) increased steadily from 6 for G0 to 10.33 for G3, a small but statistically 
significant difference(p=0.016). 
 Histological Assessment (mean value)  
for each VRS Category 
 
 Histological Observation  VRS 0 VRS 1 VRS 2 VRS 3 P value 
V
as
cu
la
r Vessel Dilatation (0, 1, 2, or 3) 0.51 0.75 1 1.7 0.051 
Vessel Congestion (0, 1 or 2) 0.54 0.75 0.56 0.33 0.29 
Microthrombi (0 or 1) 0.10 0.21 0.11 0.33 0.33 
Erythrocyte Extravasation (0, 1 or 2) 0.56 0.38 0.67 0.33 0.19 
E
pi
th
el
iu
m
 
Superficial Epithelial Loss (0, 1, 2 or 3) 0.62 0.67 0.78 0.67 0.24 
Oedema (0, 1 or 2) 0.31 0.5 0.56 0 0.45 
Fibrosis (0 or 1) 0.18 0.29 0.56 1 0.43 
Macrophages (0, 1 or 2) 0.59 0.83 0.56 0.67 0.11 
Lymphocytes (-1, 0, 1 or 2) -0.21 -0.38 -0.56 -1 0.36 
Lymphocytes (mean absolute value: 0, 1 
or 2) 
0.26 0.54 0.55 1 0.31 
Eosinophils  (0 or 1) 0.31 0.42 0.33 0.33 0.10 
Mucophages (0, 1 or 2) 0.59 1.04 1 0.67 0.04 
G
la
nd
s 
Crypt Loss (0, 1, or 2) 0.23 0.25 0.44 0.67 0.45 
Crypt Branching (0, 1, or 2) 0.36 0.42 0.78 1 0.25 
Goblet Cell Loss (0, 1 or 2) 0.41 0.71 0.56 1.33 0.58 
Proliferation Pattern (-2, -1, 0 or 1) -0.08 -0.46 -0.56 0 0.37 
Proliferation Pattern (mean absolute value: 
0, 1 or 2) 
0.18 0.54 0.56 0.67 0.44 
Apoptosis (0, 1 or 2) 0.26 0.38 0.33 0.66 0.26 
 Mean overall histological score   
(0-31): 
6 8.67 9.33 10.33 0.016 
Table 7.2 Normal histological appearance was designated zero. The degree of severity of any 
deviation from normal (-, +, ++, +++), was ascribed -1, 1, 2, 3 respectively for the purposes of a) 
creating an average to compare each VRS group, and b) to enable Kruskal-wallis tests to assess 
whether there were any trends in histological features across the four VRS groups. Averages have 
been tabulated with mean rather than median to avoid an excess of zeros. 
 
 
7.3.6  Correlation between histology and glandular distortion on pCLE 
Having shown that glandular/epithelial distortion with pCLE correlates with higher 
grades of VRS, this was compared for each of the 16 histological observations. 3 factors 
were statistically significantly different between the 2 pCLE groups: pCLE sequences 
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showing glandular disruption had around twice the histological vessel dilatation, fibrosis 
and proliferation pattern scores of those without pCLE glandular disruption. However, the 
observation of glandular disruption on pCLE was not a particularly sensitive predictor of 
any of the three factors; indeed out of the 75 sequences, 33, 14 and 17 had a normal 
glandular appearance on pCLE but abnormal vessel dilatation, fibrosis and proliferation 
pattern on histology respectively. However, the mean total histological score out of 31 is 
9.5 compared to 6.64 (p=0.028) according to whether or not there is glandular disruption. 
 Number of sequences 
with glandular 
disruption on pCLE 
 
 Histological Observation  No  Yes Percentage 
with pCLE 
glandular 
disruption 
Mean Histological Score 
(not affected by pCLE 
glandular disruption versus 
affected) 
V
as
cu
la
r 
Vessel Dilatation  0 (none) 28 1 3.45 0.59 vs 1.14 
p= 0.007 1(+) 30 11 26.8 
2(++) 3 1 25 
3(+++) 0 1 100 
Vessel Congestion  0 (none) 27 6 27.2 0.56 vs 0.64 
p= 0.76 1(+) 32 7 17.9 
2(++) 2 1 33.3 
Microthrombi  0 (none) 53 11 17.2 0.13 vs 0.21 
p= 0.42 1(+) 8 3 27.3 
Erythrocyte 
Extravasation  
0 (none) 34 7 17.1 0.49 vs 0.57 
p=0.80 1(+) 24 6 20 
2(++) 3 1 25 
E
pi
th
el
iu
m
 
Superficial 
Epithelial Loss 
0 (none) 28 3 9.68 0.62 vs 0.93 
p=0.20 1(+) 29 11 27.5 
2(++) 3 1 25 
3(+++) 1 0 0 
Oedema 0 (none) 38 9 19.1 0.38 vs 0.43 
p=0.24 1(+) 23 4 14.8 
2(++) 0 1 100 
Fibrosis 0 (none) 47 6 11.3 0.23 vs 0.57 
p=0.02 1(+) 14 8 36.4 
Macrophages  0 (none) 24 8 32 0.69 vs 0.57 
p=0.24 1(+) 32 4 11 
2(++) 5 2 28.6 
Lymphocytes  -1 (-) 20 8 28.6 -0.28 vs -0.57 
p=0.43 0 (normal conc) 39 6 13.3 
1(+) 1 0 0 
2(++) 1 0 0 
Lymphocytes 
(mean absolute 
value)  
0 (normal conc) 39 6 13.3 0.38 vs 0.57 
p=0.24 1(- or +) 21 8 27.6 
2(++) 1 0 0 
Eosinophils  0 (none) 40 9 18.4 0.34 vs 0.36 
P=0.93 1(+) 21 5 19.2 
Mucophages  0 (none) 26 5 16.1 0.44 vs 0.57 
p=0.47 1(+) 5 0 0 
2(++) 11 4 26.7 
G
la
nd
s 
Crypt Loss  0 (none) 47 9 16.1 0.25 vs 0.43 
p=0.29 1(+) 13 4 23.5 
2(++) 1 1 100 
Crypt Branching  0 (none) 37 6 14 0.43 vs 0.57 
p=0.29 1(+) 22 8 26.7 
2(++) 2 0 0 
Goblet Cell Loss  0 (none) 30 4 11.8 0.51 vs 0.79 
p=0.08 1(+) 31 9 22.5 
2(++) 0 1 100 
Proliferation 
Pattern  
-2 (--) 1 0 0 -0.23 vs 0.36 
p=0.02 -1 (-) 14 7 33.3 
0 (normal) 44 5 10.2 
1(+) 2 2 50 
Proliferation 
Pattern (mean 
absolute value) 
0 (normal) 44 5 10.2 0.30 vs 0.64 
p=0.02 1(- or +) 16 9 36 
2(++) 1 0 0 
Apoptosis  0 (none) 47 7 13 0.28 vs 0.5 
p=0.06 1(+) 11 7 38.9 
2(++) 3 0 0 
 Mean overall histological score   
(0-31): 
6.64 9.5 
p=0.028 
 
 
Table 7.3 The relationship between histological factors and glandular disruption on pCLE. 
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7.3.7  Correlation between histology and pCLE vascular appearance 
Absence of vasculature on pCLE was not statistically significantly related to any of the 
four individual vascular histological observations, or the mean overall vascular 
histological score (Table 7.4). Individually, microscopic vessel dilatation was very close 
to being significantly correlated with absence on pCLE (p=0.06). 
 Number of sequences  
Vascular Histological 
Observation  
Vasculature 
evident on 
pCLE 
Vasculature 
absent on 
pCLE 
Percentage with 
absent pCLE 
vasculature 
Mean Histological 
Score (vessels 
evident vs absent on 
pCLE) 
Vessel 
Dilatation  
0 (none) 27 2 6.9 0.63 vs 1 
p=0.06 1(+) 32 9 31 
2(++) 4 0 0 
3(+++) 0 1 100 
Vessel 
Congestion  
0 (none) 25 8 24.2 0.65 vs 0.33 
p=0.25 1(+) 35 4 10.3 
2(++) 3 0 0 
Microthrombi  0 (none) 54 10 15.6 0.14 vs 0.17 
p>0.99 1(+) 9 2 18.2 
Erythrocyte 
Extravasation  
0 (none) 34 7 17.1 0.52 vs 0.42 
p>0.99 1(+) 25 5 16.7 
2(++) 4 0 0 
 Mean overall 
vascular 
histological 
score (0-8) 
1.95 1.92 
p=0.77 
 
Table 7.4 A table showing the presence or absence of visible vessels on pCLE for each grade of 
the four vascular histological features assessed. 
 
For those pCLE sequences with a clearly visible vessel the largest vessel diameter was 
recorded. In the histological 2+ vessel dilatation group the mean largest visible vessel 
with pCLE imaging was nearly twice the calibre to that measured from the histologically 
undilated group (p=0.028) (Figure 7.7). The other vascular histology features were not 
statistically related to the maximum pCLE vessel diameter.  
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Figure 7.7 For those sequences with a visible vessel, graphs showing the mean largest vessel 
diameter with pCLE imaging, for each grade of the four vascular histological features assessed. 
Only histological vessel dilatation was significantly correlated, positively, with largest vessel 
diameter on pCLE. 
 
 
The above two pCLE criteria of absent or dilated vasculature were next combined: if a 
pCLE sequence has no distinct vasculature, or contains a vessel with diameter equal to or 
greater than 25µm (this was a slightly arbitrary threshold decided upon as the midpoint 
between the mean pCLE diameters of G1 and G2 VRS), this was for brevity termed pCLE 
dilabsence. It was statistically positively correlated with 5 of the 16 histological factors: 
vessel dilatation, fibrosis, crypt branching, lymphocytes, and an abnormal proliferation 
pattern (generally a reduction in the latter two factors) (Table 7.5). Compared to 
sequences displaying at least one vessel less than 25µm in diameter, the histological mean 
“score” for each of these factors was at least twice that of sequences featuring pCLE 
dilabsence. 
To expand, pCLE dilabsence increases from 10.3% in biopsy pairs with no histological 
vessel dilatation to 36.6%, 75% and 100% in those affected 1+, 2+ and 3+ respectively. 
For anticipating histological vessel dilatation, pCLE dilabsence has a PPV of 86.4%, a 
specificity of 74.3%, falling to an NPV of 49.1% and sensitivity of 41.3%. Lowering the 
25µm diameter threshold for ascribing pCLE vessels as dilated would improve the 
sensitivity and NPV at the expense of the PPV and specificity.  
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The overall mean histological score (0-31) was significantly greater for sequences with 
dilabsence (10.05 versus 6.4). 
 
 pCLE dilabsence 
(Number of sequences 
devoid of visible 
vessels or containing a 
vessel ≥ 25µm) 
 
 Histological Observation  No  Yes Percentage with 
pCLE 
vasculopathy 
Mean Histological Score 
(no pCLE dilabsence 
versus pCLE dilabsence) 
V
as
cu
la
r 
Vessel Dilatation  0 (none) 26 3 10.3 0.528 vs 1.09 
p=0.0021 1(+) 26 15 36.6 
2(++) 1 3 75 
3(+++) 0 1 100 
Vessel Congestion  0 (none) 23 10 30.3 0.585 vs 0.545  
p=0.29 1(+) 29 10 25.6 
2(++) 1 2 66.7 
Microthrombi  0 (none) 47 17 26.6 0.113 vs 0.227 
p=0.20 1(+) 6 5 45.5 
Erythrocyte 
Extravasation  
0 (none) 30 11 26.8 0.491 vs 0.545 
p=0.83 1(+) 20 10 33.3 
2(++) 3 1 25 
E
pi
th
el
iu
m
 
Superficial 
Epithelial Loss 
0 (none) 24 7 22.6 0.623 vs 0.727 
p=0.61 1(+) 26 14 35 
2(++) 2 1 33.3 
3(+++) 1 0 0 
Oedema 0 (none) 34 13 27.7 0.358 vs 0.455 
p=0.42 1(+) 19 8 37 
2(++) 0 1 100 
Fibrosis 0 (none) 43 10 18.9 0.189 vs 0.545 
p=0.002 1(+) 10 12 54.5 
Macrophages  0 (none) 24 8 25 0.604 vs 0.818 
p=0.29 1(+) 26 10 27.8 
2(++) 3 4 57.1 
Lymphocytes  -1 (-) 14 14 50 -0.208 vs -0.636 
p=0.011 0 (normal conc) 37 8 17.8 
1(+) 1 0 0 
2(++) 1 0 0 
Lymphocytes 
(mean absolute 
value)  
0 (normal conc) 37 8 21.6 0.321 vs 0.636 
p=0.011 1(- or +) 15 14 48.3 
2(++) 1 0 0 
Eosinophils  0 (none) 36 13 26.5 0.321 vs 0.409 
p=0.46 1(+) 17 9 34.6 
Mucophages  0 (none) 26 5 16.1 0.660 vs 1.09 
p=0.07 1(+) 19 10 34.5 
2(++) 8 7 46.7 
G
la
nd
s 
Crypt Loss  0 (none) 42 14 25 0.226 vs 0.409 
p=0.24 1(+) 10 7 41.2 
2(++) 1 1 50 
Crypt Branching  0 (none) 36 7 16.3 0.340 vs 0.727 
p=0.008 1(+) 16 14 46.7 
2(++) 1 1 50 
Goblet Cell Loss  0 (none) 26 8 23.5 0.509 vs 0.682 
p=0.22 1(+) 27 13 32.5 
2(++) 0 1 100 
Proliferation 
Pattern  
-2 (--) 1 0 0 -0.189 vs -0.409 
p=0.013 -1 (-) 10 11 52.3 
0 (normal) 40 9 18.4 
1(+) 2 2 50 
Proliferation 
Pattern (mean 
absolute value) 
0 (normal) 40 9 18.4 0.264 vs 0.591 
p=0.008 1(- or +) 12 13 52 
2(++) 1 0 0 
Apoptosis  0 (none) 41 13 24.1 0.264 vs 0.455 
p=0.17 1(+) 10 8 44.4 
2(++) 2 1 33.3 
 Mean overall histological 
score   
(0-31): 
6.40 10.05 
p=0.0033 
 
Table 7.5 The relationship between histological variables and pCLE dilabsence. 
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7.3.8  Correlation of symptoms with pCLE and endoscopic appearance 
There was little correlation between the symptom scores and either VRS grade or any 
postulated pCLE criteria for worse vasculopathy (vessel absence, vessel ≥25µm, or the 
combined pCLE dilabsence) (Table 7.6). The only identifiable statistically significant 
correlation (weakly positive) was between RTOG and maximum VRS (p=0.012).  
 
 
  Endoscopic 
Feature 
 The Mean Symptom Scores Correlated with Endoscopic 
Features & pCLE Findings 
IBDQ 
224= asymptomatic 
 
32=severely 
symptomatic 
IBDQ-B 
70=no bowel 
symptoms 
 
10=severe bowel 
symptoms 
Vaizey 
0=perfect 
continence 
 
24=total 
incontinence 
RTOG 
0=asymptomatic 
 
5=death from 
DXT morbidity 
W
hi
te
 
lig
ht
 VRS of patient’s most proctopathic 
site 
0 176 
p=
0.
87
 52 
p=
0.
84
 4 
p=
0.
29
 0.5 
p=
0.
01
2 
1 178.9 54.9 6.29 1 
2 176.8 54.9 8.13 1.5 
3 199.3 59.7 1 1.33 
pC
LE
 
Patient’s widest 
Vessel Diameter 
SRCC 0.33 0.35 0.03 -0.03 
p= 0.1 0.08 0.9 0.82 
      
Patient devoid of 
visible vessels? 
No 179 55.7 5.6 1.21 
Yes 182.5 54.9 6.9 1.36 
p= 0.92 0.7 0.93 0.47 
Patient devoid 
visible vessels or 
having a vessel 
>25µm (pCLE 
dilabsency) 
No 164.3 50.3 5.3 1.3 
Yes 189.1 58 6.6 1.29 
p= 0.06 0.12 0.8 0.56 
Table 7.6 Apart from when measured by RTOG, the severity of a patient’s symptoms has no 
correlation with their most severely proctopathic segment of colorectum as determined by VRS. 
Similarly, no pCLE feature was discovered that correlated with any of the four symptom scores. 
Kruskal-Wallis, Fisher’s Exact Test, Spearman’s Rank Correlation Coefficient (SRCC), and 
Mann-Whitney U tests were used as appropriate. 
 
7.4  Conclusion 
The primary aim of this chapter was to see if pCLE can reveal virtual histopathological 
differences in mucosa affected by radiation proctopathy. From the 76 sequences studied, 
pCLE vessel absence was associated with higher VRS grades of macroscopically 
proctopathic tissue. Where vessels were visible there was a non-statistically significant 
trend toward higher VRS grade areas yielding wider maximum vessel under pCLE 
imaging. Higher grade VRS areas were also associated with glandular/epithelial 
disruption on pCLE, characterised by slough and epithelial ridges. 
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Assuming that histology should be the “gold standard” for determining proctopathy 
characteristics and severity, vessel dilatation on histology correlated significantly with 
pCLE imaging for glandular disruption, size of vessel, dilabsence, and almost 
significantly with absent vasculature. Both histological fibrosis and an abnormal 
proliferation pattern (mostly attenuated) correlated positively with glandular disruption 
and dilabsence on pCLE. pCLE dilabsence also correlated with lymphocyte and crypt 
branching abnormalities. Collating the 16 histological features, a mean histological score 
was created which correlated significantly with both pCLE glandular disruption and with 
pCLE dilabsence. Whilst the endoscopic proctopathy severity using VRS grade also 
correlated with a collated histological score, only one individual histological observation 
(mucophages) was significantly related to VRS grade; this suggests that pCLE is at least 
as good or perhaps more powerful for predicting histological signs of proctopathy.  
The extensive histological findings alone from this study require review in the context of 
the paucity of previous study on the subject. It has been previously suggested that chronic 
radiation bowel disease is predominantly a vasculopathy with intimal fibrosis and 
thickening of the vessel wall combined with fibrin thrombi in capillaries and larger mural 
vessels, and the evolution of dilated blood vessels or telangectasia[273].  The resultant 
effect, shown using microradiography after barium infusion into mesenteric vessels of 
fresh operative specimens, is that the vascular volume/capacity within the tissue is 
reduced[275]. (Clearly, these findings are compatible with the pCLE observation of 
destruction of superficial vessels with the formation of new friable dilated abnormal ones; 
and presumed thrombi were seen in some dilated vessels).  In this current study the most 
common histological findings were vessel dilatation and congestion, together with loss of 
the superficial epithelium and goblet cells (all previously described[274, 374]), with the 
presence of mucophages or macrophages.  
Perhaps owing to the multifactorial nature of gastrointestinal symptoms post 
radiotherapy[375], neither pCLE nor VRS seemed capable of reflecting the patients’ 
symptom severity. Hovdenak et al. found that during the 6 weeks of radiotherapy 
treatment mucosal histological changes regressed despite ongoing treatment and 
worsening symptoms[268]; certainly the limited penetration of pCLE will prevent 
imaging of the submucosa, muscle, serosa, larger blood vessels and enteric nerves, 
damage to which may remain unrecognised but part of the proctopathy – indeed 
submucosal damage is much more marked in chronic than acute proctopathy, with 
atypical fibroblasts and collagen proliferation[376].  
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There are obvious limitations to the methods of this hypothesis generating study. A fuller 
study would require an assessment of interobserver/intraobserver agreement regarding a) 
pCLE factors such as the vessel presence, maximum vessel calibre, and glandular 
disruption, and b) the 16 histological factors. A more objective measure of vessel 
characteristics might be obtained using techniques employed in the studies described in 
Section 2.15 CLE for the Assessment of Vasculaturesuch as bespoke software[235] or the 
“Vessel Detection ModuleTM” available from Cellvizio®[236] (though this is currently 
only available for the laboratory based pCLE device).  
Owing to the majority of patients having been treated for prostate cancer, the more 
severely proctopathic sequences tended to be found within the lower rectum, with 
seemingly healthy sequences in the descending colon; whilst differences have not been 
described between these mucosal areas in health, further study would need to confirm that 
there are no intrinsic differences independent of any radiotherapy treatment. Furthermore, 
the “healthy” sequences were taken from patients who had relatively recently been treated 
for cancer, with radiotherapy not being the only potential insult to the tissue. Only 11 of 
the 75 sequences were G2 or G3 disease; it would have been preferable to have a more 
equal spread of macroscopic disease severity, although it is fundamentally difficult to 
judge disease severity anyway; there is no “gold standard” using symptoms, macroscopic 
appearance or a validated histology score. There was also marked heterogeneity in the 
patient cohort including the primary disease, radiotherapy regimen, duration since 
treatment, therapies for any proctopathy. It is likely that these factors create further 
variation in the clinicopathologic details of what is already a highly variable disease. 
This chapter shows that pCLE corroborates the evidence for radiation proctopathy being 
at least in part a vasculopathic condition, suggests that pCLE may be a more reliable 
indicator of the extent of histological damage than symptom severity or the macroscopic 
damage observed on endoscopy, and is the first step towards a useful optical biopsy 
technique to provide safe assessment of what is a severely debilitating and poorly studied 
condition in the era of cancer survivorship.  
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Chapter 8  Conclusion 
8.1  The Ideal Optical Biopsy Device 
The perfect clinical optical biopsy device would a) improve diagnostic accuracy beyond 
the standards of current pathological and imaging technologies, b) eliminate the need for 
conventional biopsies, or perhaps just focus them to reduce the number and improve the 
quality of biopsies taken, c) be safer and less invasive than current diagnostic modalities, 
d) provide immediate answers about tissue function and form to facilitate immediate 
management of clinical problems and assist these procedures by, for example, identifying 
the tissue margins for local treatment or resection, e) be straightforward to learn and use, 
f) provide consistent stable images of representative areas, and g) be cost-effective. These 
factors take time to achieve. To use an analogy with other technology, in 1980 
endoscopic ultrasound was an experimental research tool[377], but 30 years later, it 
combines with FNA as a standard diagnostic procedure in many thoracic and upper 
gastrointestinal lesions; this transition has occurred through a combination of technical 
developments such as linear array and doppler, advancements in process such as on-site 
endocytopathology/telecytopathology, an understanding of its diagnostic limits, and 
improvements in training to maximise the yield and enhance safety.  
As pCLE approaches its second decade of development, this thesis began by outlining the 
challenges it faces to achieve these goals and garner more widespread adoption. Force, 
accuracy, targeting and ergonomics were four themes that kept recurring: a) the role of 
contact force had scarcely been approached; b) despite some impressive diagnostic data 
pCLE’s accuracy is insufficiently consistent; c) with heterogeneity in tissue 
microarchitecture it is imperative that the exact location of probe tissue interaction is both 
known and recorded; and d) current techniques for manipulation of the pCLE probe have 
limitations. 
An examination of how the experimental chapters contribute to both an understanding of 
these four factors and a vision of future research requirements follows. 
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8.2  Achievements of this Thesis and Future Work 
This thesis addressed the issues of pCLE from several directions, using laboratory 
experimentation both in vivo and ex vivo, as well as through clinical studies. Clearly, 
though much of the work was arguably very novel, much of the data was preliminary, 
hypothesis generating and qualitative. In general, the hypotheses generated from the 
clinical work would be enhanced by further prospective studies in patients from an 
unselected population. 
 
8.2.1  Probe contact force – its importance in pCLE imaging 
Prior to this thesis, the role of contact force in pCLE imaging had barely been touched 
upon. It had been suggested that alveolar morphology is affected by axial force of the 
probe upon the pulmonary lobule[48], and that differences in fluorescence between 
different regions of a pCLE image are sometimes attributable to the probe’s inconsistent 
contact force or partial loss of contact[175]. 
During pCLE of the endobronchium and large bowel in chapter 3 the difficulty of 
controlling the distal probe contact force upon the tissue was realised (particularly during 
retroflexion) and there were unpredictable morphological variations within pCLE videos 
of in vivo endobronchial and colorectal mucosa.  It was hypothesised that the contact 
force could contribute to these variations in the image output. In chapter 4, pCLE imaging 
of the peripheral lung demonstrated realtime snapping of septal walls and microvessels 
courtesy of uncontrolled axial pressure of the probe, suggesting that contact force may 
have safety implications (although there were no complications in the study). 
In chapter 5 it was shown that force (and mucosal distension), two previously 
unconsidered factors, can affect image consistency. Firstly, the extent of colon inflation 
(in a crude in vivo porcine model) is important; compared to a hyperinflated colon a 
collapsed colon has three times the number of glands per FOV, and each gland is two 
thirds of the diameter. Secondly, and more pertinently to the topic of contact force, a 
pCLE probe abutting ex vivo colonic mucosa at 0.5N compared to “just touching” at 
0.005N had approximately double the gland diameter but a third the number of glands per 
FOV. Though in clinical practice the variations in probe contact force (and bowel 
distension) would probably be more subtle, further work needs to be done to determine 
the significance in clinical practice of these findings, particularly with gland and crypt 
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geometry and size remaining important aspects in the interpretation of pCLE images[109, 
129].  
Whilst this phenomenon may mean steady contact force is required for fair image 
interpretation, the rest of chapter 5 explored whether this phenomenon of gland 
morphology alteration secondary to variable force could be exploited to gain additional 
information about the tissue under interrogation, similar to information gleaned with 
ultrasound elastography[320] or atomic force microscopy[322]. By applying a sinusoidal 
axial force of 0.07N via the pCLE probe to ex vivo colon it was shown that the glands 
cyclically expand and shrink, as well as separate. Interestingly, when the tissue was 
artificially stiffened with formalin to produce a simplistic disease model of fibrosis or 
neoplasia, the gland’s percentage cyclical change in area halved, and the interglandular 
separation was virtually eliminated across the force cycle. Perhaps this describes the birth 
of pCLE elastography, although creating a similar cyclical force in a constrained gut 
lumen with inflated bowel wall that is not securely anchored to a firm board will be a 
very different exercise. In vivo a means of providing a) distal axial movement of the 
probe and b) stability of the tissue (perhaps with a transparent mucosectomy suction cup) 
would be required with a detailed understanding of any elastographic differences between 
healthy and diseased tissue targets. This should include hyperplastic and neoplastic 
colonic polyps and other gastrointestinal tract conditions, but there may be observable 
elastographic differences in endobronchial lesions, or between different conditions of the 
lung parenchyma (although the ergonomics would be more awkward here for force 
adjustment). 
 
8.2.2  Assessing and trying to maximise the accuracy of pCLE 
Clearly accuracy is the singlemost important characteristic in an optical biopsy device. 
Currently, in oesophageal and colonic neoplasia detection, reasonable accuracy is 
obtained from experts in high volume tertiary centres when they are given adequate time 
to review the pCLE video sequences; an answer from first pass visualisation will 
someday be the convention, though most studies conclude that offline review yields more 
accurate answers at present. In time, computed analysis and diagnosis will also play a key 
role in improving accuracy[162, 176].  
Starting in colorectal endoscopy, better accuracy may lead to the redundancy of 
histopathology, enabling hyperplastic polyps to be left in situ, and neoplastic lesions to be 
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dealt with appropriately at the time of endoscopy: so called “diagnose and leave” and 
“resect and discard” strategies. It has been estimated that this paradigm alone will save $1 
billion of histopathology costs per year in the USA[378]. Sequential endoscopic therapy 
during the diagnostic endoscopy procedure will become more de rigueur, avoiding the 
drawbacks of delays and problems of target relocation that are seen in, for example, 
endoscopically inapparent Barrett’s related neoplasia[172]. However, pCLE’s accuracy 
will need to be much improved to facilitate these shifts in management. For example, 
Bajbouj et al.’s multicentre study on Barrett’s oesophagus surveillance, described in 
chapter 2, showed that despite encouraging data on pCLE’s ability to exclude neoplasia, 
its sensitivity and PPV for predicting neoplasia were only 12% and 18% (for image 
interpretation at the time of the procedure); not only would cancer be missed if tissue 
biopsy was avoided, if all patients with pCLE features of neoplasia had been treated at the 
time of endoscopy, 82% would have been overtreated[160]. Similarly, the sensitivity and 
specificity were as low as 66% for colorectal neoplasia detection in Table 2.2. 
Establishing the grade of any dysplastic change is also imperative for the management of 
most neoplastic conditions including Barrett’s, but this is not straightforward with 
pCLE[177]. Clearly the technology alone cannot currently provide the clinician with 
sufficient diagnostic confidence to avoid tissue biopsy or justify a potentially morbid 
treatment. 
A major aim of this thesis was to explore and improve the accuracy for pCLE diagnostics 
in novel or less well investigated niches. Chapter 3 showed feasibility and tolerability for 
pCLE imaging of two new areas: 1) healthy and diseased endobronchium, and 2) 
colorectum over five occasions during chemoradiotherapy for advanced rectal cancer. 
The chapter provided a library of images for both studies and demonstrated differences 
between 1) the endobronchial basement membrane in health, when affected by nodularity, 
and when affected by carcinoma/carcinoma-in-situ; and 2) rectal mucosa in both health 
and when affected by invasive cancer. However, pCLE specificity was inadequate to 
differentiate between two diseases of endobronchial nodularity (TBOP and TBA), and 
any differences between endobronchial dysplasia, carcinoma-in-situ and small cell lung 
cancer were imperceptible. There was only one patient for the rectal cancer study and 
further investigation would be required to confirm the suspicions of greater fluorescein 
leakage after two weeks of chemoradiotherapy in the tumour, and more dilated 
microvessels within the radiation zone after treatment. 
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Chapter 4 sought to evaluate the accuracy of pCLE imaging for diagnostic bronchoscopy 
of the diseased peripheral lung. The most noticeable and consistent finding was that 
parenchymal diseases (other than emphysema) create non-specific diminishment of the 
distinct elastin alveolar structure of the pulmonary lobule creating unrecognisable 
structure. This was evident in 75%, 26% and 17% of non-emphysematous peripheral 
diseases, healthy/normal and COPD sequences respectively. Further work is essential to 
establish exactly what the cause of this loss is, but whilst exciting, the finding was neither 
sensitive nor specific enough to even accurately and reliably indicate non-
emphysematous disease. Partly because of the distinction between microvessels and 
alveolar septal walls being trickier in diseased lung, intravenous fluorescein was trialled 
in an effort to improve diagnostic accuracy; however “white-out” of the image occurred 
before the fluorescein could preferentially delineate structure, as it tends to in more 
typical epithelial surfaces. The other significant finding in the study was that severe 
emphysema seemed apparent from greater sparsity in the septal wall structure, with 
residual elastin being thickened or disrupted, and in two patients with large bullae it is 
highly likely that the fine reticular pattern being imaged with the pCLE probe represented 
the visceral pleura. However, the consistency of these findings of scanty elastin fibres 
was not adequate to allow some assessors (who had been briefly trained on alveolar 
pCLE) to accurately categorise emphysema severity according to its HRCT classification, 
despite there being “fair” intraassessor reliability. 
Having focussed mostly on force, tracking and ergonomics in chapters 5 and 6, the final 
experimental chapter aimed to explore a completely new niche for pCLE, where in vivo 
vessel assessment (one of the device’s fortes as indicated in preceding chapters) would be 
a key component. Thus a clinical study was conducted, endoscoping the lower bowel of 
26 patients to characterise and assess the severity of chronic radiation proctopathy (a 
predominantly vascular pathology) with pCLE, white light imaging and conventional 
histology. 76 pCLE sequences were acquired and there was a plethora of encouraging 
associations with pCLE observations. Higher macroscopic grades of proctopathy were 
associated with glandular/epithelial disruption on pCLE, pCLE vessel absence, and a 
trend, where vessels were actually observable under pCLE imaging, towards wider 
maximum diameter vessels. Histology until now has provided the most in depth 
evaluation of proctopathic tissue and several pCLE findings correlated well with many 
histological features of disease in this study. Conversely only one histological feature of 
disease correlated with the macroscopic appearance suggesting that the accuracy of pCLE 
for identifying histological signs of chronic radiation proctopathy is potentially greater 
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than white light imaging. Interestingly, 16 histopathological features were collated to 
form a mean histological score; this correlated with both pCLE glandular disruption and 
dilabsence. Further clinical study is needed to establish if pCLE could be used for 
accurate longitudinal assessment of chronic radiation proctopathy therapies but the initial 
results are encouraging. 
Acccuracy will be improved when there is better consensus and understanding of what 
the images represent. The speculative conclusions drawn regarding biliary tree image 
microstructure illustrate this well; the mucus globules and 3µm specks in parenchymal 
lung diseases seen in chapter 4 are other examples.  
pCLE should not be seen as an expensive realtime version of histopathology; it has 
unique qualities and strengths over histology and other optical biopsy tools. It can be 
pushed into very narrow lumens such as the biliary tree, ureter and (in chapter 4) the 
peripheral lung. It provides in vivo information on permeability, blood flow, cell 
shedding and (shown for the first time in chapter 5) tissue elasticity. Fluorescent 
molecular imaging will play a key role in the pCLE of tomorrow. pCLE 
immunohistochemistry already has promising data for the identification of a) specific 
antigens[126], VEGF[232] and EGFR expression[125] in colorectal neoplasia; b) EGF-R, 
survivin and other antigens that are expressed in oesophageal cancer[166-168]; and c) 
pulmonary aspergillosis[213]. Other mechanisms of teasing out information from the 
tissue being examined include 1) combining fluorescence lifetime imaging with confocal 
endomicroscopy[299], and 2) especially in the lung where contrast agents are not 
traditionally used, to assess confocal autofluorescence from endogenous sources other 
than elastin (such as collagen[298]) using different wavelengths. In future, contrast agents 
that can safely outline the cell nucleus will undoubtedly be created or the safety of current 
ones such as cresyl violet and acriflavin will be confirmed. In many countries there are 
still (arguably unjustifiable) reservations with regards to the safe use of intravenous 
fluorescein, leading to clinical pCLE studies remaining in the domain of clinical trials. 
With fluorescein’s excellent safety in ophthalmology, this will gradually change. 
 
8.2.3  Tracking the probe 
Even if pCLE becomes supremely accurate, it is essential that its operator can pinpoint 
where the optical biopsies have come from. This is difficult to reliably ascertain in 
“blind” areas such as the peripheral lung. Furthermore, pCLE leaves no trace on mucosal 
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surfaces, hence, a) it is difficult to confirm that pinch biopsies have come from exactly 
the same area as the optical biopsy, b) it may not be obvious where an earlier optical 
biopsy came from (for the purposes of an intervention either later in a procedure or at 
another procedure – this issue was evident in the pCLE of rectal cancer over several 
weeks in chapter 3), and c) a record of the macroscopic boundaries of pCLE identified 
disease for the purposes of later endoscopic intervention is not available. Future platforms 
may include a means of recording the exact area from where optical biopsies have been 
taken. Simlilar to the work of Mountney et al.[248], this could be a bright semi-
translucent icon (circle, or even the path the probe translated across) overlaid on the 
dynamic white light endoscope video sequences or upon a 3D or holographic 
representation of the organ undergoing assessment.  
Chapter 4 underlined the requirement for better understanding of the probe whereabouts, 
during pCLE video capture. It highlighted the scenarios of a) imperceptible 
autofluorescence on probe deployment towards emphysematous peripheral lung either 
representing a large bullous or the probe not having reached a lobule, and b) a patient 
who had two very different pCLE appearances stemming from sequential cannulations of 
the same segmental bronchus (Figure 6.1). This led to the question of whether or not the 
final location of an alveoflex pCLE probe is ever pre-determinable if it is blindly inserted 
to a specific length into the most distally accessible generation of bronchiole. Therefore 
the second part of chapter 6 used an ex vivo porcine lung to demonstrate that 
approximately half of these probe deployment starting points can physically only lead to 
one possible terminal destination, and that half would yield obvious multiple terminal 
destinations of the probe (between 2 and 4 destinations) depending on the exact 
mechanics of deployment (angle, respiratory cycle etc.). However, with the greatest 
maximum separation between multiple terminal destinations arising from a single starting 
point being 75mm (average maximum 34mm) half the time in clinical practice there is 
likely to be major guesswork as to the probe’s position. Clearly the work ideally needs to 
be repeated in ex vivo human lungs, with factors such as the degree of lung inflation 
being carefully controlled to mimic more closely the conditions of a bronchoscopy. 
Nevertheless, it suggests that, assuming it is not possible to identify the starting points 
that have only one route to the periphery,  reliable tracking may require fluoroscopy or 
the other imaging modalities thus far used for TBB which were described in chapter 6 
[353-357]. 
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8.2.4  Ergonomics of probe manipulation 
By manipulating the shaft and the twin control wheels, the flexible video endoscope has 
several degrees of freedom at the operator’s disposal, and it has traditionally provided 
adequate stability for intraluminal white light imaging and pinch biopsy. However it is 
now used for procedures that it was not originally destined for. The endoscope requires 
considerable stability for the more highly magnified imaging it now incorporates, and 
requires fine dexterity for endolumenal interventions such as submucosal resections, and 
extralumenal interventions; for example in NOTES surgery. There is a drive to improve 
the ergonomics with, for example, master and slave devices[379] or nanobots. Similarly, 
pCLE has thusfar been almost exclusively delivered via the operating channel of 
endoscopes; these are not designed to enable perpendicular optical biopsy probe 
apposition with constant pressure at a specific point in the presence of tissue flaccidity, 
peristalsis and respiratory movement, let alone facilitate slow controlled translation in an 
ordered fashion to create mosaics. pCLE particularly struggles with pedunculated lesions, 
and any resultant movement artefact has been logically shown to diminish interpretability 
and accuracy[108]. pCLE also slows down the workflow as an attempt is made to obtain 
good quality reproducible images. In this thesis, manipulation of the probe was found 
particularly challenging in chapter 3, during imaging of the narrowest of bronchi and 
during retroflexion within the lower rectum.  
Furthermore, fragile tissues require careful handling, and any clumsiness at the probe 
tissue interface will damage epithelium and affect the image output[175].  Therefore to 
improve the delivery of confocal endomicroscopy in terms of manoeuvrability, stability 
and targeting, its safety, and the predictability of contact pressure, multiple alternative 
devices to the flexible eCLE and pCLE have been devised. These include a prototype 
confocal microlaparoscope employed to image the ovary and uterine cervix[175, 177], a 
smaller device for percutaenous imaging of the liver[226], and  a rigid distal scanning 
CLE device for use in the lung[201]. 
The in vivo experiment in chapter 6 was an attempt to improve the ergonomics of pCLE 
delivery by integrating the probe into a flexible endoscopic robot. Having predicted that 
the robot should be capable transvaginally of acquiring pCLE optical biopsies of 88% of 
a human pneumperitoneum workspace (the rest of the pelvis may have been reachable if 
the algorithm was adjusted for greater than 10mm of probe deployment), the actual 
Conclusion 
166 
 
flexible endoscopic robot was inserted into a pig and with a handheld controller navigated 
around the pig’s abdominopelvic cavity. The probe was deployed and, using intravenous 
fluorescein, interpretable pCLE optical biopsies were acquired from the liver, spleen and 
peritoneal lining. Translational yaw movements of the distal degree of movement enabled 
mosaics up to 2mm to be acquired. For clinical practice, the robot would need to move 
more quickly and be more robust (especially for the gastrointestinal lumen). Nevertheless, 
the concept of highly precise thumbstick control pCLE navigation is an exciting one, 
especially if a distal force-torque sensor could facilitate constant contact and pressure 
with the tissue (such as has been done with a handheld device in our laboratory[243]. It 
may even enable a dynamic force to extract elastographic properties (as has been 
discussed). 
As regards mosaicing, a fivefold increase in the FOV has been previously demonstrable 
on the urothelium; a relatively unbound epithelial surface [59]. In this thesis, with current 
standard endoscopic techniques, mosaics up to 2.5mm in length were seen in healthy 
colorectal mucosa, essentially a tenfold increase in the 240µm diameter FOV of the UHD 
Coloflex Probe (Figure 3.5). By incorporating the 600µm diameter probe within the 
flexible endoscopic robot in chapter 6, 2mm long mosaics of peritoneal structures were 
possible (Figure 6.5). The longest mosaics from the pulmonary lobule in chapter 4 were 
only 1mm (from a 600µm FOV probe) owing to more restricted movement, and 
endobronchial mosaics were even more limited probably owing to more difficult 
translational movements and less feature distinctiveness within the images. In the future, 
improved ergonomics of pCLE delivery will enable more effective mosaicing as the 
probe is able to translate in an automated predetermined path to rapidly construct larger, 
more representative depictions of the tissue. Perhaps a means of displaying the dynamic 
information such as vascular flow will eventually be possible on a large mosaic. The 
device used to generate these mosaics may resemble the robot employed in chapter 6, or 
may use octopus inspired suction cups such as the “heartlander” cardiac robot[380].  
 
8.3  Closing Comments 
Currently pCLE increases both the cost of and time taken to perform procedures. As the 
technology develops, there will be more choice in hardware, bringing down its significant 
cost (currently >€100K initial capital outlay with probes costing in the region of €6K and 
programmed to only last for 20 patients). These time and financial implications will be 
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offset when optical biopsy either abrogates the need for pinch biopsy, or enables more 
selective biopsies to be taken (smart biopsies). Fresh niches will also appear; in the last 
few months alone there have first publications on potential roles for pCLE in the 
diagnosis of gastric ischaemia in critical care[381], microcirculatory changes in 
sepsis[382], colonic clostridium difficile infection[383], irritable bowel syndrome[384], 
and neurosurgical treatment of brain tumours[385]. It is exciting to imagine the 
endoscopy suite of 2030. Perhaps, drawing parallels with PET-CT where the co-
registration of two imaging modalities provides complementary information, a fully 
integrated multimodality robotic imaging device will use a wide field technique such as 
NBI to alert the endoscopist to a suspicious mucosal lesion, force controlled pCLE will 
then be deployed from the device to interrogate the epithelium and basement membrane 
using a combination of fluorescent molecular markers and elastography, and OCT will 
assess the depth of invasion of any neoplastic lesion. 
The pCLE machine not only plunges man more deeply into the problems of nature but 
also into the solutions to nature’s problems. 
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